Close

Form 10-Q ASSURANT INC For: Jun 30

August 2, 2016 4:13 PM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended June 30, 2016
OR 
¨
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from                      to                     
Assurant, Inc.
(Exact name of registrant as specified in its charter)
Delaware
 
001-31978
 
39-1126612
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
28 Liberty Street, 41st Floor
New York, New York 10005
(212) 859-7000
(Address, including zip code, and telephone number, including area code, of Registrant’s Principal Executive Offices)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  x    NO  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    YES  x    NO  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
x
  
Accelerated filer
 
¨
 
 
 
 
Non-accelerated filer
 
¨ (Do not check if a smaller reporting company)
  
Smaller reporting company
 
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    YES  ¨    NO  x
The number of shares of the registrant’s Common Stock outstanding at July 29, 2016 was 60,204,445.
 
 
 
 
 




ASSURANT, INC.
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2016
TABLE OF CONTENTS
 
Item
Number
 
Page
Number
 
 
 
 
 
1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.
 
 
 
3.
 
 
 
4.
 
 
 
 
 
 
 
 
1.
 
 
 
1A.
 
 
 
2.
 
 
 
6.
 
 
 
 
Amounts are presented in United States of America (“U.S.”) dollars and all amounts are in thousands, except number of shares and per share amounts.

1



Assurant, Inc.
Consolidated Balance Sheets (unaudited)
At June 30, 2016 and December 31, 2015
 
 
 



 
June 30, 2016
 
December 31, 2015
 
(in thousands except number of shares and per
share amounts)
Assets
 
 
 
Investments:
 
 
 
Fixed maturity securities available for sale, at fair value (amortized cost - $8,709,444 in 2016 and
$9,470,795 in 2015)
$
9,744,199

 
$
10,215,328

Equity securities available for sale, at fair value (cost - $382,168 in 2016 and $450,563 in 2015)
434,506

 
500,057

Commercial mortgage loans on real estate, at amortized cost
620,185

 
1,151,256

Policy loans
40,349

 
43,858

Short-term investments
498,281

 
508,950

Other investments
623,977

 
575,323

Total investments
11,961,497

 
12,994,772

Cash and cash equivalents
1,232,674

 
1,288,305

Premiums and accounts receivable, net
1,218,299

 
1,260,717

Reinsurance recoverables
8,727,343

 
7,470,403

Accrued investment income
111,985

 
129,743

Deferred acquisition costs
3,001,603

 
3,150,934

Property and equipment, at cost less accumulated depreciation
327,861

 
298,414

Tax receivable

 
24,176

Goodwill
834,173

 
833,512

Value of business acquired
36,628

 
41,154

Other intangible assets, net
250,419

 
277,163

Other assets
387,288

 
469,005

Assets held in separate accounts
1,714,443

 
1,798,104

Total assets
$
29,804,213

 
$
30,036,402

Liabilities
 
 
 
Future policy benefits and expenses
$
9,748,406

 
$
9,466,694

Unearned premiums
6,298,466

 
6,423,720

Claims and benefits payable
3,276,722

 
3,896,719

Commissions payable
357,912

 
393,260

Reinsurance balances payable
132,878

 
132,728

Funds held under reinsurance
105,475

 
94,417

Deferred gain on disposal of businesses
439,268

 
92,327

Accounts payable and other liabilities
1,876,015

 
2,049,810

Tax payable
81,302

 

Debt
1,165,255

 
1,164,656

Liabilities related to separate accounts
1,714,443

 
1,798,104

Total liabilities
25,196,142

 
25,512,435

Commitments and contingencies (Note 16)

 

Stockholders’ equity
 
 
 
Common stock, par value $0.01 per share, 800,000,000 shares authorized, 60,612,310 and 65,850,386
shares outstanding at June 30, 2016 and December 31, 2015, respectively
1,502

 
1,497

Additional paid-in capital
3,150,911

 
3,148,409

Retained earnings
5,181,375

 
4,856,674

Accumulated other comprehensive income
327,254

 
118,549

Treasury stock, at cost; 89,263,289 and 83,523,031 shares at June 30, 2016 and December 31,
2015, respectively
(4,052,971
)
 
(3,601,162
)
Total stockholders’ equity
4,608,071

 
4,523,967

Total liabilities and stockholders’ equity
$
29,804,213

 
$
30,036,402


See the accompanying notes to the consolidated financial statements

2



Assurant, Inc.
Consolidated Statements of Operations (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
 
 
 

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(in thousands except number of shares and per share amounts)
Revenues
 
 
 
 
 
 
 
Net earned premiums
$
1,202,224

 
$
2,138,258

 
$
2,617,462

 
$
4,297,820

Fees and other income
328,305

 
323,609

 
685,995

 
603,171

Net investment income
119,820

 
167,786

 
255,527

 
320,059

Net realized gains on investments, excluding other-than-temporary impairment losses
21,679

 
11,999

 
184,045

 
18,524

Total other-than-temporary impairment losses
(53
)
 

 
(364
)
 
(3,208
)
Portion of net (gain) loss recognized in other comprehensive income, before taxes

 

 
(337
)
 
638

Net other-than-temporary impairment losses recognized in earnings
(53
)
 

 
(701
)
 
(2,570
)
Amortization of deferred gain on disposal of businesses
125,818

 
3,242

 
173,414

 
6,500

Gain on pension plan curtailment

 

 
29,578

 

Total revenues
1,797,793

 
2,644,894

 
3,945,320

 
5,243,504

Benefits, losses and expenses
 
 
 
 
 
 
 
Policyholder benefits
400,814

 
1,267,714

 
944,630

 
2,478,441

Amortization of deferred acquisition costs and value of business acquired
342,640

 
353,883

 
676,982

 
722,886

Underwriting, general and administrative expenses
803,595

 
969,494

 
1,720,954

 
1,891,403

Interest expense
15,232

 
13,778

 
29,735

 
27,556

Total benefits, losses and expenses
1,562,281

 
2,604,869

 
3,372,301

 
5,120,286

Income before provision for income taxes
235,512

 
40,025

 
573,019

 
123,218

Provision for income taxes
66,163

 
7,236

 
183,352

 
40,385

Net income
$
169,349

 
$
32,789

 
$
389,667

 
$
82,833

Earnings Per Share
 
 
 
 
 
 
 
Basic
$
2.72

 
$
0.48

 
$
6.12

 
$
1.20

Diluted
$
2.70

 
$
0.47

 
$
6.06

 
$
1.18

Dividends per share
$
0.50

 
$
0.30

 
$
1.00

 
$
0.57

Share Data
 
 
 
 
 
 
 
Weighted average shares outstanding used in basic per share calculations
62,244,778

 
68,558,472

 
63,665,856

 
69,161,001

Plus: Dilutive securities
478,514

 
685,927

 
608,153

 
785,363

Weighted average shares used in diluted per share calculations
62,723,292

 
69,244,399

 
64,274,009

 
69,946,364

See the accompanying notes to the consolidated financial statements

3



Assurant, Inc.
Consolidated Statements of Comprehensive Income (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
 
 
 

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(in thousands)
Net income
$
169,349

 
$
32,789

 
$
389,667

 
$
82,833

Other comprehensive income (loss):
 
 
 
 
 
 
 
Change in unrealized gains on securities, net of taxes of $(62,503), $116,577, $(77,339) and $88,228, respectively
115,940

 
(223,064
)
 
145,812

 
(165,605
)
Change in other-than-temporary impairment gains, net of taxes of $(104), $152, $571 and $632, respectively
192

 
(281
)
 
(1,059
)
 
(1,175
)
Change in foreign currency translation, net of taxes of $(46), $(712), $(1,655) and $1,943, respectively
(14,524
)
 
20,151

 
(2,664
)
 
(45,800
)
Pension plan curtailment and amortization of pension and postretirement unrecognized net periodic benefit cost, net of taxes of $(219), $(1,409), $(35,870) and $(2,818), respectively
406

 
2,616

 
66,616

 
5,232

Total other comprehensive income (loss)
102,014

 
(200,578
)
 
208,705

 
(207,348
)
Total comprehensive income (loss)
$
271,363

 
$
(167,789
)
 
$
598,372

 
$
(124,515
)
See the accompanying notes to the consolidated financial statements

4



Assurant, Inc.
Consolidated Statement of Stockholders’ Equity (unaudited)
From December 31, 2015 through June 30, 2016
 
 
 

 
Common
Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income
 
Treasury
Stock
 
Total
 
(in thousands)
Balance at December 31, 2015
$
1,497

 
$
3,148,409

 
$
4,856,674

 
$
118,549

 
$
(3,601,162
)
 
$
4,523,967

Stock plan exercises
5

 
(19,067
)
 

 

 

 
(19,062
)
Stock plan compensation

 
13,650

 

 

 

 
13,650

Change in tax benefit from
  share-based payment
  arrangements

 
7,919

 

 

 

 
7,919

Dividends

 


 
(64,966
)
 

 

 
(64,966
)
Acquisition of common
  stock

 

 

 

 
(451,809
)
 
(451,809
)
Net income

 

 
389,667

 

 

 
389,667

Other comprehensive
 income

 

 

 
208,705

 

 
208,705

Balance, June 30, 2016
$
1,502

 
$
3,150,911

 
$
5,181,375

 
$
327,254

 
$
(4,052,971
)
 
$
4,608,071

 
See the accompanying notes to the consolidated financial statements

5



Assurant, Inc.
Consolidated Statements of Cash Flows (unaudited)
Six Months Ended June 30, 2016 and 2015
 
 
 

 
Six Months Ended June 30,
 
2016
 
2015
 
(in thousands)
Net cash used in operating activities
$
(301,705
)
 
$
168,896

Investing activities
 
 
 
Sales of:
 
 
 
Fixed maturity securities available for sale
1,270,337

 
1,219,007

Equity securities available for sale
152,472

 
96,541

Other invested assets
15,798

 
40,831

Property and equipment and other
223

 
3,407

Subsidiary, net of cash transferred (2)
857,799

 
65,002

Commercial mortgage loans on real estate (4)
268,833

 

Maturities, calls, prepayments, and scheduled redemption of:
 
 
 
Fixed maturity securities available for sale
420,050

 
394,341

Commercial mortgage loans on real estate
44,716

 
123,739

Purchases of:
 
 
 
Fixed maturity securities available for sale
(2,018,397
)
 
(1,459,405
)
Equity securities available for sale
(134,493
)
 
(122,710
)
Commercial mortgage loans on real estate
(33,900
)
 
(123,624
)
Other invested assets
(38,818
)
 
(9,344
)
Property and equipment and other
(47,721
)
 
(62,251
)
Subsidiary, net of cash transferred (3)
(19,735
)
 
(11,571
)
Equity interest (1)

 
(457
)
Change in short-term investments
6,536

 
(101,146
)
Change in policy loans
1,935

 
2,693

Change in collateral held/pledged under securities agreements

 
697

Net cash provided by investing activities
745,635

 
55,750

Financing activities
 
 
 
Issuance of debt
249,625

 

Repayment of debt
(250,000
)
 

Change in tax benefit from share-based payment arrangements
7,919

 
(1,488
)
Acquisition of common stock
(445,601
)
 
(187,752
)
Dividends paid
(64,966
)
 
(40,450
)
Change in obligation under securities agreements

 
(697
)
Net cash used in financing activities
(503,023
)
 
(230,387
)
Effect of exchange rate changes on cash and cash equivalents
(2,396
)
 
(15,479
)
Reversal of Cash included in business classified as held for sale
5,858

 

Change in cash and cash equivalents
(55,631
)
 
(21,220
)
Cash and cash equivalents at beginning of period
1,288,305

 
1,318,656

Cash and cash equivalents at end of period
$
1,232,674

 
$
1,297,436

 
(1)
Relates to the purchase of equity interest in Iké Asistencia.
(2)
Relates to the sale of Assurant's Employee Benefits segment mainly through reinsurance transactions and supplemental and small group self-funded business.
(3)
Relates primarily to the acquisition of Shipsurance, Mobile Defense and an immaterial acquisition and the purchase of renewal rights to the National Flood Insurance block of business of Nationwide Mutual Insurance Company.
(4)
For further information see the Investment footnote (Note 7).
See the accompanying notes to the consolidated financial statements

6


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 





1. Nature of Operations
Assurant, Inc. (the “Company”) is a holding company whose subsidiaries globally provide risk management solutions, protecting where consumers live and the goods they buy.
The Company is traded on the New York Stock Exchange under the symbol "AIZ."
Through its operating subsidiaries, the Company provides mobile device protection and related services; vehicle protection; pre-funded funeral insurance; credit insurance; renters insurance; lender-placed homeowners insurance; mortgage valuation and field services and manufactured housing insurance.
As previously announced, the Company will substantially exit the health insurance market by the end of 2016 and sold its Assurant Employee Benefits segment on March 1, 2016 mainly through a series of reinsurance transactions with Sun Life Assurance Company of Canada, a subsidiary of Sun Life Financial Inc. (“Sun Life”). See Notes 4 and 5, respectively, for more information.
2. Basis of Presentation
The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. Accordingly, these statements do not include all of the information and notes required by GAAP for complete financial statements.
The interim financial data as of June 30, 2016 and for the three and six months ended June 30, 2016 and 2015 is unaudited; in the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The unaudited interim consolidated financial statements include the accounts of the Company and all of its wholly owned subsidiaries. All inter-company transactions and balances are eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the 2016 presentation.
The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, and the rules and regulations thereunder (together, the “Affordable Care Act”) introduced new and significant premium stabilization programs in 2014. These programs require the Company to record amounts to our consolidated financial statements based on assumptions and estimates that could materially change as experience develops until the Company exits the Health business and settles related receivables later in 2016.
Operating results for the three and six months ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. The accompanying unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.
3. Recent Accounting Pronouncements
Adopted
On January 1, 2016 the Company adopted the amended guidance on presentation of debt issuance costs. This amended guidance requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of the debt liabilities, consistent with debt discounts or premiums, as compared to previous guidance that required capitalization as a deferred asset. The recognition and measurement guidance for debt issuance costs is not affected by the amendments. The adoption of this new presentation guidance did not impact the Company’s financial position or results of operations.
On January 1, 2016, the Company adopted the new consolidation guidance that affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. All legal entities are subject to reevaluation under the revised consolidation model. The adoption of this new consolidation guidance did not have an impact on the Company’s financial position and results of operations.

7


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




Not Yet Adopted
In June 2016, the Financial Accounting Standards Board (“FASB”) issued amended guidance on reporting credit losses for assets held at amortized cost basis and available for sale debt securities. For assets held at amortized cost basis, the amended guidance eliminates the probable initial recognition threshold, and, instead requires an entity to reflect the current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available for sale debt securities, credit losses are measured in a manner similar to current GAAP, however the amended guidance requires that credit losses be presented as an allowance rather than as a write-down. The amendments affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amended guidance is effective in fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Therefore, the Company is required to adopt the guidance on January 1, 2020. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is evaluating the requirements of this amended credit losses guidance and the potential impact on the Company’s financial position and results of operations.
In March 2016, the FASB issued amended guidance on employee share-based stock compensation. This amended guidance provides areas of simplification in several aspects of accounting for employee share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The amended guidance is effective in fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Therefore, the Company is required to adopt the guidance on January 1, 2017. Early adoption is permitted in any interim or annual period. The Company is evaluating the requirements of this amended share-based stock compensation guidance and the potential impact on the Company’s financial position and results of operations.
In February 2016, the FASB issued new guidance on leases. The new guidance will replace the current lease guidance. The new guidance requires that entities recognize the assets and liabilities associated with leases on the balance sheet and to disclose key information about leasing arrangements. The new guidance is effective in fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Therefore, the Company is required to adopt the guidance on January 1, 2019. Early adoption is permitted. The Company is evaluating the requirements of this new lease guidance and the potential impact on the Company’s financial position and results of operations.
In January 2016, the FASB issued amended guidance on the measurement and classification of financial instruments. This amended guidance requires that all equity investments be measured at fair value with changes in fair value recognized through net income (other than those accounted for under equity method of accounting or those that result in consolidation of the investee). The amendments also require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the fair value option has been elected for financial liabilities. The amendments eliminate the requirement to disclose the methods and significant assumptions used to estimate the fair value for financial instruments measured at amortized cost, however public business entities will be required to use the exit price when measuring the fair value of financial instruments measured at amortized cost for disclosure purposes. In addition, the new guidance requires financial assets and financial liabilities to be presented separately in the notes to the financial statements, grouped by measurement category and form of financial asset. The amended guidance is effective in fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Therefore, the Company is required to adopt the guidance on January 1, 2018. For the provision related to presentation of financial liabilities, early adoption is permitted for financial statements that have not been previously issued. The Company is evaluating the requirements of this amended measurement and classification of financial instruments guidance and the potential impact on the Company’s financial position and results of operations.
In May 2014, the FASB issued amended guidance on revenue recognition. In March, April and May 2016, the FASB issued implementation amendments to the May 2014 amended revenue recognition guidance. The amended guidance, including the implementation amendments (together, the “amended guidance”), affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. Insurance contracts are within the scope of other standards and therefore are specifically excluded from the scope of the amended revenue recognition guidance. The core principle of the amended guidance is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve the core principle, the entity applies a five step process outlined in the amended guidance. The amended guidance also includes a cohesive set of

8


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




disclosure requirements. In August 2015, the FASB issued guidance to defer the effective date of the revenue recognition guidance. The amended guidance is effective for interim and annual periods beginning after December 15, 2017 and earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. Therefore, the Company is required to adopt the guidance on January 1, 2018. An entity can choose to apply the amended guidance using either the full retrospective approach or a modified retrospective approach. The Company is evaluating the requirements of the revenue recognition guidance as it relates to its non-insurance contract revenue and the potential impact on the Company’s financial position and results of operations.
4. Reorganization
On June 7, 2015, the Company concluded its comprehensive review of strategic alternatives for the Assurant Health business segment and decided to sharpen its focus on housing and lifestyle specialty protection products and services. The Company expects to substantially complete its exit from the health insurance market by the end of 2016. As part of this process, Assurant reinsured its supplemental and small-group self-funded lines of business and sold certain legal entities to National General Holdings Corp. ("National General"), effective October 1, 2015.
The following table presents information regarding exit-related charges, commencing with those taken in the second quarter of 2015:
 
Severance and retention
 
Long-lived asset impairments and contract and lease terminations
 
Other transaction costs
 
Total
Balance at January 1, 2015
$

 
$

 
$

 
$

Charges

 

 

 

Cash payments

 

 

 

Balance at March 31, 2015
$

 
$

 
$

 
$

Charges
14,435

 
22,307

 
4,996

 
41,738

Non-cash adjustment

 
(21,247
)
 
(2,947
)
 
(24,194
)
Cash payments

 

 

 

Balance at June 30, 2015
$
14,435

 
$
1,060

 
$
2,049

 
$
17,544

Charges
20,927

 
13

 
5,795

 
26,735

Cash payments
(10,728
)
 
(168
)
 
(4,338
)
 
(15,234
)
Balance at September 30, 2015
$
24,634

 
$
905

 
$
3,506

 
$
29,045

Charges
16,344

 
17

 
795

 
17,156

Cash payments
(4,413
)
 
(152
)
 
(3,808
)
 
(8,373
)
Balance at December 31, 2015
$
36,565

 
$
770

 
$
493

 
$
37,828

Charges
14,561

 
4,903

 
(47
)
 
19,417

Cash payments
(16,181
)
 
(136
)
 
(436
)
 
(16,753
)
Balance at March 31, 2016
$
34,945

 
$
5,537

 
$
10

 
$
40,492

Charges
6,383

 
(32
)
 
7

 
6,358

Cash payments
(15,489
)
 
(214
)
 
(17
)
 
(15,720
)
Balance at June 30, 2016
$
25,839

 
$
5,291

 
$

 
$
31,130

 
 
 
 
 
 
 
 
Amount expected to be incurred, including charges to date
$
82,752

 
$
27,208

 
$
11,546

 
$
121,506

 
 
 
 
 
 
 
 
Premium deficiency charges
 
 
 
 
 
 
$
182,627

Total amount expected to be incurred, including charges to
  date
 
 
 
 
 
 
$
304,133


9


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




Amounts in the above table are primarily included in underwriting, general and administrative expenses on the Consolidated Statements of Operations.
The total amount expected to be incurred is an estimate that is subject to change as facts and circumstances evolve. For instance, severance and retention estimates could change if employees previously identified for separation resign from the Company before the date through which they are required to be employed in order to receive severance and retention benefits.
The premium deficiency reserve liability decreased from $91,574 at March 31, 2016 to $79,422 at June 30, 2016. The decrease is consistent with the estimate of second quarter utilization expected at March 31, 2016.
Future cash payments, for these exit-related charges, are expected to be substantially complete by December 31, 2016.
5. Dispositions
On March 1, 2016, the Company completed the sale of its Assurant Employee Benefits segment through a series of transactions with Sun Life, for net cash consideration of $926,174 and contingent consideration of $16,000 related to specified account renewals. The transaction was primarily structured as a reinsurance arrangement, as well as the sale of certain legal entities that included ceding commission and other consideration. The reinsurance transaction does not extinguish the Company's primary liability on the policies issued or assumed by subsidiaries that are parties to the reinsurance agreements, thus any gains associated with the prospective component of the reinsurance transaction are deferred and amortized over the contract period, including contractual renewal periods, in proportion to the amount of insurance coverage provided. The Company also has an obligation to continue to write and renew certain policies for a period of time until Sun Life commences policy writing and renewal.
The Company was required to allocate the proceeds considering the relative fair value of the transaction components, including the sale of certain legal entities, the reinsurance for existing claims (accounted for as retroactive reinsurance) and reinsurance for inforce policies with remaining terms and future business (primarily accounted for as prospective reinsurance). As of the close date, the Company originally estimated a gain of $638,517 (which was subsequently increased to $640,497 in the second quarter 2016 based on closing adjustments) based on proceeds compared to the relative net assets transferred and other expenses incurred along with realized gains on invested assets transferred. Of this amount, $120,077 was recognized at the close of the transaction and $518,440 was required to be deferred. The total deferred gain amount will primarily be recognized as revenue over the contract period in proportion to the amount of insurance coverage provided, including estimated contractual renewals pursuant to rate guarantees. The Company recognized $122,835 and $167,428 of amortization of the deferred gain for the three and six months ended June 30, 2016, respectively. The total pre-tax gain recognized during the six months ended June 30, 2016 was $287,505.
Over half of the remaining $352,992 deferred gain related to this transaction as of June 30, 2016 is expected to be earned over the remainder of 2016 and over 90% is expected to be earned by the end of 2018. The ultimate amortization pattern will be dependent on a number of factors including the exact timing of when Sun Life commences directly writing and renewing policies and the sales and persistency on business the Company is obligated to write and renew in the interim.

10


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The following represents a summary of the pre-tax gain recognized in 2016 by transaction component, as well as the related classification within the financial statements:
Total expected gain, after adjustment
$
640,497

 
 
 
 
Transaction closing gains on March 1, 2016:
 
 
Gain on sale of entities, net of transaction costs
$
41,098

 
Novations, resulting in recognized gains
60,913

(b)
Loss on retroactive reinsurance component, before realized gains
(128,661
)
(c)
Net loss prior to realized gains on transferred securities supporting retroactive component
(26,650
)
(a)
Realized gains on transferred securities supporting retroactive component
146,727

(c)
Net gain realized as of March 1, 2016
$
120,077

 
 
 
 
Deferred gain as of March 1, 2016, after adjustment
$
520,420

 
Amortization of deferred gain for the three months ended March 31, 2016
44,593

(d)
Amortization of deferred gain for the three months ended June 30, 2016
122,835

(d)
Deferred gain as of June 30, 2016
$
352,992

(e)
Total net gains realized for 2016
$
287,505

 
(a)
Amount classified within underwriting, general and administrative expenses within the Consolidated Statements of Operations.
(b)
Novations of certain insurance policies directly to Sun Life allowed for immediate gain recognition.
(c)
Reinsurance of existing claims liabilities requires retroactive accounting necessitating losses to be recognized immediately. However, upon transfer of the associated assets supporting the liabilities, the Company recognized realized gains which more than offset the retroactive losses. The Company was required to classify the realized gains as part of net realized gains on investments, within the Consolidated Statements of Operations.
(d)
Amount classified as amortization of deferred gain on disposal of businesses within the Consolidated Statements of Operations.
(e)
Amount classified as a component of the deferred gain on disposal of businesses within the Consolidated Balance Sheets.
The Company will review and evaluate the estimates affecting the deferred gain each period or when significant information affecting the estimates becomes known to the Company, and will adjust the prospective revenue to be recognized accordingly.
The Assurant Employee Benefits segment pretax income was $16,747 and $32,920 for the periods ending June 30, 2016 and 2015, respectively (excluding the aforementioned gains realized in 2016 which are included in the Corporate & Other segment).
6. Acquisitions
On July 1, 2016, the Company acquired 100% of American Title, Inc., a leader in title and valuation services for home equity lenders, for approximately $45,000 in cash, with a possible earn out payment based on future performance. The initial accounting for this acquisition is incomplete due to the timing of the acquisition date, thus the estimated range of outcomes for the contingent consideration and the total amount of other intangible assets and goodwill for Assurant Specialty Property is not yet available.

On March 14, 2016, the Company acquired certain renewal rights to the National Flood Insurance Program block of business of Nationwide Mutual Insurance Company. The estimated acquisition-date fair value of the consideration transferred totaled $20,329, which consists of an initial cash payment of $1,000 and an expected contingent payment of $19,329. The contingent consideration arrangement is based on future expected revenue. In connection with this asset acquisition, the Company recorded $20,329 of renewal rights intangible assets which are amortizable over a five-year period. The contingent payment may change over time, with any resulting adjustments required to be evaluated and recorded as adjustments through the income statement when a change in estimated payment is determined.

11


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




7. Investments
The following tables show the cost or amortized cost, gross unrealized gains and losses, fair value and other-than-temporary impairment (“OTTI”) of the Company's fixed maturity and equity securities as of the dates indicated: 
 
June 30, 2016
 
Cost or
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
 
OTTI in
AOCI
(a)
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
U.S. government and government
  agencies and authorities
$
165,841

 
$
7,158

 
$
(1
)
 
$
172,998

 
$

States, municipalities and political
  subdivisions
526,189

 
48,884

 

 
575,073

 

Foreign governments
504,131

 
92,848

 
(297
)
 
596,682

 

Asset-backed
2,877

 
1,245

 
(221
)
 
3,901

 
1,197

Commercial mortgage-backed
43,858

 
780

 

 
44,638

 

Residential mortgage-backed
878,548

 
69,198

 
(67
)
 
947,679

 
14,585

U.S. corporate
4,982,779

 
630,941

 
(13,220
)
 
5,600,500

 
15,060

Foreign corporate
1,605,221

 
202,343

 
(4,836
)
 
1,802,728

 
2,041

Total fixed maturity securities
$
8,709,444

 
$
1,053,397

 
$
(18,642
)
 
$
9,744,199

 
$
32,883

Equity securities:
 
 
 
 
 
 
 
 
 
Common stocks
$
12,329

 
$
7,794

 
$
(1
)
 
$
20,122

 
$

Non-redeemable preferred stocks
369,839

 
45,611

 
(1,066
)
 
414,384

 

Total equity securities
$
382,168

 
$
53,405

 
$
(1,067
)
 
$
434,506

 
$

 
 
December 31, 2015
 
Cost or
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
 
OTTI in
AOCI
(a)
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
U.S. government and government
  agencies and authorities
$
150,681

 
$
3,891

 
$
(537
)
 
$
154,035

 
$

States, municipalities and political
  subdivisions
647,335

 
48,389

 
(94
)
 
695,630

 

Foreign governments
497,785

 
65,188

 
(723
)
 
562,250

 

Asset-backed
3,499

 
1,367

 
(204
)
 
4,662

 
1,285

Commercial mortgage-backed
22,169

 
352

 

 
22,521

 

Residential mortgage-backed
953,247

 
48,676

 
(3,409
)
 
998,514

 
15,343

U.S. corporate
5,429,783

 
513,254

 
(73,344
)
 
5,869,693

 
15,705

Foreign corporate
1,766,296

 
164,295

 
(22,568
)
 
1,908,023

 
2,180

Total fixed maturity securities
$
9,470,795

 
$
845,412

 
$
(100,879
)
 
$
10,215,328

 
$
34,513

Equity securities:
 
 
 
 
 
 
 
 
 
Common stocks
$
13,048

 
$
6,623

 
$
(7
)
 
$
19,664

 
$

Non-redeemable preferred stocks
437,515

 
45,495

 
(2,617
)
 
480,393

 

Total equity securities
$
450,563

 
$
52,118

 
$
(2,624
)
 
$
500,057

 
$

 

(a)
Represents the amount of OTTI recognized in accumulated other comprehensive income (“AOCI”). Amount includes unrealized gains and losses on impaired securities relating to changes in the value of such securities subsequent to the impairment measurement date.

12


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




 
The Company's states, municipalities and political subdivisions holdings are highly diversified across the U.S. and Puerto Rico, with no individual state’s exposure (including both general obligation and revenue securities) exceeding 0.5% of the overall investment portfolio as of June 30, 2016 and December 31, 2015. At June 30, 2016 and December 31, 2015, the securities include general obligation and revenue bonds issued by states, cities, counties, school districts and similar issuers, including $265,348 and $319,654, respectively, of advance refunded or escrowed-to-maturity bonds (collectively referred to as “pre-refunded bonds”), which are bonds for which an irrevocable trust has been established to fund the remaining payments of principal and interest. As of June 30, 2016 and December 31, 2015, revenue bonds account for 51% and 50% of the holdings, respectively. Excluding pre-refunded revenue bonds, the activities supporting the income streams of the Company’s revenue bonds are across a broad range of sectors, primarily highway, water, airport and marina, higher education, specifically pledged tax revenues, and other miscellaneous sources such as bond banks, finance authorities and appropriations.
The Company’s investments in foreign government fixed maturity securities are held mainly in countries and currencies where the Company has policyholder liabilities, which allow the assets and liabilities to be more appropriately matched. At June 30, 2016, approximately 82%, 7% and 4% of the foreign government securities were held in the Canadian government/provincials and the governments of Brazil and Germany, respectively. At December 31, 2015, approximately 79%, 8% and 5% of the foreign government securities were held in the Canadian government/provincials and the governments of Brazil and Germany, respectively. No other country represented more than 3% of the Company's foreign government securities as of June 30, 2016 and December 31, 2015.
The Company has European investment exposure in its corporate fixed maturity and equity securities of $732,886 with a net unrealized gain of $75,160 at June 30, 2016 and $888,923 with a net unrealized gain of $67,957 at December 31, 2015. Approximately 23% and 25% of the corporate European exposure is held in the financial industry at June 30, 2016 and December 31, 2015, respectively. The Company's largest European country exposure (the United Kingdom) represented approximately 4% and 5% of the fair value of the Company's corporate securities as of June 30, 2016 and December 31, 2015, respectively. Approximately 7% of the fair value of the corporate European securities are pound and euro-denominated and are not hedged to U.S. dollars, but held to support those foreign-denominated liabilities. The Company's international investments are managed as part of the overall portfolio with the same approach to risk management and focus on diversification.
The Company has exposure to the energy sector in its corporate fixed maturity securities of $638,143 with a net unrealized gain of $47,797 at June 30, 2016 and $779,720 with a net unrealized loss of $6,985 at December 31, 2015. Approximately 85% and 89% of the energy exposure is rated as investment grade as of June 30, 2016 and December 31, 2015, respectively.
The cost or amortized cost and fair value of fixed maturity securities at June 30, 2016 by contractual maturity are shown below. Expected maturities may differ from contractual maturities because issuers of the securities may have the right to call or prepay obligations with or without call or prepayment penalties.
 
Cost or
Amortized
Cost
 
Fair Value
Due in one year or less
$
424,041

 
$
429,125

Due after one year through five years
1,671,193

 
1,757,547

Due after five years through ten years
2,118,236

 
2,241,236

Due after ten years
3,570,691

 
4,320,073

Total
7,784,161

 
8,747,981

Asset-backed
2,877

 
3,901

Commercial mortgage-backed
43,858

 
44,638

Residential mortgage-backed
878,548

 
947,679

Total
$
8,709,444

 
$
9,744,199



13


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The following table summarizes the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been recognized in the statement of operations as a result of those sales:
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2016
 
2015
 
2016
 
2015
Proceeds from sales
$
606,531

 
$
804,476

 
$
2,874,248

 
$
1,356,989

Gross realized gains (a)
14,667

 
13,912

 
190,984

 
26,255

Gross realized losses (b)
5,110

 
5,844

 
31,571

 
11,443

(a)
Six months ended June 30, 2016 gross realized gains includes $150,701 related to the sale of Assurant Employee Benefits as described in Note 5.
(b)
Six months ended June 30, 2016 gross realized losses includes $16,427 related to the sale of Assurant Employee Benefits as described in Note 5.
The following table sets forth the net realized gains (losses), including OTTI, recognized in the statement of operations as follows: 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2016
 
2015
 
2016
 
2015
Net realized gains related to sales and other:
 
 
 
 
 
 
 
Fixed maturity securities
$
6,625

 
$
6,746

 
$
145,774

 
$
12,259

Equity securities
3,337

 
1,080

 
13,143

 
1,954

Commercial mortgage loans on real estate
9,092

 

 
21,545

 

Other investments
2,625

 
4,173

 
3,583

 
4,311

Total net realized gains related to sales and other (a)
21,679

 
11,999

 
184,045

 
18,524

Net realized losses related to other-than-temporary
   impairments:
 
 
 
 
 
 
 
Fixed maturity securities
(53
)
 

 
(701
)
 
(2,570
)
Total net realized losses related to other-than-temporary impairments
(53
)
 

 
(701
)
 
(2,570
)
Total net realized gains
$
21,626

 
$
11,999

 
$
183,344

 
$
15,954

(a)
Six months ended June 30, 2016 net gains includes $146,727 related to the sale of Assurant Employee Benefits as described in Note 5.
Other-Than-Temporary Impairments
The Company follows the OTTI guidance, which requires entities to separate an OTTI of a debt security into two components when there are credit related losses associated with the impaired debt security for which the Company asserts that it does not have the intent to sell, and it is more likely than not that it will not be required to sell before recovery of its cost basis. Under the OTTI guidance, the amount of the OTTI related to a credit loss is recognized in earnings, and the amount of the OTTI related to other, non-credit factors (e.g., interest rates, market conditions, etc.) is recorded as a component of other comprehensive income. In instances where no credit loss exists but the Company intends to sell the security or it is more likely than not that the Company will have to sell the debt security prior to the anticipated recovery, the decline in market value below amortized cost is recognized as an OTTI in earnings. In periods after the recognition of an OTTI on debt securities, the Company accounts for such securities as if they had been purchased on the measurement date of the OTTI at an amortized cost basis equal to the previous amortized cost basis less the OTTI recognized in earnings. For debt securities for which OTTI was recognized in earnings, the difference between the new amortized cost basis and the cash flows expected to be collected will be accreted or amortized into net investment income.

14


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




For the three and six months ended June 30, 2016, the Company recorded $53 and $364, respectively, of OTTI, of which $53 and $701, respectively, was related to both credit losses and securities the Company intends to sell and recorded as net OTTI losses recognized in earnings, with the remaining $337 related to all other factors and was recorded as an unrealized gain component of AOCI. There was no OTTI recorded for the three months ended June 30, 2015. For the six months ended June 30, 2015, the Company recorded $3,208 of OTTI, of which $2,570 was related to credit losses and recorded as net OTTI losses recognized in earnings, with the remaining $638 related to all other factors and recorded as an unrealized loss component of AOCI.
The following table sets forth the amount of credit loss impairments recognized within the results of operations on fixed maturity securities held by the Company as of the dates indicated, for which a portion of the OTTI loss was recognized in AOCI, and the corresponding changes in such amounts. 
 
Three Months Ended June 30,
 
2016
 
2015
Balance, March 31,
$
30,981

 
$
36,057

Reductions for increases in cash flows expected to be collected that are recognized over
  the remaining life of the security
(709
)
 
(603
)
Reductions for credit loss impairments previously recognized on securities which
  matured, paid down, prepaid or were sold during the period
(1,168
)
 
(1,146
)
Balance, June 30,
$
29,104

 
$
34,308

 
 
Six Months Ended June 30,
 
2016
 
2015
Balance, January 1,
$
32,377

 
$
35,424

Additions for credit loss impairments recognized in the current period on securities
  previously impaired
554

 

Additions for credit loss impairments recognized in the current period on securities not
  previously impaired

 
2,570

Reductions for increases in cash flows expected to be collected that are recognized over
  the remaining life of the security
(1,318
)
 
(1,075
)
Reductions for credit loss impairments previously recognized on securities which
  matured, paid down, prepaid or were sold during the period
(2,509
)
 
(2,611
)
Balance, June 30,
$
29,104

 
$
34,308

The Company regularly monitors its investment portfolio to ensure investments that may be other-than-temporarily impaired are timely identified, properly valued, and charged against earnings in the proper period. The determination that a security has incurred an other-than-temporary decline in value requires the judgment of management. Assessment factors include, but are not limited to, the length of time and the extent to which the market value has been less than cost, the financial condition and rating of the issuer, whether any collateral is held, the intent and ability of the Company to retain the investment for a period of time sufficient to allow for recovery for equity securities and the intent to sell or whether it is more likely than not that the Company will be required to sell for fixed maturity securities. Inherently, there are risks and uncertainties involved in making these judgments. Changes in circumstances and critical assumptions such as a continued weak economy, a more pronounced economic downturn or unforeseen events which affect one or more companies, industry sectors, or countries could result in additional impairments in future periods for other-than-temporary declines in value. Any equity security whose price decline is deemed other-than-temporary is written down to its then current market value with the amount of the impairment reported as a realized loss in that period. The impairment of a fixed maturity security that the Company has the intent to sell or that it is more likely than not that the Company will be required to sell is deemed other-than-temporary and is written down to its market value at the balance sheet date with the amount of the impairment reported as a realized loss in that period. For all other-than-temporarily impaired fixed maturity securities that do not meet either of these two criteria, the Company is required to analyze its ability to recover the amortized cost of the security by calculating the net present value of projected future cash flows. For these other-than-temporarily impaired fixed maturity securities, the net amount recognized in earnings is equal to the difference between the amortized cost of the fixed maturity security and its net present value.  

15


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The Company considers different factors to determine the amount of projected future cash flows and discounting methods for corporate debt and residential and commercial mortgage-backed or asset-backed securities. For corporate debt securities, the split between the credit and non-credit losses is driven principally by assumptions regarding the amount and timing of projected future cash flows. The net present value is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the security at the date of acquisition. For residential and commercial mortgage-backed and asset-backed securities, cash flow estimates, including prepayment assumptions, are based on data from widely accepted third-party data sources or internal estimates. In addition to prepayment assumptions, cash flow estimates vary based on assumptions regarding the underlying collateral including default rates, recoveries and changes in value. The net present value is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security prior to impairment at the balance sheet date. The discounted cash flows become the new amortized cost basis of the fixed maturity security.
In periods subsequent to the recognition of an OTTI, the Company generally accretes the discount (or amortizes the reduced premium) into net investment income, up to the non-discounted amount of projected future cash flows, resulting from the reduction in cost basis, based upon the amount and timing of the expected future cash flows over the estimated period of cash flows.

16


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The investment category and duration of the Company’s gross unrealized losses on fixed maturity securities and equity securities at June 30, 2016 and December 31, 2015 were as follows:
 
June 30, 2016
 
Less than 12 months
 
12 Months or More
 
Total
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
 
 
U.S. government and government
  agencies and authorities
$
2,176

 
$
(1
)
 
$

 
$

 
$
2,176

 
$
(1
)
Foreign governments

 

 
27,644

 
(297
)
 
27,644

 
(297
)
Asset-backed

 

 
991

 
(221
)
 
991

 
(221
)
Residential mortgage-backed
19,861

 
(58
)
 
812

 
(9
)
 
20,673

 
(67
)
U.S. corporate
235,238

 
(3,543
)
 
139,876

 
(9,677
)
 
375,114

 
(13,220
)
Foreign corporate
55,075

 
(1,479
)
 
39,037

 
(3,357
)
 
94,112

 
(4,836
)
Total fixed maturity securities
$
312,350

 
$
(5,081
)
 
$
208,360

 
$
(13,561
)
 
$
520,710

 
$
(18,642
)
Equity securities:
 
 
 
 
 
 
 
 
 
 
 
Common stock
$
339

 
$
(1
)
 
$

 
$

 
$
339

 
$
(1
)
Non-redeemable preferred stocks
13,531

 
(337
)
 
13,139

 
(729
)
 
26,670

 
(1,066
)
Total equity securities
$
13,870

 
$
(338
)
 
$
13,139

 
$
(729
)
 
$
27,009

 
$
(1,067
)
 
 
December 31, 2015
 
Less than 12 months
 
12 Months or More
 
Total
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
 
 
U.S. government and government
  agencies and authorities
$
90,008

 
$
(465
)
 
$
5,564

 
$
(72
)
 
$
95,572

 
$
(537
)
States, municipalities and political
  subdivisions
6,881

 
(94
)
 

 

 
6,881

 
(94
)
Foreign governments
24,071

 
(347
)
 
22,239

 
(376
)
 
46,310

 
(723
)
Asset-backed

 

 
1,136

 
(204
)
 
1,136

 
(204
)
Residential mortgage-backed
260,620

 
(3,179
)
 
11,147

 
(230
)
 
271,767

 
(3,409
)
U.S. corporate
1,287,545

 
(65,631
)
 
38,224

 
(7,713
)
 
1,325,769

 
(73,344
)
Foreign corporate
348,912

 
(19,616
)
 
15,805

 
(2,952
)
 
364,717

 
(22,568
)
Total fixed maturity securities
$
2,018,037

 
$
(89,332
)
 
$
94,115

 
$
(11,547
)
 
$
2,112,152

 
$
(100,879
)
Equity securities:
 
 
 
 
 
 
 
 
 
 
 
Common stock
$
623

 
$
(7
)
 
$

 
$

 
$
623

 
$
(7
)
Non-redeemable preferred stocks
63,665

 
(1,632
)
 
13,806

 
(985
)
 
77,471

 
(2,617
)
Total equity securities
$
64,288

 
$
(1,639
)
 
$
13,806

 
$
(985
)
 
$
78,094

 
$
(2,624
)

17


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




Total gross unrealized losses represent approximately 4% and 5% of the aggregate fair value of the related securities at June 30, 2016 and December 31, 2015, respectively. Approximately 27% and 88% of these gross unrealized losses have been in a continuous loss position for less than twelve months at June 30, 2016 and December 31, 2015, respectively. The total gross unrealized losses are comprised of 232 and 884 individual securities at June 30, 2016 and December 31, 2015, respectively. In accordance with its policy described above, the Company concluded that for these securities an adjustment to its results of operations for other-than-temporary impairments of the gross unrealized losses was not warranted at June 30, 2016 and December 31, 2015. These conclusions were based on a detailed analysis of the underlying credit and expected cash flows of each security. As of June 30, 2016, the gross unrealized losses that have been in a continuous loss position for twelve months or more were concentrated in the Company’s corporate fixed maturity securities and in non-redeemable preferred stocks. The non-redeemable preferred stocks are perpetual preferred securities that have characteristics of both debt and equity securities. To evaluate these securities, the Company applies an impairment model similar to that used for the Company's fixed maturity securities. As of June 30, 2016, the Company did not intend to sell these securities and it was not more likely than not that the Company would be required to sell them and no underlying cash flow issues were noted. Therefore, the Company did not recognize an OTTI on those perpetual preferred securities that had been in a continuous unrealized loss position for twelve months or more. As of June 30, 2016, the Company did not intend to sell the fixed maturity securities and it was not more likely than not that the Company would be required to sell the securities before the anticipated recovery of their amortized cost basis. The gross unrealized losses are primarily attributable to widening credit spreads associated with an underlying shift in overall credit risk premium.
The Company has entered into commercial mortgage loans, collateralized by the underlying real estate, on properties located throughout the U.S. and Canada. At June 30, 2016, approximately 35% of the outstanding principal balance of commercial mortgage loans was concentrated in the states of California, New York, and Texas. Although the Company has a diversified loan portfolio, an economic downturn could have an adverse impact on the ability of its debtors to repay their loans. The outstanding balance of commercial mortgage loans range in size from $18 to $14,404 at June 30, 2016 and from $17 to $14,625 at December 31, 2015.
Credit quality indicators for commercial mortgage loans are loan-to-value and debt-service coverage ratios. Loan-to-value and debt-service coverage ratios are measures commonly used to assess the credit quality of commercial mortgage loans. The loan-to-value ratio compares the principal amount of the loan to the fair value of the underlying property collateralizing the loan, and is commonly expressed as a percentage. The debt-service coverage ratio compares a property’s net operating income to its debt-service payments and is commonly expressed as a ratio. The loan-to-value and debt-service coverage ratios are generally updated annually in the third quarter.
 

18


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The following summarizes the Company's loan-to-value and average debt-service coverage ratios as of the dates indicated:
 
June 30, 2016
Loan-to-Value
Carrying
Value
 
% of Gross
Mortgage
Loans
 
Debt-Service
Coverage Ratio
70% and less
$
592,516

 
95.1
%
 
1.88

71 – 80%
16,585

 
2.7
%
 
1.13

81 – 95%
8,850

 
1.4
%
 
1.26

Greater than 95%
4,816

 
0.8
%
 
3.52

Gross commercial mortgage loans
622,767

 
100
%
 
1.87

Less valuation allowance
(2,582
)
 
 
 
 
Net commercial mortgage loans
$
620,185

 
 
 
 
 
 
December 31, 2015
Loan-to-Value
Carrying
Value
 
% of Gross
Mortgage
Loans
 
Debt-Service
Coverage Ratio
70% and less
$
1,101,572

 
95.5
%
 
2.01

71 – 80%
39,080

 
3.4
%
 
1.19

81 – 95%
8,370

 
0.7
%
 
1.05

Greater than 95%
4,816

 
0.4
%
 
3.52

Gross commercial mortgage loans
1,153,838

 
100
%
 
1.98

Less valuation allowance
(2,582
)
 
 
 
 
Net commercial mortgage loans
$
1,151,256

 
 
 
 
All commercial mortgage loans that are individually impaired have an established mortgage loan valuation allowance for losses. An additional valuation allowance is established for incurred, but not specifically identified impairments. Changing economic conditions affect the Company's valuation of commercial mortgage loans. Changing vacancies and rents are incorporated into the discounted cash flow analysis that the Company performs for monitored loans and may contribute to the establishment of (or an increase or decrease in) a commercial mortgage loan valuation allowance for losses. In addition, the Company continues to monitor the entire commercial mortgage loan portfolio to identify risk. Areas of emphasis are properties that have exposure to specific geographic events, have deteriorating credits or have experienced a reduction in debt-service coverage ratio. During the six months ended June 30 2016, the Company did not establish or increase the valuation allowance based upon this analysis.
Commercial Mortgage Loan Securitization

On May 31, 2016, the Company transferred $259,741 of certain commercial mortgage loans on real estate into a trust. Upon transfer, the loans were securitized as a source of funding for the Company and as a means of transferring the economic risk of the loans to third parties. The securitized assets are legally isolated from the creditors of the Company and are not available to satisfy its obligations and were accounted for as a sale. The securitized assets can only be used to settle obligations of the trust. The Company does not have the power to direct the activities of the trust, nor does it provide guarantees or recourse to the trust other than standard representations and warranties. The Company retained interest in the trust in the form of subordinate securities issued by the trust. The trust is a variable interest entity ("VIE") that the Company does not consolidate.

The cash proceeds, including accrued investment income, from the securitization were $269,828, with a corresponding realized gain of $9,092. At closing, the Company purchased $30,822 of securities at fair value from the trust. As of June 30, 2016, the maximum loss exposure the Company has to the trust is $30,906. The Company calculates its maximum loss exposure based on the unlikely event that all the assets in the trust become worthless and the effect it would have on the Company’s consolidated balance sheets based upon its retained interest in the trust. The securities purchased from the trust are included within fixed maturity securities available for sale at fair value on the consolidated balance sheet and are part of the

19


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




Company’s ongoing other-than-temporary impairment review. See Note 8, Fair Values, Inputs, and Valuation Techniques for Financial Assets and Liabilities Disclosures for further description of the Company’s fair value inputs and valuation techniques.

Variable Interest Entities

A VIE is a legal entity which does not have sufficient equity at risk to allow the entity to finance its activities without additional financial support or in which the equity investors, as a group, do not have the characteristic of a controlling financial interest. The Company's investments in VIEs include private equity limited partnerships and real estate joint ventures. These investments are generally accounted for under the equity method and included in the consolidated balance sheets in other investments. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of June 30, 2016, the Company's maximum exposure to loss is $231,364 in recorded carrying value and $64,928 in unfunded commitments. See Commercial Mortgage Loan Securitization section above for the disclosures relating to the commercial mortgage loan securitization trust.

8. Fair Value Disclosures
Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities Disclosures
The fair value measurements and disclosures guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.
The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and takes into account factors specific to the asset or liability.
The levels of the fair value hierarchy are described below:
Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access.
Level 2 inputs utilize other than quoted prices included in Level 1 that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Level 2 inputs include quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active and inputs other than quoted prices that are observable in the marketplace for the asset. The observable inputs are used in valuation models to calculate the fair value for the asset.
Level 3 inputs are unobservable but are significant to the fair value measurement for the asset, and include situations where there is little, if any, market activity for the asset. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset.
The Company reviews fair value hierarchy classifications on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy.
 

20


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The following tables present the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis as of June 30, 2016 and December 31, 2015. The amounts presented below for Other investments, Cash equivalents, Other assets, Assets and Liabilities held in separate accounts and Other liabilities differ from the amounts presented in the consolidated balance sheets because only certain investments or certain assets and liabilities within these line items are measured at estimated fair value. Other investments are comprised of investments in the Assurant Investment Plan, American Security Insurance Company Investment Plan, Assurant Deferred Compensation Plan, modified coinsurance arrangements and other derivatives. Other liabilities are comprised of investments in the Assurant Investment Plan and other derivatives. The fair value amount and the majority of the associated levels presented for Other investments and Assets and Liabilities held in separate accounts are received directly from third parties. 
 
June 30, 2016
 
 
Total
 
Level 1
 
 
Level 2
 
 
Level 3
 
Financial Assets
 
 
 
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
 
U.S. government and government agencies and
  authorities
$
172,998

 
$

  
 
$
172,998

  
 
$

  
State, municipalities and political subdivisions
575,073

 

  
 
572,073

  
 
3,000

  
Foreign governments
596,682

 
932

  
 
595,750

  
 

  
Asset-backed
3,901

 

  
 
3,901

  
 

  
Commercial mortgage-backed
44,638

 

  
 
13,629

  
 
31,009

  
Residential mortgage-backed
947,679

 

  
 
947,679

  
 

  
U.S. corporate
5,600,500

 

 
 
5,535,793

 
 
64,707

 
Foreign corporate
1,802,728

 

  
 
1,774,085

  
 
28,643

  
Equity securities:
 
 
 
 
 
 
 
 
 
 
Common stocks
20,122

 
19,438

  
 
684

  
 

  
Non-redeemable preferred stocks
414,384

 

  
 
412,084

  
 
2,300

  
Short-term investments
498,281

 
223,017

 
275,264

 

  
Other investments
287,103

 
66,495

 
219,751

 
857

Cash equivalents
726,424

 
699,356

 
27,068

 

  
Other assets
8,251

 

  
 
7,954

e
 
297

Assets held in separate accounts
1,668,611

 
1,488,102

 
180,509

 

  
Total financial assets
$
13,367,375

 
$
2,497,340

  
 
$
10,739,222

  
 
$
130,813

  
 
 
 
 
 
 
 
 
 
 
 
Financial Liabilities
 
 
 
 
 
 
 
 
 
 
Other liabilities
$
92,499

 
$
66,495

 
$
26

e
 
$
25,978

e
Liabilities related to separate accounts
1,668,611

 
1,488,102

 
180,509

 

   
Total financial liabilities
$
1,761,110

 
$
1,554,597

  
 
$
180,535

   
 
$
25,978

   

 
 

21


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




 
December 31, 2015
 
 
Total
 
Level 1
 
 
Level 2
 
 
Level 3
 
Financial Assets
 
 
 
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
 
U.S. government and government agencies and
  authorities
$
154,035

 
$

 
 
$
154,035

 
 
$

 
State, municipalities and political subdivisions
695,630

 

 
 
695,630

 
 

 
Foreign governments
562,250

 
944

 
 
561,306

 
 

 
Asset-backed
4,662

 

 
 
4,662

 
 

 
Commercial mortgage-backed
22,521

 

 
 
22,317

 
 
204

 
Residential mortgage-backed
998,514

 

 
 
998,514

 
 

 
U.S. corporate
5,869,693

 

 
 
5,835,189

 
 
34,504

 
Foreign corporate
1,908,023

 

 
 
1,879,381

 
 
28,642

 
Equity securities:
 
 
 
 
 
 
 
 
 
 
Common stocks
19,664

 
18,981

 
 
683

 
 

 
Non-redeemable preferred stocks
480,393

 

 
 
478,143

 
 
2,250

 
Short-term investments
508,950

 
453,335

 
55,615

 

 
Other investments
253,708

 
62,076

 
189,407

 
2,225

Cash equivalents
908,936

 
907,248

 
1,688

 

 
Other assets
1,320

 

  
 
886

e
 
434

Assets held in separate accounts
1,750,556

 
1,570,000

 
180,556

 

 
Total financial assets
$
14,138,855

 
$
3,012,584

 
 
$
11,058,012

 
 
$
68,259

 
 
 
 
 
 
 
 
 
 
 
 
Financial Liabilities
 
 
 
 
 
 
 
 
 
 
Other liabilities
$
89,765

 
$
62,076

 
$
6

e
 
$
27,683

e
Liabilities related to separate accounts
1,750,556

 
1,570,000

 
180,556

 

 
Total financial liabilities
$
1,840,321

 
$
1,632,076

 
 
$
180,562

 
 
$
27,683

 
 

a.
Mainly includes mutual funds.
b.
Mainly includes money market funds.
c.
Mainly includes fixed maturity securities.
d.
Mainly includes fixed maturity securities and other derivatives.
e.
Mainly includes other derivatives.


There were no transfers between Level 1 and Level 2 financial assets during either period. However, there were transfers between Level 2 and Level 3 financial assets during the periods, which are reflected in the “Transfers in” and “Transfers out” columns below. Transfers between Level 2 and Level 3 most commonly occur from changes in the availability of observable market information and re-evaluation of the observability of pricing inputs. Any remaining unpriced securities are submitted to independent brokers who provide non-binding broker quotes or are priced by other qualified sources.

22


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The following tables summarize the change in balance sheet carrying value associated with Level 3 financial assets and liabilities carried at fair value during the three and six months ended June 30, 2016 and 2015: 
 
Three Months Ended June 30, 2016
 
Balance,
beginning 
of
period
 
Total
 (losses) gains
(realized/
unrealized)
included in
earnings (1)
 
Net unrealized
gains (losses)
included in
other
comprehensive
income (2)
 
Purchases
 
Sales
 
Transfers
in (3)
 
Balance,
end of
period
Financial Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed Maturity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
States, municipalities and
  political subdivisions
$

 
$

 
$

 
$
3,600

 
$
(600
)
 
$

 
$
3,000

Commercial mortgage-backed
154

 
(291
)
 
374

 
30,822

 
(50
)
 

 
31,009

U.S. corporate
37,400

 
146

 
1,169

 
14,516

 
(930
)
 
12,406

 
64,707

Foreign corporate
28,492

 
18

 
854

 

 
(721
)
 


 
28,643

Equity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-redeemable preferred stocks
2,360

 

 
(60
)
 

 

 

 
2,300

  Other investments
1,552

 
(663
)
 
(9
)
 

 
(23
)
 

 
857

  Other assets
361

 
(64
)
 

 

 

 

 
297

Financial Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
  Other liabilities
(27,592
)
 
1,614

 

 

 

 

 
(25,978
)
Total level 3 assets and liabilities
$
42,727

 
$
760

 
$
2,328

 
$
48,938

 
$
(2,324
)
 
$
12,406

 
$
104,835

 

  
Three Months Ended June 30, 2015
 
Balance,
beginning of
period
 
Total (losses) gains
(realized/
unrealized)
included in
earnings  (1)
 
Net unrealized
(losses) gains
included in
other
comprehensive
income (2)
 
Purchases
 
Sales
 
Transfers
out (3)
 
Balance,
end of
period
Financial Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed Maturity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial mortgage-backed
$
354

 
$

 
$
(3
)
 
$

 
$
(47
)
 
$

 
$
304

U.S. corporate
96,798

 
(64
)
 
(1,491
)
 
6,523

 
(2,473
)
 
(52,777
)
 
46,516

Foreign corporate
4,192

 
640

 
(535
)
 

 
(1,003
)
 

 
3,294

Equity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-redeemable preferred stocks
2,060

 

 
60

 

 

 

 
2,120

  Other investments
2,460

 
(33
)
 
(11
)
 

 
(35
)
 

 
2,381

  Other assets
944

 
(156
)
 

 

 

 

 
788

Financial Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
  Other liabilities
(26,181
)
 
(2,473
)
 

 
77

 

 

 
(28,577
)
Total level 3 assets and liabilities
$
80,627

 
$
(2,086
)
 
$
(1,980
)
 
$
6,600

 
$
(3,558
)
 
$
(52,777
)
 
$
26,826


23


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




 
Six Months Ended June 30, 2016
 
Balance,
beginning of
period
 
Total
(losses) gains
(realized/
unrealized)
included in
earnings (1)
 
Net unrealized
gains (losses)
included in
other
comprehensive
income (2)
 
Purchases
 
Sales
 
Transfers
in (3)
 
Transfers
out (3)
 
Balance,
end of
period
Financial Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed Maturity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
States, municipalities
  and political
  subdivisions
$

 
$

 
$

 
$
3,600

 
$
(600
)
 
$

 
$

 
$
3,000

Commercial mortgage-
  backed
204

 
(291
)
 
373

 
30,822

 
(99
)
 

 

 
31,009

U.S. corporate
34,504

 
278

 
1,380

 
22,616

 
(1,646
)
 
12,406

 
(4,831
)
 
64,707

Foreign corporate
28,642

 
31

 
694

 

 
(724
)
 

 

 
28,643

Equity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-redeemable
  preferred stocks
2,250

 

 
50

 

 

 

 

 
2,300

Other investments
2,225

 
(1,299
)
 
(20
)
 

 
(49
)
 

 

 
857

Other assets
434

 
(137
)
 

 

 

 

 

 
297

Financial Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other liabilities
(27,683
)
 
1,705

 

 

 

 

 

 
(25,978
)
Total level 3 assets and
  liabilities
$
40,576

 
$
287

 
$
2,477

 
$
57,038

 
$
(3,118
)
 
$
12,406

 
$
(4,831
)
 
$
104,835




24


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




 
Six Months Ended June 30, 2015
 
Balance,
beginning of
period
 
Total
(losses)
gains
(realized/
unrealized)
included in
earnings (1)
 
Net unrealized
(losses) gains
included in
other
comprehensive
income (2)
 
Purchases
 
Sales
 
Transfers
in (3)
 
Transfers
out (3)
 
Balance,
end of
period
Financial Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed Maturity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial mortgage-
  backed
$
403

 
$

 
$
(6
)
 
$

 
$
(93
)
 
$

 
$

 
$
304

Residential mortgage-
  backed
4,645

 

 

 

 

 

 
(4,645
)
 

U.S. corporate
100,133

 
(112
)
 
(655
)
 
6,523

 
(4,594
)
 
2,130

 
(56,909
)
 
46,516

Foreign corporate
4,142

 
680

 
(491
)
 

 
(1,037
)
 

 

 
3,294

Equity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-redeemable
  preferred stocks
2,000

 

 
120

 

 

 

 

 
2,120

Other investments
2,121

 
95

 
(15
)
 

 
(56
)
 
236

 

 
2,381

Other assets
807

 
(19
)
 

 

 

 

 

 
788

Financial Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other liabilities
(25,233
)
 
(3,421
)
 

 
77

 

 

 

 
(28,577
)
Total level 3 assets and
  liabilities
$
89,018

 
$
(2,777
)
 
$
(1,047
)
 
$
6,600

 
$
(5,780
)
 
$
2,366

 
$
(61,554
)
 
$
26,826


(1)
Included as part of net realized gains on investments in the consolidated statement of operations.
(2)
Included as part of change in unrealized gains on securities in the consolidated statement of comprehensive income.
(3)
Transfers are primarily attributable to changes in the availability of observable market information and re-evaluation of the observability of pricing inputs.
Three different valuation techniques can be used in determining fair value for financial assets and liabilities: the market, income or cost approaches. The three valuation techniques described in the fair value measurements and disclosures guidance are consistent with generally accepted valuation methodologies. The market approach valuation techniques use prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. When possible, quoted prices (unadjusted) in active markets are used as of the period-end date (such as for mutual funds and money market funds). Otherwise, the Company uses valuation techniques consistent with the market approach including matrix pricing and comparables. Matrix pricing is a mathematical technique employed principally to value debt securities without relying exclusively on quoted prices for those securities but, rather, relying on the securities’ relationship to other benchmark quoted securities. Market approach valuation techniques often use market multiples derived from a set of comparables. Multiples might lie in ranges with a different multiple for each comparable. The selection of where within the range the appropriate multiple falls requires judgment, considering both qualitative and quantitative factors specific to the measurement.
Income approach valuation techniques convert future amounts, such as cash flows or earnings, to a single present amount, or a discounted amount. These techniques rely on current market expectations of future amounts as of the period-end date. Examples of income approach valuation techniques include present value techniques, option-pricing models, binomial or lattice models that incorporate present value techniques and the multi-period excess earnings method. 
Cost approach valuation techniques are based upon the amount that would be required to replace the service capacity of an asset at the period-end date, or the current replacement cost. That is, from the perspective of a market participant (seller), the price that would be received for the asset is determined based on the cost to a market participant (buyer) to acquire or construct a substitute asset of comparable utility, adjusted for obsolescence.
While not all three approaches are applicable to all financial assets or liabilities, where appropriate, the Company may use one or more valuation techniques. For all the classes of financial assets and liabilities included in the above hierarchy, excluding

25


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




certain derivatives and certain privately placed corporate bonds, the Company generally uses the market valuation technique. For certain privately placed corporate bonds and certain derivatives, the Company generally uses the income valuation technique. For the periods ended June 30, 2016 and December 31, 2015, the application of the valuation technique applied to the Company’s classes of financial assets and liabilities has been consistent.
Level 1 Securities
The Company’s investments and liabilities classified as Level 1 as of June 30, 2016 and December 31, 2015, consisted of mutual funds and money market funds, foreign government fixed maturities and common stocks that are publicly listed and/or actively traded in an established market.
Level 2 Securities
The Company values Level 2 securities using various observable market inputs obtained from a pricing service. The pricing service prepares estimates of fair value measurements for the Company’s Level 2 securities using proprietary valuation models based on techniques such as matrix pricing which include observable market inputs. The fair value measurements and disclosures guidance defines observable market inputs as the assumptions market participants would use in pricing the asset or liability developed on market data obtained from sources independent of the Company. The extent of the use of each observable market input for a security depends on the type of security and the market conditions at the balance sheet date. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary. The Company uses the following observable market inputs (“standard inputs”), listed in the approximate order of priority, in the pricing evaluation of Level 2 securities: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research data. Further details for Level 2 investment types follow:
United States Government and government agencies and authorities: U.S. government and government agencies and authorities securities are priced by the Company’s pricing service utilizing standard inputs. Included in this category are U.S. Treasury securities which are priced using vendor trading platform data in addition to the standard inputs.
State, municipalities and political subdivisions: State, municipalities and political subdivisions securities are priced by the Company’s pricing service using material event notices and new issue data inputs in addition to the standard inputs.
Foreign governments: Foreign government securities are primarily fixed maturity securities denominated in Canadian dollars which are priced by the Company’s pricing service using standard inputs. The pricing service also evaluates each security based on relevant market information including relevant credit information, perceived market movements and sector news.
Commercial mortgage-backed, residential mortgage-backed and asset-backed: Commercial mortgage-backed, residential mortgage-backed and asset-backed securities are priced by the Company’s pricing service using monthly payment information and collateral performance information in addition to the standard inputs. Additionally, commercial mortgage-backed securities and asset-backed securities utilize new issue data while residential mortgage-backed securities utilize vendor trading platform data.
Corporate: Corporate securities are priced by the Company’s pricing service using standard inputs. Non-investment grade securities within this category are priced by the Company’s pricing service using observations of equity and credit default swap curves related to the issuer in addition to the standard inputs. Certain privately placed corporate bonds are priced by a non-pricing service source using a model with observable inputs including, but not limited to, the credit rating, credit spreads, sector add-ons, and issuer specific add-ons. 
Non-redeemable preferred stocks: Non-redeemable preferred stocks are priced by the Company’s pricing service using observations of equity and credit default swap curves related to the issuer in addition to the standard inputs.
Short-term investments, other investments, cash equivalents, and assets/liabilities held in separate accounts: To price the fixed maturity securities in these categories, the pricing service utilizes the standard inputs.
Other assets: A non-pricing service source prices foreign exchange forwards using a pricing model which utilizes market observable inputs including foreign exchange spot rate, forward points and date to settlement.

26


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




Valuation models used by the pricing service can change period to period, depending on the appropriate observable inputs that are available at the balance sheet date to price a security. When market observable inputs are unavailable to the pricing service, the remaining unpriced securities are submitted to independent brokers who provide non-binding broker quotes or are priced by other qualified sources. If the Company cannot corroborate the non-binding broker quotes with Level 2 inputs, these securities are categorized as Level 3 securities.
Level 3 Securities
The Company’s investments classified as Level 3 as of June 30, 2016 and December 31, 2015 consisted of fixed maturity and equity securities and derivatives. All of the Level 3 fixed maturity and equity securities are priced using non-binding broker quotes which cannot be corroborated with Level 2 inputs. Of the Company’s total Level 3 fixed maturity and equity securities $5,859 and $304 were priced by a pricing service using single broker quotes due to insufficient information to provide an evaluated price as of June 30, 2016 and December 31, 2015, respectively. The single broker quotes are provided by market makers or broker-dealers who are recognized as market participants in the markets in which they are providing the quotes. The remaining $124,034 and $65,600 were priced internally using independent and non-binding broker quotes as of June 30, 2016 and December 31, 2015, respectively. The inputs factoring into the broker quotes include trades in the actual bond being priced, trades of comparable bonds, quality of the issuer, optionality, structure and liquidity. Significant changes in interest rates, issuer credit, liquidity, and overall market conditions would result in a significantly lower or higher broker quote. The prices received from both the pricing service and internally are reviewed for reasonableness by management and if necessary, management works with the pricing service or broker to further understand how they developed their price. Further details on Level 3 derivative investment types follow:
Other investments and other liabilities: The Company prices swaptions using a Black-Scholes pricing model incorporating third-party market data, including swap volatility data. The Company prices credit default swaps using non-binding quotes provided by market makers or broker-dealers who are recognized as market participants. Inputs factored into the non-binding quotes include trades in the actual credit default swap which is being priced, trades in comparable credit default swaps, quality of the issuer, structure and liquidity. The net option related to the investment in Iké is valued using an income approach; specifically, a Monte Carlo simulation option pricing model. The inputs to the model include, but are not limited to, the projected normalized earnings before interest, tax, depreciation, and amortization (EBITDA) and free cash flow for the underlying asset, the discount rate, and the volatility of and the correlation between the normalized EBITDA and the value of the underlying asset. Significant increases (decreases) in the projected normalized EBITDA relative to the value of the underlying asset in isolation would result in a significantly higher (lower) fair value.
Other assets: A non-pricing service source prices certain derivatives using a model with inputs including, but not limited to, the time to expiration, the notional amount, the strike price, the forward rate, implied volatility and the discount rate.
Management evaluates the following factors in order to determine whether the market for a financial asset is inactive. The factors include, but are not limited to:
There are few recent transactions,
Little information is released publicly,
The available prices vary significantly over time or among market participants,
The prices are stale (i.e., not current), and
The magnitude of the bid-ask spread. 

Illiquidity did not have a material impact in the fair value determination of the Company’s financial assets.
The Company generally obtains one price for each financial asset. The Company performs a monthly analysis to assess if the evaluated prices represent a reasonable estimate of their fair value. This process involves quantitative and qualitative analysis and is overseen by investment and accounting professionals. Examples of procedures performed include, but are not limited to, initial and on-going review of pricing service methodologies, review of the prices received from the pricing service, review of pricing statistics and trends, and comparison of prices for certain securities with two different appropriate price sources for reasonableness. Following this analysis, the Company generally uses the best estimate of fair value based upon all available inputs. On infrequent occasions, a non-pricing service source may be more familiar with the market activity for a particular security than the pricing service. In these cases the price used is taken from the non-pricing service source. The

27


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




pricing service provides information to indicate which securities were priced using market observable inputs so that the Company can properly categorize the Company’s financial assets in the fair value hierarchy.
For the net option, the Company performs a periodic analysis to assess if the evaluated price represents a reasonable estimate of the fair value for the financial liability. This process involves quantitative and qualitative analysis overseen by finance and accounting professionals. Examples of procedures performed include, but are not limited to, initial and on-going review of the pricing methodology and review of the projection for the underlying asset including the probability distribution of possible scenarios.
Disclosures for Non-Financial Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis
The Company also measures the fair value of certain assets and liabilities on a non-recurring basis, generally on an annual basis, or when events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. These assets include commercial mortgage loans, goodwill and finite-lived intangible assets.

The Company utilizes both the income and market valuation approaches to measure the fair value of its reporting units when required. Under the income approach, the Company determined the fair value of the reporting units considering distributable earnings, which were estimated from operating plans. The resulting cash flows were then discounted using a market participant weighted average cost of capital estimated for the reporting units. After discounting the future discrete earnings to their present value, the Company estimated the terminal value attributable to the years beyond the discrete operating plan period. The discounted terminal value was then added to the aggregate discounted distributable earnings from the discrete operating plan period to estimate the fair value of the reporting units. Under the market approach, the Company derived the fair value of the reporting units based on various financial multiples, including but not limited to: price to tangible book value of equity, price to estimated 2014 earnings and price to estimated 2015 earnings, which were estimated based on publicly available data related to comparable guideline companies. In addition, financial multiples were also estimated from publicly available purchase price data for acquisitions of companies operating in the insurance industry. The estimated fair value of the reporting units was more heavily weighted towards the income approach because in the current economic environment the earnings capacity of a business is generally considered the most important factor in the valuation of a business enterprise. This fair value determination was categorized as Level 3 (unobservable) in the fair value hierarchy.
Fair Value of Financial Instruments Disclosures
The financial instruments guidance requires disclosure of fair value information about financial instruments, for which it is practicable to estimate such fair value. Therefore, it requires fair value disclosure for financial instruments that are not recognized or are not carried at fair value in the consolidated balance sheets. However, this guidance excludes certain financial instruments, including those related to insurance contracts and those accounted for under the equity method (such as partnerships).
For the financial instruments included within the following financial assets and financial liabilities, the carrying value in the consolidated balance sheets equals or approximates fair value. Please refer to the Fair Value Inputs and Valuation Techniques for Financial Assets and Liabilities Disclosures section above for more information on the financial instruments included within the following financial assets and financial liabilities and the methods and assumptions used to estimate fair value:
Cash and cash equivalents 
Fixed maturity securities
Equity securities
Short-term investments
Other investments
Other assets
Assets held in separate accounts
Other liabilities
Liabilities related to separate accounts

28


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




In estimating the fair value of the financial instruments that are not recognized or are not carried at fair value in the consolidated balance sheets, the Company used the following methods and assumptions:
Commercial mortgage loans: the fair values of mortgage loans are estimated using discounted cash flow models. The model inputs include mortgage amortization schedules and loan provisions, an internally developed credit spread based on the credit risk associated with the borrower and the U.S. Treasury spot curve. Mortgage loans with similar characteristics are aggregated for purposes of the calculations.
Policy loans: the carrying value of policy loans reported in the consolidated balance sheets approximates fair value.
Other investments: Other investments include equity investments accounted for under the cost method, Certified Capital Company and low income housing tax credits, business debentures, credit tenant loans and social impact loans which are recorded at cost or amortized cost. The carrying value reported for these investments approximates fair value. Due to the nature of these investments, there is a lack of liquidity in the primary market which results in the holdings being classified as Level 3.
Policy reserves under investment products: the fair values for the Company’s policy reserves under investment products are determined using discounted cash flow analysis. Key inputs to the valuation include projections of policy cash flows, reserve run-off, market yields and risk margins.
Funds held under reinsurance: the carrying value reported approximates fair value due to the short maturity of the instruments.
Debt: the fair value of debt is based upon matrix pricing performed by the pricing service utilizing the standard inputs. The carrying value of the promissory note approximates fair value due to the short maturity of the instrument.


29


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The following tables disclose the carrying value, fair value amount and hierarchy level of the financial instruments that are not recognized or are not carried at fair value in the consolidated balance sheets:
 
June 30, 2016
 
 
 
Fair Value
 
Carrying
Value
 
Total
 
Level 1
 
Level 2
 
Level 3
Financial Assets
 
 
 
 
 
 
 
 
 
Commercial mortgage loans on real estate
$
620,185

 
$
658,901

 
$

 
$

 
$
658,901

Policy loans
40,349

 
40,349

 
40,349

 

 

Other investments
29,243

 
29,243

 

 

 
29,243

Total financial assets
$
689,777

 
$
728,493

 
$
40,349

 
$

 
$
688,144

Financial Liabilities
 
 
 
 
 
 
 
 
 
Policy reserves under investment products
  (Individual and group annuities, subject
  to discretionary withdrawal) (1)
$
670,445

 
$
692,037

 
$

 
$

 
$
692,037

Funds withheld under reinsurance
105,475

 
105,475

 
105,475

 

 

Debt
1,165,255

 
1,302,817

 

 
1,302,817

 

Total financial liabilities
$
1,941,175

 
$
2,100,329

 
$
105,475

 
$
1,302,817

 
$
692,037

 
 
December 31, 2015
 
 
 
Fair Value
  
Carrying
Value
 
Total
 
Level 1
 
Level 2
 
Level 3
Financial Assets
 
 
 
 
 
 
 
 
 
Commercial mortgage loans on real estate
$
1,151,256

 
$
1,201,806

 
$

 
$

 
$
1,201,806

Policy loans
43,858

 
43,858

 
43,858

 

 

Other investments
27,534

 
27,534

 

 

 
27,534

Total financial assets
$
1,222,648

 
$
1,273,198

 
$
43,858

 
$

 
$
1,229,340

Financial Liabilities
 
 
 
 
 
 
 
 
 
Policy reserves under investment products
  (Individual and group annuities, subject
  to discretionary withdrawal) (1)
$
666,068

 
$
676,586

 
$

 
$

 
$
676,586

Funds withheld under reinsurance
94,417

 
94,417

 
94,417

 

 

Debt
1,164,656

 
1,250,602

 

 
1,250,602

 

Total financial liabilities
$
1,925,141

 
$
2,021,605

 
$
94,417

 
$
1,250,602

 
$
676,586

 

(1)
Only the fair value of the Company’s policy reserves for investment-type contracts (those without significant mortality or morbidity risk) are reflected in the table above.
Reinsurance Recoverables Credit Disclosures
A key credit quality indicator for reinsurance is the A.M. Best financial strength ratings of the reinsurer. The A.M. Best ratings are an independent opinion of a reinsurer’s ability to meet ongoing obligations to policyholders. The A.M. Best ratings for new reinsurance agreements where there is material credit exposure are reviewed at the time of execution. The A.M. Best ratings for existing reinsurance agreements are reviewed on a periodic basis, at least annually. The A.M. Best ratings have not changed significantly since December 31, 2015.
An allowance for doubtful accounts for reinsurance recoverables is recorded on the basis of periodic evaluations of balances due from reinsurers (net of collateral), reinsurer solvency, management’s experience and current economic conditions.

30


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The Company carries an allowance for doubtful accounts for reinsurance recoverables of $10,820 as of June 30, 2016 and December 31, 2015, respectively.
9. Debt
On March 28, 2013, the Company issued two series of senior notes with an aggregate principal amount of $700,000 (the “2013 Senior Notes”). The Company received net proceeds of $698,093 from this transaction, which represents the principal amount less the discount before offering expenses. The discount of $1,907 is being amortized over the life of the 2013 Senior Notes and is included as part of interest expense on the consolidated statements of operations. The first series is $350,000 in principal amount, bears interest at 2.50% per year and is payable in a single installment due March 15, 2018 and was issued at a 0.18% discount. The second series is $350,000 in principal amount, bears interest at 4.00% per year and is payable in a single installment due March 15, 2023 and was issued at a 0.37% discount. Interest on the 2013 Senior Notes is payable semi-annually on March 15 and September 15 of each year. The 2013 Senior Notes are unsecured obligations and rank equally with all of the Company’s other senior unsecured indebtedness. The Company may redeem each series of the 2013 Senior Notes in whole or in part at any time and from time to time before their maturity at the redemption price set forth in the Indenture. The 2013 Senior Notes are registered under the Securities Act of 1933, as amended.
The interest expense and related amortization incurred related to the 2013 Senior Notes was $5,947 and $5,747 for the three months ended June 30, 2016 and 2015, respectively, and $11,890 and $11,493 for the six months ended June 30, 2016 and 2015, respectively. There was $6,635 of accrued interest at both June 30, 2016 and 2015. The Company made interest payments on the 2013 Senior Notes of $11,375 on March 15, 2016 and 2015.
In February 2004, the Company issued two series of senior notes with an aggregate principal amount of $975,000 (the “2004 Senior Notes”). The Company received proceeds of $971,537 from this transaction, which represents the principal amount less the discount before offering expenses. The discount of $3,463 is being amortized over the life of the 2004 Senior Notes and is included as part of interest expense on the statements of operations. The first series was $500,000 in principal amount, issued at a 0.11% discount, bore interest at 5.63% per year and was repaid on February 18, 2014. The second series is $475,000 in principal amount, bears interest at 6.75% per year and is payable in a single installment due February 15, 2034 and was issued at a 0.61% discount. Interest on the 2004 Senior Notes is payable semi-annually on February 15 and August 15 of each year. The 2004 Senior Notes are unsecured obligations and rank equally with all of the Company’s other senior unsecured indebtedness. The 2004 Senior Notes are not redeemable prior to maturity. All of the holders of the 2004 Senior Notes exchanged their notes in May 2004 for new notes registered under the Securities Act of 1933, as amended.
The interest expense and related amortization incurred related to the 2004 Senior Notes was $8,057 and $8,032 for the three months ended June 30, 2016 and 2015, respectively, and $16,114 and $16,063 for the six months ended June 30, 2016 and 2015, respectively. There was $12,023 of accrued interest at both June 30, 2016 and 2015. The Company made interest payments on the 2004 Senior Notes of $16,031 on February 15, 2016 and 2015.
Promissory Note
On March 4, 2016, the Company entered into a private loan agreement in the form of a Promissory Note (the "Note") with a single financial institution, for an aggregate principal amount of $250,000. The Company received net proceeds of $249,625 from this transaction, which represented the principal amount less fees. Interest on the Note was a floating rate tied to LIBOR and was payable at least quarterly. The Note was payable in a single installment due March 3, 2017; however, terms of the agreement required that the Company promptly repay the loan with any dividends received from Union Security Insurance Company and Union Security Life Insurance Company of New York, the Company's wholly owned subsidiaries that received the cash proceeds related to the sale of the Assurant Employee Benefits segment, or the issuance of debt or equity securities (other than in connection with employee benefit plans).
On June 2, 2016, the Company repaid $50,000 of the principal balance of the Note. Following the receipt of a dividend from Union Security Insurance Company on June 23, 2016, the Company made a final payment of $200,223, which represented the remaining principal amount plus accrued interest and fees.
The interest expense and related fee amortization incurred related to the Note was $1,228 for the three months ended June 30, 2016 and $1,731 for the six months ended June 30, 2016.

31


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




 Credit Facility
The Company’s commercial paper program requires the Company to maintain liquidity facilities either in an available amount equal to any outstanding notes from the commercial paper program or in an amount sufficient to maintain the ratings assigned to the notes issued from the commercial paper program. The Company’s subsidiaries do not maintain commercial paper or other borrowing facilities. This program is currently backed up by a $400,000 senior revolving credit facility, of which $395,960 was available at June 30, 2016, due to $4,040 of outstanding letters of credit related to this program.
On September 16, 2014, the Company entered into a five-year unsecured $400,000 revolving credit agreement, as amended by Amendment No. 1, dated as of March 5, 2015 (the “2014 Credit Facility”) with a syndicate of banks arranged by JP Morgan Chase Bank, N.A. and Wells Fargo, N.A. The 2014 Credit Facility replaced the Company's prior four-year $350,000 revolving credit facility (the "2011 Credit Facility"), which was entered into on September 21, 2011 and was scheduled to expire in September 2015. The 2011 Credit Facility terminated upon the effectiveness of the 2014 Credit Facility. The 2014 Credit Facility provides for revolving loans and the issuance of multi-bank, syndicated letters of credit and/or letters of credit from a sole issuing bank in an aggregate amount of $400,000 and is available until September 2019, provided the Company is in compliance with all covenants. The 2014 Credit Facility has a sublimit for letters of credit issued thereunder of $50,000. The proceeds of these loans may be used for the Company’s commercial paper program or for general corporate purposes. The Company may increase the total amount available under the 2014 Credit Facility to $525,000 subject to certain conditions. No bank is obligated to provide commitments above their share of the $400,000 facility.
The Company did not use the commercial paper program during the six months ended June 30, 2016 and 2015 and there were no amounts relating to the commercial paper program outstanding at June 30, 2016 and December 31, 2015. The Company made no borrowings using the 2014 Credit Facility and no loans are outstanding at June 30, 2016.
The 2014 Credit Facility contains restrictive covenants and requires that the Company maintain certain specified minimum ratios and thresholds. Among others, these covenants include maintaining a maximum debt to capitalization ratio and a minimum consolidated adjusted net worth. At June 30, 2016, the Company was in compliance with all covenants, minimum ratios and thresholds.
10. Accumulated Other Comprehensive Income
Certain amounts included in the consolidated statements of comprehensive income are net of reclassification adjustments. The following tables summarize those reclassification adjustments (net of taxes): 
 
Three Months Ended June 30, 2016
 
Foreign
currency
translation
adjustment
 
Unrealized
gains on
securities
 
OTTI
 
Pension
under-
funding
 
Accumulated
other
comprehensive
income
Balance at March 31, 2016
$
(258,874
)
 
$
525,315

 
$
21,183

 
$
(62,384
)
 
$
225,240

Change in accumulated other comprehensive
  income (loss) before reclassifications
(14,524
)
 
120,275

 
158

 

 
105,909

Amounts reclassified from accumulated other
  comprehensive income

 
(4,335
)
 
34

 
406

 
(3,895
)
Net current-period other comprehensive (loss)
  income
(14,524
)
 
115,940

 
192

 
406

 
102,014

Balance at June 30, 2016
$
(273,398
)
 
$
641,255

 
$
21,375

 
$
(61,978
)
 
$
327,254

 
 
 
 
 
 
 
 
 
 

32


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




 
Three Months Ended June 30, 2015
 
Foreign
currency
translation
adjustment
 
Unrealized
gains on
securities
 
OTTI
 
Pension
under-
funding
 
Accumulated
other
comprehensive
income
Balance at March 31, 2015
$
(193,662
)
 
$
850,541

 
$
25,700

 
$
(133,582
)
 
$
548,997

Change in accumulated other comprehensive
  income (loss) before reclassifications
20,151

 
(216,522
)
 
95

 

 
(196,276
)
Amounts reclassified from accumulated other
  comprehensive income

 
(6,542
)
 
(376
)
 
2,616

 
(4,302
)
Net current-period other comprehensive income
  (loss)

20,151

 
(223,064
)
 
(281
)
 
2,616

 
(200,578
)
Balance at June 30, 2015
$
(173,511
)
 
$
627,477

 
$
25,419

 
$
(130,966
)
 
$
348,419

 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2016
 
Foreign
currency
translation
adjustment
 
Unrealized
gains on
securities
 
OTTI
 
Pension
under-
funding
 
Accumulated
other
comprehensive
income
Balance at December 31, 2015
$
(270,734
)
 
$
495,443

 
$
22,434

 
$
(128,594
)
 
$
118,549

Change in accumulated other comprehensive
  income (loss) before reclassifications
(2,664
)
 
246,281

 
(1,374
)
 
85,029

 
327,272

Amounts reclassified from accumulated other
  comprehensive income

 
(100,469
)
 
315

 
(18,413
)
 
(118,567
)
Net current-period other comprehensive (loss)
  income
(2,664
)
 
145,812

 
(1,059
)
 
66,616

 
208,705

Balance at June 30, 2016
$
(273,398
)
 
$
641,255

 
$
21,375

 
$
(61,978
)
 
$
327,254

 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2015
 
Foreign
currency
translation
adjustment
 
Unrealized
gains on
securities
 
OTTI
 
Pension
under-
funding
 
Accumulated
other
comprehensive
income
Balance at December 31, 2014
$
(127,711
)
 
$
793,082

 
$
26,594

 
$
(136,198
)
 
$
555,767

Change in accumulated other comprehensive
  income (loss) before reclassifications
(45,800
)
 
(155,127
)
 
(2,470
)
 
(1
)
 
(203,398
)
Amounts reclassified from accumulated other
  comprehensive income

 
(10,478
)
 
1,295

 
5,233

 
(3,950
)
Net current-period other comprehensive (loss) income
(45,800
)
 
(165,605
)
 
(1,175
)
 
5,232

 
(207,348
)
Balance at June 30, 2015
$
(173,511
)
 
$
627,477

 
$
25,419

 
$
(130,966
)
 
$
348,419

 

33


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The following tables summarize the reclassifications out of accumulated other comprehensive income for the three and six months ended June 30, 2016 and 2015:
Details about accumulated other comprehensive income components
 
Amount reclassified from
accumulated other
comprehensive income
 
Affected line item in the
statement where net
income is presented
 
 
Three Months Ended June 30,
 
 
 
 
2016
 
2015
 
 
Unrealized gains on securities
 
$
(6,669
)
 
$
(10,064
)
 
Net realized gains on investments, excluding other-than-temporary impairment losses
 
 
2,334

 
3,522

 
Provision for income taxes
 
 
$
(4,335
)
 
$
(6,542
)
 
Net of tax
OTTI
 
$
53

 
$
(578
)
 
Portion of net loss recognized in other comprehensive income, before taxes
 
 
(19
)
 
202

 
Provision for income taxes
 
 
$
34

 
$
(376
)
 
Net of tax
Amortization of pension and postretirement
  unrecognized net periodic benefit cost:
 
 
 
 
 
 
Amortization of prior service cost
 
$

 
$
(25
)
 
(1)
Amortization of net loss
 
625

 
4,050

 
(1)
 
 
625

 
4,025

 
Total before tax
 
 
(219
)
 
(1,409
)
 
Provision for income taxes
 
 
$
406

 
$
2,616

 
Net of tax
Total reclassifications for the period
 
$
(3,895
)
 
$
(4,302
)
 
Net of tax
 
 
 
 
 
 
 
Details about accumulated other comprehensive income components
 
Amount reclassified from
accumulated other
comprehensive income
 
Affected line item in the
statement where net
income is presented
 
 
Six Months Ended June 30,
 
 
 
 
2016
 
2015
 
 
Unrealized gains on securities
 
$
(154,567
)
 
$
(16,120
)
 
Net realized gains on investments, excluding other-than-temporary impairment losses
 
 
54,098

 
5,642

 
Provision for income taxes
 
 
(100,469
)
 
(10,478
)
 
Net of tax
OTTI
 
485

 
1,992

 
Portion of net loss recognized in other comprehensive income, before taxes
 
 
(170
)
 
(697
)
 
Provision for income taxes
 
 
$
315

 
$
1,295

 
Net of tax
Amortization of pension and postretirement
  unrecognized net periodic benefit cost:
 
 
 
 
 
 
Amortization of prior service cost
 
$

 
$
(50
)
 
(1)
Amortization of net loss
 
1,250

 
8,100

 
(1)
Gain on pension plan curtailment
 
(29,578
)
 

 
Gain on pension plan curtailment
 
 
(28,328
)
 
8,050

 
Total before tax
 
 
9,915

 
(2,817
)
 
Provision for income taxes
 
 
(18,413
)
 
5,233

 
Net of tax
Total reclassifications for the period
 
$
(118,567
)
 
$
(3,950
)
 
Net of tax
(1)
These accumulated other comprehensive income components are included in the computation of net periodic pension cost. See Note 14 - Retirement and Other Employee Benefits for additional information.

34


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




11. Stock Based Compensation
Long-Term Equity Incentive Plan
Under the Assurant, Inc. Long-Term Equity Incentive Plan (“ALTEIP”), as amended and restated in May 2010, the Company is authorized to issue up to 5,300,000 new shares of the Company's common stock to employees, officers and non-employee directors. Under the ALTEIP, the Company may grant awards based on shares of its common stock, including stock options, stock appreciation rights (“SARs”), restricted stock (including performance shares), unrestricted stock, restricted stock units (“RSUs”), performance share units (“PSUs”) and dividend equivalents. All share-based grants are awarded under the ALTEIP.
The Compensation Committee of the Board of Directors (the “Compensation Committee”) awards PSUs and RSUs annually. RSUs and PSUs are promises to issue actual shares of common stock at the end of a vesting period or performance period. The RSUs granted to employees under the ALTEIP are based on salary grade and performance and vest one-third each year over a three-year period. RSUs granted to non-employee directors also vest one-third each year over a three-year period, however, issuance of vested shares is deferred until separation from Board service. RSUs receive dividend equivalents in cash during the restricted period and do not have voting rights during the restricted period. PSUs accrue dividend equivalents during the performance period based on a target payout, and will be paid in cash at the end of the performance period based on the actual number of shares issued. The fair value of RSUs is estimated using the fair market value of a share of the Company’s common stock at the date of grant. The fair value of PSUs is estimated using the Monte Carlo simulation model and is described in further detail below.
     For the PSU portion of an award, the number of shares a participant will receive upon vesting is contingent upon the Company’s performance with respect to selected metrics, as identified below. The payout levels for 2016 awards can vary between 0% and 200% (maximum) of the target (100%) ALTEIP award amount and the payout levels for 2015 awards and prior can vary between 0% and 150% (maximum) of the target (100%) ALTEIP award amount, based on the Company’s level of performance against the selected metrics.
2016 PSU Performance Goals. The Compensation Committee established total shareholder return and net operating earnings per diluted share, excluding reportable catastrophe losses, as the two equally weighted performance measures for PSU awards in 2016. Total shareholder return is defined as appreciation in Company stock plus dividend yield to stockholders and will be measured by the performance of the Company relative to the S&P 500 Index over the three-year performance period. Net operating earnings per diluted share, excluding reportable catastrophe losses, is a Company-specific profitability metric and is defined as the Company’s net operating earnings, excluding reportable catastrophe losses, divided by the number of fully diluted shares outstanding at the end of the period. This metric is an absolute metric that is measured against a three-year cumulative target established by the Compensation Committee at the award date, and is not tied to the performance of peer companies.
2015 and prior PSU Performance Goals. The Compensation Committee established book value per share (“BVPS”) growth excluding AOCI, revenue growth and total stockholder return as the three performance measures for PSU awards in 2015 and prior. BVPS growth is defined as the year-over-year growth of the Company’s stockholders’ equity excluding AOCI divided by the number of fully diluted total shares outstanding at the end of the period. Revenue growth is defined as the year-over-year change in total revenues as disclosed in the Company’s annual statement of operations. Total stockholder return is defined as appreciation in Company stock plus dividend yield to stockholders. Payouts will be determined by measuring performance against the average performance of companies included in an insurance industry market index.
From 2009 to 2013, the Company used the A.M. Best U.S. Insurance Index to measure its relative performance ranking. In 2014, A.M. Best stopped publishing this index. As of January 1, 2014, the Company is using the S&P Total Market Index to measure the Company’s performance for all outstanding PSU awards in 2015 and prior. Consistent with adjustments made to the A.M. Best U.S. Insurance Index, adjustments will be made to the S&P Total Market Index to exclude companies with revenues of less than $1,000,000 or that are not in the insurance or managed healthcare Global Industry Classification Standard codes. In addition, companies within the Company’s compensation peer group, but not otherwise in the S&P Total Market Index, will be included. The adjusted S&P Total Market Index is substantially similar in composition to the previous A.M. Best U.S. Insurance Index.
Under the ALTEIP, the Company’s Chief Executive Officer (“CEO”) is authorized by the Board of Directors to grant common stock, restricted stock and RSUs to employees other than the executive officers of the Company (as defined in

35


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). The Compensation Committee reviews these grants semi-annually. Restricted stock and RSUs granted under this program may have different vesting periods.
Restricted Stock Units
RSUs granted to employees and to non-employee directors were 62,116 and 54,576 for the three months ended June 30, 2016 and 2015, respectively, and 310,094 and 339,398 for the six months ended June 30, 2016 and 2015, respectively. The compensation expense recorded related to RSUs was $5,429 and $5,951 for the three months ended June 30, 2016 and 2015, respectively, and $8,799 and $10,459 for the six months ended June 30, 2016 and 2015, respectively. The related total income tax benefit was $1,899 and $2,082 for the three months ended June 30, 2016 and 2015, respectively, and $3,076 and $3,660 for the six months ended June 30, 2016 and 2015, respectively. The weighted average grant date fair value for RSUs granted during the six months ended June 30, 2016 and 2015 was $78.28 and $62.22, respectively.
As of June 30, 2016, there was $24,882 of unrecognized compensation cost related to outstanding RSUs. That cost is expected to be recognized over a weighted-average period of 1.51 years. The total fair value of RSUs vested during the three months ended June 30, 2016 and 2015 was $1,713 and $4,959, respectively, and $21,270 and $24,474 for the six months ended June 30, 2016 and 2015, respectively.
Performance Share Units
PSUs granted to employees were 10,182 for the three months ended June 30, 2016. No PSUs were granted to employees during the three months ended June 30, 2015. PSUs granted to employees were 258,646 and 355,688 for the six months ended June 30, 2016 and 2015, respectively. The compensation expense recorded related to PSUs was $1,387 and $1,266 for the three months ended June 30, 2016 and 2015, respectively, and $4,235 and $2,332 for the six months ended June 30, 2016 and 2015, respectively. The related total income tax benefit was $486 and $440 for the three months ended June 30, 2016 and 2015, respectively, and $1,478 and $813 for the six months ended June 30, 2016 and 2015, respectively. The weighted average grant date fair value for PSUs granted during the six months ended June 30, 2016 and 2015 was $80.82 and $61.82, respectively.
As of June 30, 2016, there was $26,163 of unrecognized compensation cost related to outstanding PSUs. That cost is expected to be recognized over a weighted-average period of 1.18 years. 
The fair value of PSUs with market conditions was estimated on the date of grant using a Monte Carlo simulation model, which utilizes multiple variables that determine the probability of satisfying the market condition stipulated in the award. Expected volatilities for awards issued during the six months ended June 30, 2016 and 2015 were based on the historical stock prices of the Company’s stock and peer group. The expected term for grants issued during the six months ended June 30, 2016 and 2015 was assumed to equal the average of the vesting period of the PSUs. The risk-free rate was based on the U.S. Treasury yield curve in effect at the time of grant.
Employee Stock Purchase Plan
Under the Employee Stock Purchase Plan (“ESPP”), the Company is authorized to issue up to 5,000,000 new shares to employees who are participants in the ESPP. Eligible employees can purchase shares at a 10% discount applied to the lower of the closing price of the common stock on the first or last day of the offering period.
In January 2016, the Company issued 59,102 shares at a discounted price of $61.70 for the offering period of July 1, 2015 through December 31, 2015. In January 2015, the Company issued 65,302 shares at a discounted price of $59.65 for the offering period of July 1, 2014 through December 31, 2014.
In July 2016, the Company issued 45,649 shares at a discounted price of $70.67 for the offering period of January 1, 2016 through June 30, 2016. In July 2015, the Company issued 65,320 shares at a discounted price of $60.30 for the offering period of January 1, 2015 through June 30, 2015.
The compensation expense recorded related to the ESPP was $320 and $316 for the three months ended June 30, 2016 and 2015, respectively, and $640 and $632 for the six months ended June 30, 2015 and 2016, respectively.
The fair value of each award under the ESPP was estimated at the beginning of each offering period using the Black-Scholes option-pricing model. Expected volatilities are based on implied volatilities from traded options on the Company’s stock and the historical volatility of the Company’s stock. The risk-free rate for periods within the contractual life of the option

36


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield is based on the current annualized dividend and share price as of the grant date.
12. Stock Repurchase
The following table shows the shares repurchased during the periods indicated: 
Period in 2016
Number of
Shares Repurchased
 
Average Price
Paid Per Share
 
Total Number of Shares
Repurchased as Part of
Publicly Announced
Programs
January
1,147,337

 
$
78.44

 
1,147,337

February
869,898

 
70.69

 
869,898

March
1,405,025

 
76.12

 
1,405,025

April
1,033,098

 
79.90

 
1,033,098

May
845,869

 
87.01

 
845,869

June
439,031

 
84.75

 
439,031

Total
5,740,258

 
$
78.71

 
5,740,258

On November 15, 2013, and September 9, 2015, the Company’s Board of Directors authorized the Company to repurchase up to $600,000 and an additional $750,000, respectively, of its outstanding common stock.
During the six months ended June 30, 2016, the Company repurchased 5,740,258 shares of the Company’s outstanding common stock at a cost of $451,697, exclusive of commissions, leaving $500,406 remaining under the total repurchase authorization at June 30, 2016.
The timing and the amount of future repurchases will depend on market conditions, the Company's financial condition, results of operations, liquidity and other factors.

37


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




13. Earnings Per Common Share
The following table presents net income, the weighted average common shares used in calculating basic earnings per common share (“EPS”) and those used in calculating diluted EPS for each period presented below. 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2016
 
2015
 
2016
 
2015
Numerator
 
 
 
 
 
 
 
Net income
$
169,349

 
$
32,789

 
$
389,667

 
$
82,833

Deduct dividends paid
(32,519
)
 
(21,616
)
 
(64,966
)
 
(40,450
)
Undistributed earnings
$
136,830

 
$
11,173

 
$
324,701

 
$
42,383

Denominator
 
 
 
 
 
 
 
Weighted average shares outstanding used in basic
  earnings per share
62,244,778

 
68,558,472

 
63,665,856

 
69,161,001

Incremental common shares from:
 
 
 
 
 
 
 
PSUs
431,575

 
621,327

 
561,214

 
720,763

ESPPs
46,939

 
64,600

 
46,939

 
64,600

Weighted average shares used in diluted earnings per
  share calculations
62,723,292

 
69,244,399

 
64,274,009

 
69,946,364

Earnings per common share - Basic
 
 
 
 
 
 
 
Distributed earnings
$
0.52

 
$
0.30

 
$
1.02

 
$
0.57

Undistributed earnings
2.20

 
0.18

 
5.10

 
0.63

Net income
$
2.72

 
$
0.48

 
$
6.12

 
$
1.20

Earnings per common share - Diluted
 
 
 
 
 
 
 
Distributed earnings
$
0.52

 
$
0.30

 
$
1.01

 
$
0.57

Undistributed earnings
2.18

 
0.17

 
5.05

 
0.61

Net income
$
2.70

 
$
0.47

 
$
6.06

 
$
1.18

Average PSUs totaling 2,909 and 2,944 for the three and six months ended June 30, 2016, respectively, were outstanding but were anti-dilutive and thus not included in the computation of diluted EPS under the treasury stock method. There were no anti-dilutive PSUs outstanding during the three and six months ended June 30, 2015.

38


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




14. Retirement and Other Employee Benefits
The components of net periodic benefit (gain) cost for the Company’s qualified pension benefits plan, nonqualified pension benefits plan and retirement health benefits plan for the three and six months ended June 30, 2016 and 2015 were as follows: 
 
Qualified Pension
Benefits
 
Nonqualified Pension
Benefits (1)
 
Retirement Health
Benefits
 
For the Three Months Ended June 30,
 
For the Three Months Ended June 30,
 
For the Three Months Ended June 30,
 
2016 Plan 1
2016 Plan 2
 
2015
 
2016
 
2015
 
2016
 
2015
Service cost
$

$

 
$
9,750

 
$
100

 
$
1,125

 
$

 
$
625

Interest cost
3,400

3,500

 
9,050

 
925

 
1,350

 
875

 
950

Expected return on plan assets
(7,800
)
(5,950
)
 
(13,725
)
 

 

 
(750
)
 
(825
)
Amortization of prior service cost


 

 

 
200

 

 
(225
)
Amortization of net loss

325

 
3,325

 
300

 
725

 

 

Curtailment/settlement charge


 

 

 
400

 

 

Net periodic benefit (gain) cost
$
(4,400
)
$
(2,125
)
 
$
8,400

 
$
1,325

 
$
3,800

 
$
125

 
$
525

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Qualified Pension
Benefits
 
Nonqualified Pension
Benefits (1)
 
Retirement Health
Benefits
 
For the Six Months Ended June 30,
 
For the Six Months Ended June 30,
 
For the Six Months Ended June 30,
 
2016 Plan 1
2016 Plan 2
 
2015
 
2016
 
2015
 
2016
 
2015
Service cost
$

$

 
$
19,500

 
$
200

 
$
2,250

 
$

 
$
1,250

Interest cost
6,800

7,000

 
18,100

 
1,850

 
2,700

 
1,750

 
1,900

Expected return on plan assets
(15,600
)
(11,900
)
 
(27,450
)
 

 

 
(1,500
)
 
(1,650
)
Amortization of prior service cost


 

 

 
400

 

 
(450
)
Amortization of net loss

650

 
6,650

 
600

 
1,450

 

 

Curtailment/settlement (gain) charge
(23,057
)

 

 
(2,285
)
 
800

 
(4,236
)
 

Net periodic benefit (gain) cost
$
(31,857
)
$
(4,250
)
 
$
16,800

 
$
365

 
$
7,600

 
$
(3,986
)
 
$
1,050

 
(1)
The Company’s nonqualified plan is unfunded.
Effective January 1, 2014, the Assurant Pension Plan (the "Plan"), Assurant Executive Pension Plan and Assurant Supplemental Executive Retirement Plan ("SERP") were closed to new hires. Effective January 1, 2016, the Plan was amended and split into two separate plans, the Assurant Pension Plan No. 1 (Plan No. 1) and the Assurant Pension Plan No. 2 (Plan No. 2). Plan No. 2 generally includes a subset of the terminated vested population and the total population who commenced distribution of their accrued benefit prior to January 1, 2016. Plan No. 1 generally covers all other eligible employees (including the active population as of January 1, 2016, the remainder of the terminated vested population and all Puerto Rico participants). Assets for both plans will remain in the Assurant, Inc. Pension Plan Trust.
Effective March 1, 2016, the Plan, the Assurant Executive Pension Plan, the SERP and the Retiree Medical Plan were amended such that no additional benefits will be earned after February 29, 2016. In connection with this amendment, the Company recorded a non-cash, curtailment gain of $29,578 in the first quarter 2016, which is included in the gain on pension plan curtailment caption in the consolidated statements of operations.
Also as a result of the curtailment, the Plan's funded status increased to $33,353 (based on the fair value of the assets compared to the accumulated benefit obligation) at June 30, 2016 from $(51,973) (based on the fair value of the assets compared to the projected benefit obligation) at December 31, 2015. This equates to a 104% and 94% funded status at June 30, 2016 and December 31, 2015, respectively. During the first six months of 2016, no cash was contributed to the Plan. Due to the Plan's current funded status, no additional cash is expected to be contributed to the Plan over the remainder of 2016.

39


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




During the first quarter of 2016, the Company announced that it will make a special, one-time contribution of three percent of eligible pay into the defined contribution plan for all active employees as of December 31, 2016. Employees whose employment ends between March 1 and December 30, 2016 due to death, total disability, retirement (as defined in the Plan) or as part of an involuntary termination without cause initiated by the Company are also eligible for this contribution. The Company had $11,540 accrued in connection with this special, one-time contribution as of June 30, 2016.
15. Segment Information
During 2016, the Company announced its plans to realign its lines of business under a newly created Chief Operating Officer position. The senior management team continues to work on the new organizational framework and corresponding operating structure. The presentation of the segments described below is expected to be modified accordingly and prior periods' presentations revised to conform to the new operating segments. The Company expects such changes to be in effect in 2017.
As previously announced, the Company will substantially exit the health insurance market by the end of 2016 and sold its Assurant Employee Benefits segment on March 1, 2016, mainly through a series of reinsurance transactions. For more information see Notes 4 and 5, respectively. As of June 30, 2016, the Company has five reportable segments, which are defined based on the nature of the products and services offered:
Assurant Solutions: provides mobile device protection and related services; vehicle protection; pre-funded funeral insurance and credit insurance.
Assurant Specialty Property: provides renters insurance; lender-placed homeowners insurance; mortgage valuation and field services and manufactured housing insurance.
Corporate & Other: includes activities of the holding company, financing and interest expenses, net realized gains (losses) on investments and interest income earned from short-term investments held. Corporate & Other also includes the amortization of deferred gains associated with the sales of Fortis Financial Group, Long-Term Care and Assurant Employee Benefits through reinsurance agreements and other unusual and infrequent items, including the loss related to the sale of Assurant Employee Benefits.
Assurant Health: includes amounts related to the previously announced exit from the health insurance market.
Assurant Employee Benefits: includes the results of operations for the periods prior to its sale on March 1, 2016.
The Company evaluates performance of the operating segments (Assurant Solutions; Assurant Specialty Property and Corporate & Other) based on segment income (loss) after-tax. The Company determines reportable segments in a manner consistent with the way the Chief Operating Decision Maker makes operating decisions and assesses performance.

40


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




The following tables summarize selected financial information by segment: 
 
Three Months Ended June 30, 2016
 
Solutions
 
Specialty
Property
 
Health
 
Corporate &
Other
 
Consolidated
Revenues
 
 
 
 
 
 
 
 
 
Net earned premiums
$
755,252

 
$
451,318

 
$
(4,346
)
 
$

 
$
1,202,224

Fees and other income
202,908

 
109,846

 
8,284

 
7,267

 
328,305

Net investment income
88,362

 
17,823

 
1,983

 
11,652

 
119,820

Net realized gains on investments

 

 

 
21,626

 
21,626

Amortization of deferred gain on disposal of
  businesses (1)

 

 

 
125,818

 
125,818

Total revenues
1,046,522

 
578,987

 
5,921

 
166,363

 
1,797,793

Benefits, losses and expenses
 
 
 
 
 
 
 
 
 
Policyholder benefits
222,230

 
202,659

 
(24,075
)
 

 
400,814

Amortization of deferred acquisition
  costs and value of business acquired
283,032

 
59,608

 

 

 
342,640

Underwriting, general and
  administrative expenses (2)
475,935

 
231,920

 
37,763

 
57,977

 
803,595

Interest expense

 

 

 
15,232

 
15,232

Total benefits, losses and expenses
981,197

 
494,187

 
13,688

 
73,209

 
1,562,281

Segment income (loss) before
  provision (benefit) for income tax
65,325

 
84,800

 
(7,767
)
 
93,154

 
235,512

Provision (benefit) for income taxes
3,925

 
27,859

 
(2,341
)
 
36,720

 
66,163

Segment income (loss) after tax
$
61,400

 
$
56,941

 
$
(5,426
)
 
$
56,434

 
 
Net income
 
 
 
 
 
 
 
 
$
169,349


(1)
Includes $122,835 related to the additional deferred gain related to the Assurant Employee Benefits sale on March 1, 2016.
(2)
Corporate & Other includes a $16,672 intangible asset impairment charge related to trade names that will no longer be used or defended by the Company.

41


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 





 
Three Months Ended June 30, 2015
 
Solutions
 
Specialty
Property
 
Health
 
Employee
Benefits
 
Corporate &
Other
 
Consolidated
Revenues
 
 
 
 
 
 
 
 
 
 
 
Net earned premiums
$
752,604

 
$
532,022

 
$
584,443

 
$
269,189

 
$

 
$
2,138,258

Fees and other income
178,578

 
106,128

 
17,047

 
6,460

 
15,396

 
323,609

Net investment income
99,976

 
25,443

 
7,014

 
30,020

 
5,333

 
167,786

Net realized gains on investments

 

 

 

 
11,999

 
11,999

Amortization of deferred gain on
  disposal of businesses

 

 

 

 
3,242

 
3,242

Total revenues
1,031,158

 
663,593

 
608,504

 
305,669

 
35,970

 
2,644,894

Benefits, losses and expenses
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits
235,099

 
214,605

 
625,323

 
192,687

 

 
1,267,714

Amortization of deferred acquisition
  costs and value of business acquired
276,823

 
66,111

 
2,917

 
8,032

 

 
353,883

Underwriting, general and
  administrative expenses
437,917

 
252,495

 
158,608

 
88,241

 
32,233

 
969,494

Interest expense

 

 

 

 
13,778

 
13,778

Total benefits, losses and
  expenses
949,839

 
533,211

 
786,848

 
288,960

 
46,011

 
2,604,869

Segment income (loss) before
  provision (benefit) for income tax
81,319

 
130,382

 
(178,344
)
 
16,709

 
(10,041
)
 
40,025

Provision (benefit) for income taxes
20,504

 
42,848

 
(54,569
)
 
5,441

 
(6,988
)
 
7,236

Segment income (loss) after tax
$
60,815

 
$
87,534

 
$
(123,775
)
 
$
11,268

 
$
(3,053
)
 
 
Net income
 
 
 
 
 
 
 
 
 
 
$
32,789


42


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




 
Six Months Ended June 30, 2016
 
Solutions
 
Specialty
Property
 
Health
 
Employee
Benefits (1)
 
Corporate &
Other
 
Consolidated
Revenues
 
 
 
 
 
 
 
 
 
 
 
Net earned premiums
$
1,494,176

 
$
920,927

 
$
24,388

 
$
177,971

 
$

 
$
2,617,462

Fees and other income
441,017

 
217,608

 
13,402

 
4,244

 
9,724

 
685,995

Net investment income
177,285

 
36,167

 
5,921

 
17,340

 
18,814

 
255,527

Net realized gains on investments (2)

 

 

 

 
183,344

 
183,344

Amortization of deferred gain on
  disposal of businesses (3)

 

 

 

 
173,414

 
173,414

Gain on pension plan curtailment

 

 

 

 
29,578

 
29,578

Total revenues
2,112,478

 
1,174,702

 
43,711

 
199,555

 
414,874

 
3,945,320

Benefits, losses and expenses
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits
448,981

 
382,131

 
(4,963
)
 
118,481

 

 
944,630

Amortization of deferred acquisition
  costs and value of business acquired
552,042

 
119,082

 

 
5,858

 

 
676,982

Underwriting, general and
  administrative expenses
977,145

 
473,354

 
90,718

 
58,469

 
121,268

 
1,720,954

Interest expense

 

 

 

 
29,735

 
29,735

Total benefits, losses and
  expenses
1,978,168

 
974,567

 
85,755

 
182,808

 
151,003

 
3,372,301

Segment income (loss) before
  provision (benefit) for income tax
134,310

 
200,135

 
(42,044
)
 
16,747

 
263,871

 
573,019

Provision (benefit) for income taxes
25,776

 
66,843

 
(9,445
)
 
6,277

 
93,901

 
183,352

Segment income (loss) after tax
$
108,534

 
$
133,292

 
$
(32,599
)
 
$
10,470

 
$
169,970

 
 
Net income
 
 
 
 
 
 
 
 
 
 
$
389,667

 
As of June 30, 2016
 
 
 
 
 
 
 
 
 
 
 
 
Segment assets:
$
14,830,610

 
$
3,632,142

 
$
723,107

 
$

 
$
10,618,354

 
$
29,804,213

 
(1)
Assurant Employee Benefits amounts represent January and February results of operations prior to the sale on March 1, 2016.
(2)
Includes $146,727 related to assets transferred to Sun Life as part of the Assurant Employee Benefits sale on March 1, 2016.
(3)
Includes $167,428 related to the additional deferred gain related to the Assurant Employee Benefits sale on March 1, 2016.

43


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




 
Six Months Ended June 30, 2015
 
Solutions
 
Specialty
Property
 
Health
 
Employee
Benefits
 
Corporate &
Other
 
Consolidated
Revenues
 
 
 
 
 
 
 
 
 
 
 
Net earned premiums
$
1,507,081

 
$
1,060,468

 
$
1,194,185

 
$
536,086

 
$

 
$
4,297,820

Fees and other income
351,646

 
190,364

 
33,023

 
12,734

 
15,404

 
603,171

Net investment income
192,167

 
45,958

 
14,021

 
57,841

 
10,072

 
320,059

Net realized gains on investments

 

 

 

 
15,954

 
15,954

Amortization of deferred gain on
  disposal of businesses

 

 

 

 
6,500

 
6,500

Total revenues
2,050,894

 
1,296,790

 
1,241,229

 
606,661

 
47,930

 
5,243,504

Benefits, losses and expenses
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits
450,647

 
419,208

 
1,230,086

 
378,500

 

 
2,478,441

Amortization of deferred acquisition
  costs and value of business acquired
541,855

 
158,180

 
7,190

 
15,661

 

 
722,886

Underwriting, general and
  administrative expenses
897,201

 
476,107

 
287,786

 
179,580

 
50,729

 
1,891,403

Interest expense

 

 

 

 
27,556

 
27,556

Total benefits, losses and
  expenses
1,889,703

 
1,053,495

 
1,525,062

 
573,741

 
78,285

 
5,120,286

Segment income (loss) before
  provision (benefit) for income tax
161,191

 
243,295

 
(283,833
)
 
32,920

 
(30,355
)
 
123,218

Provision (benefit) for income taxes
46,017

 
80,674

 
(76,089
)
 
11,504

 
(21,721
)
 
40,385

Segment income (loss) after tax
$
115,174

 
$
162,621

 
$
(207,744
)
 
$
21,416

 
$
(8,634
)
 
 
Net income
 
 
 
 
 
 
 
 
 
 
$
82,833

 
As of December 31, 2015
 
 
 
 
 
 
 
 
 
 
 
 
Segment assets:
$
14,356,484

 
$
3,648,738

 
$
1,437,032

 
$
2,190,808

 
$
8,403,340

 
$
30,036,402

 


16. Commitments and Contingencies
In the normal course of business, letters of credit are issued primarily to support reinsurance arrangements in which the Company is the reinsurer. These letters of credit are supported by commitments under which the Company is required to indemnify the financial institution issuing the letter of credit if the letter of credit is drawn. The Company had $12,491 and $19,809 of letters of credit outstanding as of June 30, 2016 and December 31, 2015, respectively.
On January 16, 2015, the National Association of Insurance Commissioners (the "NAIC") authorized a multistate targeted market conduct examination regarding the Company's lender placed insurance products. Various underwriting companies, including American Security Insurance Company, are subject to the examination. At present, 44 jurisdictions are participating. The Company has cooperated in responding to requests for information and documents and has engaged in various communications with the examiners. The examination and discussions with the examiners continue.
In addition, the Company is involved in a variety of litigation relating to its current and past business operations and, from time to time, it may become involved in other such actions. In particular, the Company is a defendant in class actions in a number of jurisdictions regarding its lender-placed insurance programs. These cases assert a variety of claims under a number of legal theories. The plaintiffs seek premium refunds and other relief. The Company continues to defend itself vigorously in these class actions. We have participated and may participate in settlements on terms that we consider reasonable given the strength of our defenses and other factors.

44


Assurant, Inc.
Notes to Consolidated Financial Statements (unaudited)
Three and Six Months Ended June 30, 2016 and 2015
(In thousands, except number of shares and per share amounts)
 
 
 




In July 2007 an Assurant subsidiary acquired Swansure Group, a privately held U.K. company, which owned D&D Homecare Limited (“D&D”). D&D was a packager of mortgages and certain insurance products, including Payment Protection Insurance (“PPI”) policies that, for a period of time, were underwritten by an Assurant subsidiary and sold by various alleged agents, including Carrington Carr Home Finance Limited (“CCHFL”), which is now in administration. In early 2014, as a result of consumer complaints alleging that CCHFL missold certain D&D-packaged PPI policies between August 8, 2003 and November 1, 2004, the U.K. Financial Ombudsman Service (“FOS”) requested that an Assurant subsidiary, Assurant Intermediary Limited (“AIL”), review complaints relating to CCHFL’s sale of such PPI policies. In February 2016, the FOS issued a final decision in favor of AIL’s challenge to the FOS’s jurisdiction on the CCHF population of cases.
The Company has accrued a liability for the legal and regulatory proceedings discussed above. However, the possible loss or range of loss resulting from such litigation and regulatory proceedings, if any, in excess of the amounts accrued is inherently unpredictable and uncertain. Consequently, no estimate can be made of any possible loss or range of loss in excess of the accrual. Although the Company cannot predict the outcome of any pending legal or regulatory action, or the potential losses, fines, penalties or equitable relief, if any, that may result, it is possible that such outcome could have a material adverse effect on the Company’s consolidated results of operations or cash flows for an individual reporting period. However, based on currently available information, management does not believe that the pending matters are likely to have a material adverse effect, individually or in the aggregate, on the Company’s financial condition.
17. Income Taxes
During the three months ended June 30, 2016, the Company recorded a net tax benefit of $18,000 in the Assurant Solutions segment. The tax benefit was driven by an international restructuring, in which there was a redemption of shares. For U.S. tax purposes, the redemption was treated as a dividend of the shares, attracted foreign tax credits and resulted in a tax benefit of $18,000.
During the three months ended June 30, 2015, the Company recorded a net tax benefit of $8,448 in the Assurant Solutions segment. The tax benefit was primarily a result of an international reorganization.
18. Catastrophe Bond Program
On June 26, 2013, certain of the Company's subsidiaries ("the Subsidiaries") entered into three reinsurance agreements with Ibis Re II Ltd. ("Ibis Re II") providing up to $185,000 of reinsurance coverage for protection against losses over a three-year period from individual hurricane events in Hawaii, Puerto Rico, and along the Gulf and Eastern Coasts of the United States. Ibis Re II financed the property catastrophe reinsurance coverage by issuing $185,000 in catastrophe bonds to unrelated investors (the “Series 2013-1 Notes”). The agreements expired in June 2016.


45


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
(Dollar amounts in thousands, except number of shares and per share amounts)
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) addresses the financial condition of Assurant, Inc. (which we refer to as “Assurant” or the "Company”) as of June 30, 2016, compared with December 31, 2015, and our results of operations for the three and six months ended June 30, 2016 and 2015. This discussion should be read in conjunction with our MD&A and annual audited consolidated financial statements for the year ended December 31, 2015 included in our Annual Report on Form 10-K for the year ended December 31, 2015 filed with the U.S. Securities and Exchange Commission (the “SEC”) and the unaudited consolidated financial statements for the three and six months ended June 30, 2016 and related notes included elsewhere in this Quarterly Report on Form 10-Q (this "Report"). The 2015 Annual Report on Form 10-K, this Report, and other documents related to the Company are available free of charge through the SEC website at www.sec.gov and through our website at www.assurant.com.
Some statements in this MD&A and elsewhere in this Report, particularly those anticipating future financial performance, business prospects, growth and operating strategies and similar matters, are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of words such as “will,” “may,” “anticipates,” “expects,” “estimates,” “projects,” “intends,” “plans,” “believes,” “targets,” “forecasts,” “potential,” “approximately,” or the negative version of those words and other words and terms with a similar meaning. Any forward-looking statements contained in this Report are based upon our historical performance and on current plans, estimates and expectations. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved. Our actual results might differ materially from those projected in the forward-looking statements. The Company undertakes no obligation to update or review any forward-looking statement, whether as a result of new information, future events or other developments.
In addition to the factors described under “Critical Factors Affecting Results,” the following risk factors could cause our actual results to differ materially from those currently estimated by management:
i.
actions by governmental agencies or government sponsored entities or other circumstances, including pending regulatory matters affecting our lender-placed insurance business, that could result in reductions of premium rates or increases in expenses, including claims, commissions, fines, penalties or other expenses;
ii.
loss of significant client relationships or business, distribution sources or contracts and reliance on a few clients;
iii.
potential variations between the final risk adjustment amount and reinsurance amounts, as determined by the U.S. Department of Health and Human Services under the Affordable Care Act, and the Company's estimate;
iv.
unfavorable outcomes in litigation and/or regulatory investigations that could negatively affect our results, business and reputation;
v.
inability to execute strategic plans related to acquisitions, dispositions or new ventures;
vi.
failure to adequately predict or manage benefits, claims and other costs;
vii.
inadequacy of reserves established for future claims;
viii.
current or new laws and regulations that could increase our costs and decrease our revenues;
ix.
significant competitive pressures in our businesses;
x.
failure to attract and retain sales representatives, key managers, agents or brokers;
xi.
losses due to natural or man-made catastrophes;
xii.
a decline in our credit or financial strength ratings (including the risk of ratings downgrades in the insurance industry);
xiii.
deterioration in the Company’s market capitalization compared to its book value that could result in an impairment of goodwill;
xiv.
risks related to our international operations, including fluctuations in exchange rates;
xv.
data breaches compromising client information and privacy;

46


xvi.
general global economic, financial market and political conditions (including difficult conditions in financial, capital, credit and currency markets, the global economic slowdown, fluctuations in interest rates or a prolonged period of low interest rates, monetary policies, unemployment and inflationary pressure);
xvii.
cyber security threats and cyber attacks;
xviii.
failure to effectively maintain and modernize our information systems;
xix.
uncertain tax positions and unexpected tax liabilities;
xx.
risks related to outsourcing activities;
xxi.
unavailability, inadequacy and unaffordable pricing of reinsurance coverage;
xxii.
diminished value of invested assets in our investment portfolio (due to, among other things, volatility in financial markets; the global economic slowdown; credit, currency and liquidity risk; other than temporary impairments and increases in interest rates);
xxiii.
insolvency of third parties to whom we have sold or may sell businesses through reinsurance or modified co-insurance;
xxiv.
inability of reinsurers to meet their obligations;
xxv.
credit risk of some of our agents in Assurant Specialty Property and Assurant Solutions;
xxvi.
inability of our subsidiaries to pay sufficient dividends;
xxvii.
failure to provide for succession of senior management and key executives; and
xxviii.
cyclicality of the insurance industry.
For a more detailed discussion of the risk factors that could affect our actual results, please refer to “Item 1A-Risk Factors” and “Item 7-MD&A Critical Factors Affecting Results” in our 2015 Annual Report on Form 10-K and “Item 1A-Risk Factors” in the Quarterly Report on Form 10-Q for the three months ended March 31, 2016 (the "First Quarter Report").
General
During 2016, the Company announced its plans to realign its lines of business under a newly created Chief Operating Officer position. The senior management team continues to work on the new organizational framework and corresponding operating structure. The presentation of the segments described below is expected to be modified accordingly and prior periods' presentations revised to conform to the new operating segments. The Company expects such changes to be in effect in 2017.
As previously announced, the Company will substantially exit the health insurance market by the end of 2016 and sold its Assurant Employee Benefits segment on March 1, 2016, mainly through a series of reinsurance transactions. For more information see Notes 4 and 5, respectively, to the consolidated financial statements, included elsewhere in the Report. As of June 30, 2016, the Company has five reportable segments, which are defined based on the nature of the products and services offered:
Assurant Solutions: provides mobile device protection and related services; vehicle protection; pre-funded funeral insurance and credit insurance.
Assurant Specialty Property: provides renters insurance; lender-placed homeowners insurance; mortgage valuation and field services and manufactured housing insurance.
Corporate & Other: includes activities of the holding company, financing and interest expenses, net realized gains (losses) on investments and interest income earned from short-term investments held. Corporate & Other also includes the amortization of deferred gains associated with the sales of Fortis Financial Group, Long-Term Care and Assurant Employee Benefits through reinsurance agreements and other unusual and infrequent items, including the loss related to the sale of Assurant Employee Benefits.
Assurant Health: includes amounts related to the previously announced exit from the health insurance market.
Assurant Employee Benefits: includes the results of operations for the periods prior to its sale on March 1, 2016.

47


The Company evaluates performance of the operating segments (Assurant Solutions; Assurant Specialty Property and Corporate & Other) based on segment income (loss) after-tax. The Company determines reportable segments in a manner consistent with the way the Chief Operating Decision Maker makes operating decisions and assesses performance.
The following discussion relates to the three and six months ended June 30, 2016 (“Second Quarter 2016” and "Six Months 2016") and the three and six months ended June 30, 2015 (“Second Quarter 2015” and "Six Months 2015").
Executive Summary
As previously announced, the Company concluded a comprehensive review of its portfolio and has sharpened its focus on specialty housing and lifestyle protection products and services. As a result, the Company will substantially exit the health insurance market by December 31, 2016 and, on March 1, 2016, the Company completed the sale, mainly through a series of reinsurance transactions, of its Assurant Employee Benefits segment to Sun Life Assurance Company of Canada, a subsidiary of Sun Life Financial Inc. (“Sun Life”), for net cash consideration of $926,174. For more information on the sale, see Note 5 to the consolidated financial statements, included elsewhere in this Report.
Consolidated net income increased $136,560, or 416%, to $169,349 for Second Quarter 2016, compared with $32,789 of net income for Second Quarter 2015. For Six Months 2016, net income increased $306,834, or 370%, to $389,667, compared with $82,833 for Six Months 2015. The increase in Second Quarter 2016 compared to Second Quarter 2015 was primarily due to lower losses and exit-related charges from the wind down of Assurant Health and the increase in the amortization of deferred gains due to the first quarter 2016 sale of Assurant Employee Benefits.
Assurant Solutions net income increased $585, or 1%, to $61,400 for Second Quarter 2016 from $60,815 for Second Quarter 2015. The increase was due to a larger tax benefit related to a redemption of shares in our international structure. Absent this item, segment net income declined, primarily due to lower service contract contributions from North American retail clients and the previously disclosed loss of a domestic tablet program.
Second Quarter 2016 net earned premiums and fees increased $26,978 compared with Second Quarter 2015 primarily due to an increase in covered mobile devices and growth in vehicle service contracts. Our vehicle service contracts business benefited from strong U.S. vehicle sales and a one-time contribution from a client. This was partially offset by declines in service contract revenue from certain North American retailers, the impact of the loss of the tablet program and foreign currency exchange volatility, particularly in Argentina.
Overall, we expect Assurant Solution's full year net income and net earned premiums and fees to increase from 2015 levels. We expect the increase in net income to be driven by increased revenue from new mobile programs, improved international profitability and savings from expense initiatives focused on legacy, run-off businesses. We expect 2016 results to be affected by foreign currency exchange volatility, lower service contract revenue from North American retail clients and continued declines in our credit insurance business.
Assurant Specialty Property net income decreased $30,593, or 35%, to $56,941 for Second Quarter 2016 from $87,534 for Second Quarter 2015 primarily due to the ongoing normalization of lender-placed homeowners insurance business, lower real-estate owned ("REO") policy volume, the previously disclosed loss of business and higher weather-related claims. The REO product is insurance we provide on foreclosed properties managed by our clients. Second Quarter 2016 results include $16,004 (after-tax) of reportable catastrophe losses, compared to $6,105 (after-tax) in Second Quarter 2015.
Net earned premiums and fees decreased $76,986 in Second Quarter 2016 compared with Second Quarter 2015, primarily due to lower placement and premium rates in the lender-placed homeowners insurance business, previously disclosed loss of client business as well as lower REO policies. Partially offsetting these items was growth in our multi-family housing and mortgage solutions businesses. Multi-family housing revenue increased due to growth in our affinity channels and property management network, while mortgage solutions fees grew due to increases in property preservation and default appraisal services.
In June 2016, we finalized our catastrophe reinsurance program, purchasing $1,400,000 of coverage while lowering our U.S. retention approximately 20% to $125,000, mainly due to declining exposure.
Overall, we expect Assurant Specialty Property’s full year 2016 net income and net earned premiums to decrease from 2015 levels, reflecting the ongoing normalization of our lender-placed insurance business. We expect the decline to be partially offset by contributions from multi-family housing and mortgage solutions businesses and increased efficiencies and expense savings initiatives. Overall results will be affected by catastrophe losses.


48


As mentioned above, the Company expects to substantially complete the process to exit the health insurance market by December 31, 2016. During the remainder of the exit process, we expect to incur $13,000 to $23,000 of additional exit-related charges, as well as certain overhead expenses that are excluded from the premium deficiency reserve accrual.
Critical Factors Affecting Results and Liquidity
Our results depend on the appropriateness of our product pricing, underwriting and the accuracy of our methodology for the establishment of reserves for future policyholder benefits and claims, returns on and values of invested assets and our ability to manage our expenses. Factors affecting these items, including unemployment, difficult conditions in financial markets and the global economy, may have a material adverse effect on our results of operations or financial condition. For more information on these factors, see “Item 1A—Risk Factors” and “Item 7—MD&A Critical Factors Affecting Results” in our 2015 Annual Report on Form 10-K and “Item 1A-Risk Factors” in the First Quarter Report.
Management believes the Company will have sufficient liquidity to satisfy its needs over the next twelve months including the ability to pay interest on our debt and dividends on our common stock.
For the six months ended June 30, 2016, net cash used in operating activities, including the effect of exchange rate changes and the reclassification of assets held for sale, totaled $298,243; net cash provided by investing activities totaled $745,635 and net cash used in financing activities totaled $503,023. We had $1,232,674 in cash and cash equivalents as of June 30, 2016. Please see “—Liquidity and Capital Resources,” below for further details.
Critical Accounting Policies and Estimates
Our 2015 Annual Report on Form 10-K describes the accounting policies and estimates that are critical to the understanding of our results of operations, financial condition and liquidity. The accounting policies and estimation process described in the 2015 Annual Report on Form 10-K were consistently applied to the unaudited interim consolidated financial statements for Second Quarter 2016.



49


Results of Operations

Assurant Consolidated
Overview
The table below presents information regarding our consolidated results of operations: 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
Revenues:
 
 
 
 
 
 
 
Net earned premiums
$
1,202,224

 
$
2,138,258

 
$
2,617,462

 
$
4,297,820

Fees and other income
328,305

 
323,609

 
685,995

 
603,171

Net investment income
119,820

 
167,786

 
255,527

 
320,059

Net realized gains on investments
21,626

 
11,999

 
183,344

 
15,954

Amortization of deferred gain on disposal of businesses
125,818

 
3,242

 
173,414

 
6,500

Gain on pension plan curtailment

 

 
29,578

 

Total revenues
1,797,793

 
2,644,894

 
3,945,320

 
5,243,504

Benefits, losses and expenses:
 
 
 
 
 
 
 
Policyholder benefits
400,814

 
1,267,714

 
944,630

 
2,478,441

Selling, underwriting and general expenses
1,146,235

 
1,323,377

 
2,397,936

 
2,614,289

Interest expense
15,232

 
13,778

 
29,735

 
27,556

Total benefits, losses and expenses
1,562,281

 
2,604,869

 
3,372,301

 
5,120,286

Income before provision for income taxes
235,512

 
40,025

 
573,019

 
123,218

Provision for income taxes
66,163

 
7,236

 
183,352

 
40,385

Net income
$
169,349

 
$
32,789

 
$
389,667

 
$
82,833

 

The following discussion provides a general overall analysis of how the consolidated results were affected by our segments for Second Quarter 2016 and Six Months 2016 compared to Second Quarter 2015 and Six Months 2015, respectively. Please see the discussion that follows for each of these segments for a more detailed analysis of the fluctuations.
For the Three Months Ended June 30, 2016 Compared to the Three Months Ended June 30, 2015
Net Income
Net income increased $136,560, or 416%, to $169,349 for Second Quarter 2016, compared with $32,789 of net income for Second Quarter 2015. The increase was primarily due to lower exit-related charges from the wind down of Assurant Health runoff operations and an increase in the amortization of deferred gain on disposal of businesses related to the transfer of assets and other items associated with the sale of our Assurant Employee Benefits segment, mainly through a series of reinsurance transactions, to Sun Life. For more information on the sale, see Note 5 to the consolidated financial statements, included elsewhere in this Report.
For the Six Months Ended June 30, 2016 Compared to the Six Months Ended June 30, 2015
Net Income
Net income increased $306,834, or 370%, to $389,667 for Six Months 2016, compared with $82,833 of net income for Six Months 2015. The increase was primarily due to lower exit-related charges from the wind down of the Assurant Health runoff operations and an additional $108,804 (after-tax) in net realized gains on investments and a $108,494 (after-tax) increase in amortization of deferred gain on disposal of businesses, both related to the transfer of assets and other items associated with the sale of Assurant Employee Benefits segment, mainly through a series or reinsurance transactions, to Sun Life. For more information on the sale, see Note 5 to the consolidated financial statements, included elsewhere in this Report. In addition, Six Months 2016 includes a $19,226 (after-tax) one-time curtailment gain associated with our previously disclosed pension plan freeze, effective March 1, 2016. For more information on the pension plan freeze, see Note 14 to the consolidated financial statements, included elsewhere in this Report.

50


Assurant Solutions
Overview
The table below presents information regarding Assurant Solutions’ segment results of operations: 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
Revenues:
 
 
 
 
 
 
 
Net earned premiums
$
755,252

 
$
752,604

 
$
1,494,176

 
$
1,507,081

Fees and other income
202,908

 
178,578

 
441,017

 
351,646

Net investment income
88,362

 
99,976

 
177,285

 
192,167

Total revenues
1,046,522

 
1,031,158

 
2,112,478

 
2,050,894

Benefits, losses and expenses:
 
 
 
 
 
 
 
Policyholder benefits
222,230

 
235,099

 
448,981

 
450,647

Selling, underwriting and general expenses
758,967

 
714,740

 
1,529,187

 
1,439,056

Total benefits, losses and expenses
981,197

 
949,839

 
1,978,168

 
1,889,703

Segment income before provision for income taxes
65,325

 
81,319

 
134,310

 
161,191

Provision for income taxes
3,925

 
20,504

 
25,776

 
46,017

Segment net income
$
61,400

 
$
60,815

 
$
108,534

 
$
115,174

 
 
 
 
 
 
 
 
Net earned premiums, fees and other:
 
 
 
 
 
 
 
Global connected living
$
616,268

 
$
621,411

 
$
1,278,447

 
$
1,241,794

Global vehicle protection
196,557

 
145,550

 
362,445

 
290,270

Global preneed
43,216

 
44,017

 
85,944

 
84,726

Global credit and other
102,119

 
120,204

 
208,357

 
241,937

Total
$
958,160

 
$
931,182

 
$
1,935,193

 
$
1,858,727


For the Three Months Ended June 30, 2016 Compared to the Three Months Ended June 30, 2015
Net Income
Segment net income increased $585, or 1%, to $61,400 for Second Quarter 2016 from $60,815 for Second Quarter 2015. The increase was due to a larger tax benefit related to a redemption of shares in our international structure. Absent this item, segment net income declined, primarily due to lower service contract contributions from North American retail clients and the previously disclosed loss of a domestic tablet program.
Total Revenues
Total revenues increased $15,364, or 1%, to $1,046,522 for Second Quarter 2016 from $1,031,158 for Second Quarter 2015. Net earned premiums increased $2,648 primarily due to growth from our domestic vehicle protection business, including a one time contribution from a large dealership client. This was partially offset by foreign currency exchange volatility and the loss of a domestic tablet program. Fees and other income increased $24,330, primarily driven by growth in mobile programs. Net investment income decreased $11,614, primarily due to $6,017 of lower investment income from real estate joint venture partnerships and lower invested assets and lower investment yields. A few significant clients continued to account for a substantial portion of segment revenues.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses increased $31,358, or 3%, to $981,197 for Second Quarter 2016 from $949,839 for Second Quarter 2015. Policyholder benefits decreased $12,869, primarily due to improved results from a North American connected living retail client. Selling, underwriting and general expenses increased $44,227, mostly related to growth in our domestic vehicle protection business and domestic mobile programs. These items were partially offset by foreign currency exchange volatility and lower legal expenses. 


51


For the Six Months Ended June 30, 2016 Compared to the Six Months Ended June 30, 2015
Net Income
Segment net income decreased $6,640, or 6%, to $108,534 for Six Months 2016 from $115,174 for Six Months 2015. The decrease was primarily due to the loss of a domestic tablet program, lower service contract contributions from North American retail clients and an adjustment related to the amortization of deferred acquisition costs and policyholders benefits for an older block of preneed policies. These items were partially offset by the aforementioned larger net tax benefit, and growth in mobile programs globally.
Total Revenues
Total revenues increased $61,584, or 3%, to $2,112,478 for Six Months 2016 from $2,050,894 for Six Months 2015. Net earned premiums decreased $12,905 primarily due to foreign currency exchange volatility, the loss of a domestic tablet program and the continued run-off of our credit insurance business. These items were partially offset by growth from our domestic vehicle protection business. Fees and other income increased $89,371, primarily driven by global growth in mobile covered devices and programs in our global connected living business. A few significant clients continued to account for a substantial portion of segment revenues.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses increased $88,465, or 5%, to $1,978,168 for Six Months 2016 from $1,889,703 for Six Months 2015. Policyholder benefits decreased $1,666 primarily driven by improved results from a North American connected living retail client, partially offset by expansion of our international mobile business in Asia and Europe and an adjustment related to the amortization of policyholder benefits for an older block of preneed policies. Selling, underwriting and general expenses increased $90,131, mostly related to our domestic mobile protection programs and related services, growth in our domestic vehicle protection business and an adjustment related to the amortization of a deferred acquisition cost adjustment mentioned earlier. These items were partially offset by foreign currency exchange volatility and lower legal expenses.


52


Assurant Specialty Property
Overview
The table below presents information regarding Assurant Specialty Property’s segment results of operations:
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
Revenues:
 
 
 
 
 
 
 
Net earned premiums
$
451,318

 
$
532,022

 
$
920,927

 
$
1,060,468

Fees and other income
109,846

 
106,128

 
217,608

 
190,364

Net investment income
17,823

 
25,443

 
36,167

 
45,958

Total revenues
578,987

 
663,593

 
1,174,702

 
1,296,790

Benefits, losses and expenses:
 
 
 
 
 
 
 
Policyholder benefits
202,659

 
214,605

 
382,131

 
419,208

Selling, underwriting and general expenses
291,528

 
318,606

 
592,436

 
634,287

Total benefits, losses and expenses
494,187

 
533,211

 
974,567

 
1,053,495

Segment income before provision for income taxes
84,800

 
130,382

 
200,135

 
243,295

Provision for income taxes
27,859

 
42,848

 
66,843

 
80,674

Segment net income
$
56,941

 
$
87,534

 
$
133,292

 
$
162,621

 
 
 
 
 
 
 
 
Net earned premiums, fees and other:
 
 
 
 
 
 
 
Lender-placed insurance
$
321,665

 
$
412,841

 
$
668,355

 
$
826,927

Multi-family housing
78,355

 
70,372

 
155,370

 
133,026

Mortgage solutions
79,434

 
76,351

 
155,350

 
135,746

Manufactured housing and other
81,710

 
78,586

 
159,460

 
155,133

Total
$
561,164

 
$
638,150

 
$
1,138,535

 
$
1,250,832

 
 
 
 
 
 
 
 

Regulatory Matters    
In January 2015, New York Department of Financial Services ("NYDFS") issued regulations regarding tracking costs associated with lender placed insurance rates. The Company reached an agreement with the NYDFS to file for a 6.2% reduction in lender-placed hazard insurance rates in New York. The rates have been filed and approved, and were effective for new and renewing policies starting February 1, 2016.
Lender-placed insurance products accounted for 69% and 75% of net earned premiums for Six Months 2016 and Six Months 2015, respectively. The approximate corresponding contributions to the segment net income in these periods were 64% and 70%. The portion of total segment net income attributable to lender-placed products may vary substantially over time depending on the frequency, severity and location of catastrophic losses, the cost of catastrophe reinsurance and reinstatement coverage, the variability of claim processing costs and client acquisition costs, and other factors. In addition, we expect placement rates for these products to decline.


53


For the Three Months Ended June 30, 2016 Compared to the Three Months Ended June 30, 2015
Net Income
Segment net income decreased $30,593, or 35%, to $56,941 for Second Quarter 2016 from $87,534 for Second Quarter 2015 primarily due to the ongoing normalization of lender-placed homeowners insurance business, lower REO policy volume, the previously disclosed loss of business and higher weather-related claims. The REO product is insurance we provide on foreclosed properties managed by our clients. Second Quarter 2016 results include $16,004 (after-tax) of reportable catastrophe losses, compared to $6,105 (after-tax) in Second Quarter 2015.

Total Revenues
Total revenues decreased $84,606, or 13%, to $578,987 for Second Quarter 2016 from $663,593 for Second Quarter 2015. The decrease was primarily due to lower lender-placed homeowners insurance net earned premiums and lower REO policy volume. The decline in lender-placed homeowners net earned premiums was primarily due to expected decline in placement rates, lower premium rates, and previously disclosed loss of client business. These items were partially offset by an increase in revenue from the multi-family housing and mortgage solutions businesses. A few significant clients continued to account for a substantial portion of segment revenues.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses decreased $39,024, or 7%, to $494,187 for Second Quarter 2016 from $533,211 for Second Quarter 2015. Total policyholder benefits decreased $11,946 to $202,659 for Second Quarter 2016, compared with $214,605 for Second Quarter 2015. The decrease was primarily related to lower non-catastrophe losses, mainly due to lower exposure, partially offset by higher reportable catastrophe losses. Reportable catastrophe losses in Second Quarter 2016 were $24,622 compared with $9,393 in Second Quarter 2015. Reportable catastrophe losses include only individual catastrophic events that generated losses to the Company in excess of $5,000, pre-tax and net of reinsurance. Selling, underwriting and general expenses decreased $27,078 in Second Quarter 2016 compared with Second Quarter 2015 mainly due to savings from cost efficiency efforts.
For the Six Months Ended June 30, 2016 Compared to the Six Months Ended June 30, 2015
Net Income
Segment net income decreased $29,329, or 18%, to $133,292 for Six Months 2016 from $162,621 for Six Months 2015 primarily due to the ongoing normalization of lender-placed homeowners insurance business, lower REO policy volume, the previously disclosed loss of business and higher weather-related claims. The REO product is insurance we provide on foreclosed properties managed by our clients.

Total Revenues
Total revenues decreased $122,088, or 9%, to $1,174,702 for Six Months 2016 from $1,296,790 for Six Months 2015. The decrease was primarily due to lower lender-placed homeowners insurance net earned premiums and lower REO policy volume. The decline in lender-placed homeowners net earned premiums was primarily due to expected decline in placement rates, lower premium rates, and previously disclosed loss of client business. These items were partially offset by an increase in revenues from the multi-family housing and mortgage solutions businesses. A few significant clients continued to account for a substantial portion of segment revenues.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses decreased $78,928, or 7%, to $974,567 for Six Months 2016 from $1,053,495 for Six Months 2015. Total policyholder benefits decreased $37,077 to $382,131 for Six Months 2016 compared with $419,208 for Six Months 2015. The decrease was primarily related to favorable non-catastrophe losses due to lower claims frequency and severity, partially offset by increased reportable catastrophe losses. Reportable catastrophe losses for Six Months 2016 were $39,023 compared to $14,612 for Six Months 2015. Reportable catastrophe losses include only individual catastrophic events that generated losses to the Company in excess of $5,000, pre-tax and net of reinsurance. Selling, underwriting and general expenses decreased $41,851 in Six Months 2016 compared with Six Months 2015 mainly due to savings from cost efficiency efforts.





54


Assurant Health
Overview
The table below presents information regarding Assurant Health’s segment results of operations:
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
Revenues:
 
 
 
 
 
 
 
Net earned premiums (1)
$
(4,346
)
 
$
584,443

 
$
24,388

 
$
1,194,185

Fees and other income
8,284

 
17,047

 
13,402

 
33,023

Net investment income
1,983

 
7,014

 
5,921

 
14,021

Total revenues
5,921

 
608,504

 
43,711

 
1,241,229

Benefits, losses and expenses:
 
 
 
 
 
 
 
Policyholder benefits (2)
(24,075
)
 
625,323

 
(4,963
)
 
1,230,086

Selling, underwriting and general expenses
37,763

 
161,525

 
90,718

 
294,976

Total benefits, losses and expenses
13,688

 
786,848

 
85,755

 
1,525,062

Segment loss before benefit for
   income taxes
(7,767
)
 
(178,344
)
 
(42,044
)
 
(283,833
)
Benefit for income taxes
(2,341
)
 
(54,569
)
 
(9,445
)
 
(76,089
)
Segment net loss
$
(5,426
)
 
$
(123,775
)
 
$
(32,599
)
 
$
(207,744
)
Net earned premiums:
 
 
 
 
 
 
 
Individual
$
(12,382
)
 
$
488,285

 
$
9,496

 
$
1,002,483

Small employer group
8,036

 
96,158

 
14,892

 
191,702

Total (1)
$
(4,346
)
 
$
584,443

 
$
24,388

 
$
1,194,185

 
(1)    Second Quarter 2016 amount is negative due to reduction of previously accrued risk adjustment premiums.
(2)
Second Quarter 2016 and Six Months 2016 amounts are negative primarily due to a pharmacy rebate accrual and favorable claims development.

As previously announced, the Company concluded a comprehensive review of its portfolio and sharpened its focus on specialty housing and lifestyle protection products and services. As a result, the Company will substantially exit the health insurance market by the end of 2016. For more information, see Note 4 of the Notes to the consolidated financial statements included elsewhere in this Report.
The Affordable Care Act
Some provisions of the Affordable Care Act continue to affect our health insurance business, even though it is in run-off. For more information, see Item 1A, "Risk Factors—Risk related to our industry—Reform of the health insurance industry could materially reduce the profitability of certain of our businesses or render them unprofitable" in our 2015 Annual Report on Form 10-K and "Item 1A-Risk Factors" in the First Quarter Report.
Because all individuals now have a guaranteed right to purchase health insurance policies, the Affordable Care Act introduced new and significant premium stabilization programs in 2014: reinsurance, risk adjustment, and risk corridor (together, the “3 Rs”). These programs, discussed in further detail below, are meant to mitigate the potential adverse impact to individual health insurers as a result of Affordable Care Act provisions that became effective January 1, 2014.

Reinsurance
This is a transitional program for 2014-2016, with decreasing benefit over the three years. All commercial individual and group medical health plans are required to contribute to the funding of the program. Only for individual health plans that are in compliance with the essential health benefits of the Affordable Care Act are insurers eligible to receive benefits from the program.

We are required to make contributions, which are recorded quarterly, based on both our Affordable Care Act and non-Affordable Care Act business. Contributions based on our non-Affordable Care Act business are included in selling, underwriting and general expenses and contributions based on our Affordable Care Act business are included as ceded

55


premiums. Recoveries are recorded quarterly as ceded policyholder benefits and reflect the anticipated experience of our Affordable Care Act plans based on our analysis of current and historical claim data.

For the Second Quarter 2016 and Six Months 2016, due to a change in estimate and following receipt of the final payment notifications for the 2015 risk mitigation programs from the Centers for Medicare and Medicaid Services ("CMS"), we reduced our reinsurance recoveries by $5,017 and $7,901, respectively, in our consolidated statements of operations. We did not record any reinsurance contributions for the Second Quarter 2016 and Six Months 2016. As of June 30, 2016, we have reinsurance contributions payable of $2,597 and reinsurance recoverables of $222,219 on our consolidated balance sheets. During Second Quarter 2016 and Six Months 2016, we collected $37,746 and $66,300, respectively, under the 2015 program.
   
Risk Adjustment
This is a permanent program to transfer funds between health insurers based on the average health risk scores of their Affordable Care Act insured populations. Insurers with below-average risk scores contribute into the pool. Insurers with above-average risk scores receive payments out of the pool.
Risk scores are evaluated at the state, market, and legal entity level for policies that comply with the Affordable Care Act. Risk adjustment amounts payable and receivable are reflected as adjustments to net earned premiums, and are recorded quarterly based on our current estimated loss experience of our Affordable Care Act business.
Based on the demographics of our Affordable Care Act population, extensive analytical evaluations, current and historical claim data as well as other internal and external data sources, external market studies and other published data, we believe that our average risk scores will be significantly higher than the industry averages.
For Second Quarter 2016 and Six Months 2016, following receipt of the final payment notifications for the 2015 risk mitigation programs from CMS, we recorded net risk adjustment premiums of $(23,095) and $(21,806), respectively, in our consolidated statements of operations, reflecting a change in our relative risk score. As of June 30, 2016, we carried net risk adjustment receivables, net of an allowance for adverse development, of $196,241 on our consolidated balance sheets. During Second Quarter 2016 and Six Months 2016, we collected $2,120 and $7,147, respectively, under the 2014 program. We did not collect any amounts under the 2015 program.
Risk Corridor
This is a temporary risk-sharing program for 2014-2016. Based on ratios of allowable costs to target costs as defined by the Affordable Care Act, health insurers will make payments to the Department of Health and Human Services (“HHS”) or receive funds from HHS. Because Assurant Health did not participate in any public insurance marketplaces for 2014, risk corridors had no impact on our 2014 operations. Assurant Health began participating in the public insurance marketplaces for 2015. However, we have not recorded a net receivable for Second Quarter 2016 or Six Months 2016 because payments from HHS under this program are uncertain.
Estimates of amounts receivable from these programs are subject to considerable uncertainty and actual amounts received may vary substantially from our estimates.

For the Three Months Ended June 30, 2016 Compared to the Three Months Ended June 30, 2015
Net Loss
Segment net loss was $5,426 for Second Quarter 2016 compared to a net loss of $123,775 for Second Quarter 2015. The relative difference was primarily attributable to the establishment of a premium deficiency reserve and exit related costs in Second Quarter 2015 due to the aforementioned decision to put the segment into runoff.
Total Revenues
Total revenues decreased to $5,921 for Second Quarter 2016 from $608,504 for Second Quarter 2015. Net earned premiums from our individual medical and our small employer group businesses decreased due to the decline in membership and sales as we exit the health insurance market.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses decreased to $13,688 for Second Quarter 2016 from $786,848 for Second Quarter 2015. The decrease in policyholder benefits was attributable to the decrease of inforce policies as a result of the exit from the health insurance market including all of the individual Affordable Care Act medical policies which were terminated at the end of 2015. Selling, underwriting and general expenses decreased primarily due to lower commission expense resulting from the

56


discontinuance of sales and decreased general expenses as we run-off the business. This decrease was partially offset by $6,383 of severance costs.

For the Six Months Ended June 30, 2016 Compared to the Six Months Ended June 30, 2015
Net Loss
Segment net loss was $32,599 for Six Months 2016 compared to a net loss of $207,744 for Six Months 2015. The change was primarily due to the items noted above.
Total Revenues
Total revenues decreased to $43,711 for Six Months 2016 from $1,241,229 for Six Months 2015. Net earned premiums from our individual medical business decreased $992,987, while net earned premiums from our small employer group business decreased $176,810. The decrease for both products is due to the decline in membership and sales as we exit the health insurance market.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses decreased to $85,755 for Six Months 2016 from $1,525,062 for Six Months 2015. Policyholder benefits decreased $1,235,049. The decrease in policyholders benefits was attributable to the decrease of inforce policies as a result of the exit from the health insurance market, including all of the individual Affordable Care Act medical policies which were terminated at the end of 2015. Selling, underwriting and general expenses decreased $204,258, due to decreased commission expense resulting from the discontinuance of sales and decreased general expenses as we run-off the business. This decrease was partially offset by $20,944 of severance costs.

57


Assurant Employee Benefits
Overview
The table below presents information regarding Assurant Employee Benefits’ segment results of operations:
 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
Revenues:
 
 
 
 
 
 
 
Net earned premiums
$

 
$
269,189

 
$
177,971

 
$
536,086

Fees and other income

 
6,460

 
4,244

 
12,734

Net investment income

 
30,020

 
17,340

 
57,841

Total revenues

 
305,669

 
199,555

 
606,661

Benefits, losses and expenses:
 
 
 
 
 
 
 
Policyholder benefits

 
192,687

 
118,481

 
378,500

Selling, underwriting and general expenses

 
96,273

 
64,327

 
195,241

Total benefits, losses and expenses

 
288,960

 
182,808

 
573,741

Segment income before provision for income taxes

 
16,709

 
16,747

 
32,920

Provision for income taxes

 
5,441

 
6,277

 
11,504

Segment net income
$

 
$
11,268

 
$
10,470

 
$
21,416


On March 1, 2016, the Company sold its Assurant Employee Benefits segment to Sun Life Assurance Company of Canada, the wholly-owned subsidiary of Sun Life Financial Inc., for net cash considerations of $926,174 and contingent consideration of $16,000 related to specified account renewals. For more information on the sale see Note 5 to the consolidated financial statements, included elsewhere in this Report.
The amounts included in Six Months 2016 represent January and February 2016 results of operations, the period prior to the sale. All amounts related to the sale are included in the Corporate and Other segment, discussed later. Since this business has been sold and is no longer part of our ongoing operations a discussion of results for the periods presented has been excluded.




58


Assurant Corporate & Other
The table below presents information regarding the Corporate & Other segment’s results of operations:
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
Revenues:
 
 
 
 
 
 
 
Fees and other income
$
7,267

 
$
15,396

 
$
9,724

 
$
15,404

Net investment income
11,652

 
5,333

 
18,814

 
10,072

Net realized gains on investments
21,626

 
11,999

 
183,344

 
15,954

Amortization of deferred gain on disposal of businesses
125,818

 
3,242

 
173,414

 
6,500

Gain on pension plan curtailment

 

 
29,578

 

Total revenues
166,363

 
35,970

 
414,874

 
47,930

Benefits, losses and expenses:
 
 
 
 
 
 
 
Selling, underwriting and general expenses
57,977

 
32,233

 
121,268

 
50,729

Interest expense
15,232

 
13,778

 
29,735

 
27,556

Total benefits, losses and expenses
73,209

 
46,011

 
151,003

 
78,285

Segment income (loss) before provision (benefit) for income taxes
93,154

 
(10,041
)
 
263,871

 
(30,355
)
Provision (benefit) for income taxes
36,720

 
(6,988
)
 
93,901

 
(21,721
)
Segment net income (loss)
$
56,434

 
$
(3,053
)
 
$
169,970

 
$
(8,634
)
For the Three Months Ended June 30, 2016 Compared to the Three Months Ended June 30, 2015
Net Income (Loss)
Segment results improved $59,487, or 1,948%, to $56,434 for Second Quarter 2016 compared with $(3,053) for Second Quarter 2015. The improvement was primarily due to a $79,674 (after-tax) increase in amortization of deferred gain on disposal of businesses related to the sale, mainly through a series of reinsurance transactions, of our Assurant Employee Benefits segment. For more information on the sale see Note 5 to the consolidated financial statements included elsewhere in this Report. Partially offsetting this item was a $10,837 (after-tax) intangible asset impairment charge related to trade names that will no longer be used or defended by the Company.
Total Revenues
Total revenues increased $130,393, or 363%, to $166,363 for Second Quarter 2016 compared with $35,970 for Second Quarter 2015. The increase is primarily related to a $122,576 increase in amortization of deferred gain on disposal of business related to the sale of our Assurant Employee Benefits segment.
Total Benefits, Losses and Expenses
Total expenses increased $27,198, or 59%, to $73,209 for Second Quarter 2016 compared with $46,011 for Second Quarter 2015. The increase is primarily due to a $16,672 intangible asset impairment charge related to trade names that will no longer be used or defended by the Company. In addition, Second Quarter 2016 includes overhang expenses related to the sale of our Assurant Employee Benefits segment.
For the Six Months Ended June 30, 2016 Compared to the Six Months Ended June 30, 2015
Net Income (Loss)
Segment results improved $178,604, or 2,069%, to $169,970 for Six Months 2016 compared with $(8,634) for Six Months 2015. The improvement was primarily due to an additional $108,804 (after-tax) in net realized gains on investments and a $108,494 (after-tax) increase in amortization of deferred gain on disposal of businesses, both related to the sale, mainly through a series of reinsurance transactions, of our Assurant Employee Benefits segment. For more information on the sale see Note 5 to the consolidated financial statements, included elsewhere in this Report. In addition, Six Months 2016 includes a $19,226 (after-tax) one-time curtailment gain associated with our previously disclosed pension plan freeze, effective March 1, 2016. Partially offsetting these items is a $17,323 (after-tax) loss on the sale of our Assurant Employee Benefits segment, an aforementioned $10,837 (after-tax) intangible asset impairment charge, employee-related benefit costs and overhang expenses

59


related to the sale of Assurant Employee Benefits segment. Six Months 2015 included a tax consolidating benefit that reversed over the course of 2015.
Total Revenues
Total revenues increased $366,944, or 766%, to $414,874 for Six Months 2016 compared with $47,930 for Six Months 2015. The increase is primarily related to an additional $167,390 in net realized gains on investments and a $166,914 increase in amortization of deferred gain on disposal of businesses, both related to the sale of our Assurant Employee Benefits segment. In addition, Six Months 2016 includes a $29,578 one-time curtailment gain associated with our pension plan freeze.
Total Benefits, Losses and Expenses
Total expenses increased $72,718, or 93%, to $151,003 for Six Months 2016 compared with $78,285 for Six Months 2015. The increase is primarily due to a $26,650 loss on the sale of Assurant Employee Benefits segment, mainly representing transaction fees incurred. Six Months 2016 includes a $16,672 intangible asset impairment charge, mentioned above. In addition, employee-related benefit costs increased in Six Months 2016 compared with Six Months 2015 and Six Months 2016 includes overhang expenses related to the sale of Assurant Employee Benefits segment.


60


Investments
The Company had total investments of $11,961,497 and $12,994,772 as of June 30, 2016 and December 31, 2015, respectively. Net unrealized gains on the Company's fixed maturity portfolio increased $290,222 during Six Months 2016, from $744,533 at December 31, 2015 to $1,034,755 at June 30, 2016. This increase was mainly due to a decrease in treasury yields and credit spreads. For more information on the Company's investments see Note 7 to the consolidated financial statements included elsewhere in this Report.
The following table shows the credit quality of the Company's fixed maturity securities portfolio as of the dates indicated:
 
As of
Fixed Maturity Securities by Credit Quality (Fair Value)
June 30, 2016
 
December 31, 2015
Aaa / Aa / A
$
6,073,365

 
62.3
%
 
$
6,326,800

 
61.9
%
Baa
3,035,139

 
31.2
%
 
3,309,719

 
32.4
%
Ba
421,103

 
4.3
%
 
389,349

 
3.8
%
B and lower
214,592

 
2.2
%
 
189,460

 
1.9
%
Total
$
9,744,199

 
100.0
%
 
$
10,215,328

 
100.0
%
Major categories of net investment income were as follows: 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2016
 
2015
 
2016
 
2015
Fixed maturity securities
$
100,424

 
$
123,792

 
$
212,248

 
$
247,283

Equity securities
5,939

 
7,594

 
12,681

 
14,805

Commercial mortgage loans on real estate
10,316

 
17,042

 
24,039

 
35,146

Policy loans
585

 
684

 
1,191

 
1,227

Short-term investments
1,435

 
462

 
2,066

 
881

Other investments
141

 
19,616

 
1,895

 
23,849

Cash and cash equivalents
5,441

 
4,414

 
10,463

 
8,495

Total investment income
124,281

 
173,604

 
264,583

 
331,686

Investment expenses
(4,461
)
 
(5,818
)
 
(9,056
)
 
(11,627
)
Net investment income
$
119,820

 
$
167,786

 
$
255,527

 
$
320,059

Net investment income decreased $47,966, or 29%, to $119,820 for Second Quarter 2016 from $167,786 for Second Quarter 2015. The decrease was primarily attributable to a $13,367 decrease in investment income from real estate joint ventures, lower investment yields and lower invested assets. Net investment income decreased $64,532, or 20%, to $255,527 for Six Months 2016 from $320,059 for Six Months 2015. This decrease was primarily attributable to a $13,969 decrease in investment income from real estate joint ventures, lower investment yields and lower invested assets.
As of June 30, 2016, the Company owned $145,401 of securities guaranteed by financial guarantee insurance companies. Included in this amount was $133,725 of municipal securities, whose credit rating was A+ with the guarantee, but would have had a rating of A without the guarantee.
The Company has exposure to sub-prime and related mortgages within the Company's fixed maturity security portfolio. At June 30, 2016, approximately 2% of the residential mortgage-backed holdings had exposure to sub-prime mortgage collateral. This represented less than 1% of the total fixed income portfolio and approximately 1% of the total unrealized gain position. Of the securities with sub-prime exposure, approximately 6% are rated as investment grade. All residential mortgage-backed securities, including those with sub-prime exposure, are reviewed as part of the ongoing other-than-temporary impairment monitoring process.


61


Liquidity and Capital Resources
Regulatory Requirements
Assurant, Inc. is a holding company and, as such, has limited direct operations of its own. Our holding company’s assets consist primarily of the capital stock of our subsidiaries. Accordingly, our holding company’s future cash flows depend upon the availability of dividends and other statutorily permissible payments from our subsidiaries, such as payments under our tax allocation agreement and under management agreements with our subsidiaries. The ability to pay such dividends and to make such other payments will be limited by applicable laws and regulations of the states in which our subsidiaries are domiciled, which subject our subsidiaries to significant regulatory restrictions. The dividend requirements and regulations vary from state to state and by type of insurance provided by the applicable subsidiary. These laws and regulations require, among other things, our insurance subsidiaries to maintain minimum solvency requirements and limit the amount of dividends they can pay to the holding company. For further information on pending amendments to state insurance holding company laws, including the NAIC’s “Solvency Modernization Initiative,” see “Item 1A—Risk Factors—Risks Related to Our Industry—Changes in regulation may reduce our profitability and limit our growth” in our 2015 Annual Report on Form 10-K and “Item 1A-Risk Factors” in the First Quarter Report. Along with solvency regulations, the primary driver in determining the capital used for subsidiary dividends is the level of capital needed to maintain desired financial strength ratings from A.M. Best.
Regulators or rating agencies could become more conservative in their methodology and criteria, increasing capital requirements for our insurance subsidiaries. This in turn, could negatively affect our capital resources. As previously announced, the Company will exit the health insurance market and has sold its Assurant Employee Benefits segment on March 1, 2016, mainly through a series of reinsurance transactions with Sun Life. Following the sale of Assurant Employee Benefits, the following actions were taken by the rating agencies:
A.M. Best
Removed ratings of Union Security Insurance Company and Union Security Life Insurance Company of New York from under review with negative implications and affirmed with a stable outlook.
Ratings of Assurant's senior debt were upgraded from bbb to bbb+.
Ratings of Assurant's commercial paper were upgraded from AMB-2 to AMB-1.
Ratings of all other rated entities were affirmed with a stable outlook.
Moody's Investor Services ("Moody's")
Rating of Union Security Insurance Company was affirmed and the outlook revised from developing to stable.
All other ratings remain unchanged.
Standard and Poor’s (“S&P”)
Rating of Union Security Insurance Company was upgraded from A- to A.
Withdrew the ratings of John Alden Life Insurance Company and Time Insurance Company.
All other ratings remain unchanged.

For further information on our ratings and the risks of ratings downgrades, see “Item 1—Business” and “Item 1A—Risk Factors—Risks Related to Our Company—A.M. Best, Moody’s and S&P rate the financial strength of our insurance company subsidiaries, and a decline in these ratings could affect our standing in the insurance industry and cause our sales and earnings to decrease” in our 2015 Annual Report on Form 10-K and "Item 1A- Risk Factors" in the First Quarter Report.
For 2016, the maximum dividends our U.S. domiciled insurance subsidiaries could pay without prior regulatory approval is approximately $564,000.

Liquidity
As of June 30, 2016, we had $725,272 in holding company capital. We use the term “holding company capital” to represent the portion of cash and other liquid marketable securities held at Assurant, Inc., out of a total of $900,589, that we are not otherwise holding for a specific purpose as of the balance sheet date. We can use such capital for stock repurchases, stockholder dividends, acquisitions, and other corporate purposes. $250,000 of the $725,272 of holding company capital is intended to serve as a buffer against remote risks (such as large-scale hurricanes). The $45,000 used to purchase American Title, Inc. on July 1, 2016, was excluded from the $725,272 since that amount was specifically held for that purchase as of June 30, 2016. For more information on the acquisition, see Note 6 to the consolidated financial statements, included elsewhere in this Report. Dividends or returns of capital, net of infusions, made to the holding company by its operating companies were $895,438 for Six Months 2016. The $895,438 includes approximately $604,000 of dividends from statutory insurance

62


subsidiaries that received the cash proceeds related to the sale of the Assurant Employee Benefits segment. The sale of Assurant Employee Benefits is expected to ultimately provide approximately $1,000,000 to the holding company including net proceeds and capital releases. In 2015, dividends, net of infusions, made to the holding company from its operating companies were $174,579, and used primarily to pay expenses, to make interest payments on indebtedness, to make dividend payments to our stockholders, to fund acquisitions and to repurchase our shares.
In addition to paying expenses and making interest payments on indebtedness, our capital management strategy provides for several uses for the cash generated by our subsidiaries, including without limitation, returning capital to shareholders through share repurchases and dividends, investing in our businesses to support growth in targeted areas, and making prudent and opportunistic acquisitions. From time to time, the Company may also seek to purchase outstanding debt in open market repurchases or privately negotiated transactions. We made share repurchases and paid dividends to our stockholders of $516,775 and $378,819 during Six Months 2016 and the year ended December 31, 2015, respectively. We expect operating segment dividends, from Assurant Solutions and Assurant Specialty Property, to approximate segment net income, subject to the growth of the business, rating agency and regulatory capital requirements. We also expect approximately $475,000 in dividends from Assurant Health insurance subsidiaries for full year 2016, of which approximately $84,000 was received in Second Quarter 2016 and totaled approximately $149,000 for Six Months 2016, subject to ultimate development of claims, actual expenses needed to wind down operations, recoveries from Affordable Care Act risk mitigation payments and regulatory approval.
The primary sources of funds for our subsidiaries consist of premiums and fees collected, proceeds from the sales and maturity of investments and net investment income. We use cash primarily to pay insurance claims, agent commissions, operating expenses and taxes. We generally invest our subsidiaries’ excess funds to generate investment income.
We conduct periodic asset liability studies to measure the duration of our insurance liabilities, to develop optimal asset portfolio maturity structures for our significant lines of business and ultimately to assess whether cash flows are sufficient to meet cash needs. These studies are conducted in accordance with formal company-wide Asset Liability Management (“ALM”) guidelines.
To complete a study for a particular line of business, we develop models to project asset and liability cash flows and balance sheet items under a large, varied set of plausible economic scenarios. These models consider many factors including the current investment portfolio, the required capital for the related assets and liabilities, our tax position and projected cash flows from both existing and projected new business.
Alternative asset portfolio structures are analyzed for significant lines of business. An investment portfolio maturity structure is then selected from these profiles given our return hurdle and risk preference. Sensitivity testing of significant liability assumptions and new business projections is also performed.
Our liabilities generally have limited policyholder optionality, which means that the timing of payments is relatively insensitive to the interest rate environment. In addition, our investment portfolio is largely comprised of highly liquid fixed maturity securities with a sufficient component of such securities invested that are near maturity which may be sold with minimal risk of loss to meet cash needs. Therefore, we believe we have limited exposure to disintermediation risk.
Generally, our subsidiaries’ premiums, fees and investment income, along with planned asset sales and maturities, provide sufficient cash to pay claims and expenses. However, there may be instances when unexpected cash needs arise in excess of that available from usual operating sources. In such instances, we have several options to raise needed funds, including selling assets from the subsidiaries’ investment portfolios, using holding company cash (if available), issuing commercial paper, or drawing funds from our revolving credit facility. In addition, we have filed an automatically effective shelf registration statement on Form S-3 with the SEC. This registration statement allows us to issue equity, debt or other types of securities through one or more methods of distribution. The terms of any offering would be established at the time of the offering, subject to market conditions. If we decide to make an offering of securities, we will consider the nature of the cash requirement as well as the cost of capital in determining what type of securities we may offer.
We paid dividends of $0.50 per common share on June 14, 2016 to stockholders of record as of May 31, 2016. Any determination to pay future dividends will be at the discretion of our Board of Directors and will be dependent upon: our subsidiaries’ payment of dividends and/or other statutorily permissible payments to us; our results of operations and cash flows; our financial position and capital requirements; general business conditions; legal, tax, regulatory and contractual restrictions on the payment of dividends; and other factors our Board of Directors deems relevant.
On September 9, 2015, our Board of Directors authorized the Company to repurchase up to an additional $750,000 of its outstanding common stock. During the six months ended June 30, 2016, we repurchased 5,740,258 shares of our outstanding common stock at a cost of $451,697, exclusive of commissions. As of June 30, 2016, $500,406 remained under the total

63


repurchase authorization. The timing and the amount of future repurchases will depend on market conditions, our financial condition, results of operations, liquidity and other factors.

Management believes the Company will have sufficient liquidity to satisfy its needs over the next 12 months, including the ability to pay interest on our debt and dividends on our common shares.
Retirement and Other Employee Benefits
For information on our retirement and other employee benefits see Note 14 to the consolidated financial statements, included elsewhere in this Report.
Debt
For information on our Senior Notes, Commercial Paper Program and Revolving Credit Facility see Note 9 to the consolidated financial statements, included elsewhere in this Report.
Cash Flows
We monitor cash flows at the consolidated, holding company and subsidiary levels. Cash flow forecasts at the consolidated and subsidiary levels are provided on a monthly basis, and we use trend and variance analyses to project future cash needs, making adjustments to the forecasts when needed.
The table below shows our recent net cash flows:
 
For the Six Months Ended June 30,
Net cash (used in) provided by:
2016
 
2015
Operating activities (1)
$
(298,243
)
 
$
153,417

Investing activities
745,635

 
55,750

Financing activities
(503,023
)
 
(230,387
)
Net change in cash
$
(55,631
)
 
$
(21,220
)
 
____________________
(1)
Includes effect of exchange rate changes and the reclassification of assets held for sale on cash and cash equivalents.
We typically generate operating cash inflows from premiums collected from our insurance products and income received from our investments while outflows consist of policy acquisition costs, benefits paid, and operating expenses. These net cash flows are then invested to support the obligations of our insurance products and required capital supporting these products. Our cash flows from operating activities are affected by the timing of premiums, fees, and investment income received and expenses paid.
Net cash (used in) provided by operating activities was $(298,243) and $153,417 for Six Months 2016 and Six Months 2015, respectively. The increase in cash used by operating activities was primarily due to Assurant Health paying claims without any corresponding collection of premiums since this business in now in runoff and timing of other payments in the normal course of business.
Net cash provided by investing activities was $745,635 and $55,750 for Six Months 2016 and Six Months 2015, respectively. The increase in cash provided by investing activities was primarily due to the sale of the Assurant Employee Benefits segment, mainly through reinsurance transactions, to Sun Life and an increase in sales of commercial mortgage loans. See Note 7 to the consolidated financial statements for more information on the sale of commercial mortgage loans. These increases are partially offset by the purchase of fixed maturity securities.
Net cash used in financing activities was $503,023 and $230,387 for Six Months 2016 and Six Months 2015, respectively. The increase in cash used in financing activities was primarily due to an increase in the repurchase of our outstanding common stock.


64


The table below shows our cash outflows for interest and dividends for the periods indicated:
 
For the Six Months Ended June 30,
 
2016
 
2015
Interest paid on debt
$
29,137

 
$
27,406

Common stock dividends
64,966

 
40,450

Total
$
94,103

 
$
67,856

Letters of Credit
In the normal course of business, we issue letters for various purposes, including to support reinsurance agreements. These letters of credit are supported by commitments with financial institutions. We had $12,491 and $19,809 of letters of credit outstanding as of June 30, 2016 and December 31, 2015.
Recent Accounting Pronouncements
For a discussion of recent accounting pronouncements, see Note 3 of the Notes to the Consolidated Financial Statements included elsewhere in this report.

Item 3. Quantitative and Qualitative Disclosures About Market Risk
Our 2015 Annual Report on Form 10-K described our Quantitative and Qualitative Disclosures About Market Risk. There were no material changes to the assumptions or risks during Second Quarter 2016.

Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures pursuant to Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of June 30, 2016. They have concluded that the Company’s disclosure controls and procedures are effective, and provide reasonable assurance that information the Company is required to disclose in its reports under the Exchange Act is recorded, processed, summarized and reported accurately. They also have concluded that information that the Company is required to disclose is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure.
Internal Control over Financial Reporting
During the quarter ended June 30, 2016, we made no changes in our internal control over financial reporting pursuant to Rule 13a-15(f) or 15d-15(f) under the Exchange Act that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

65


PART II
OTHER INFORMATION
Item 1. Legal Proceedings

The Company is involved in litigation in the ordinary course of business, both as a defendant and as a plaintiff, and may from time to time be subject to a variety of legal and regulatory actions relating to our current and past business operations. See Note 16 to the Notes to Consolidated Financial Statements for a description of certain matters, which description is incorporated herein by reference. Although the Company cannot predict the outcome of any litigation, regulatory examinations or investigations, it is possible that the outcome of such matters could have a material adverse effect on the Company’s consolidated results of operations or cash flows for an individual reporting period. However, based on currently available information, management does not believe that any pending matter is likely to have a material adverse effect, individually or in the aggregate, on the Company’s financial condition.

Item 1A. Risk Factors
Certain factors may have a material adverse effect on our business, financial condition and results of operations and you should carefully consider them. It is not possible to predict or identify all such factors. For discussion of potential risks or uncertainties affecting us, please refer to “Item 1A-Risk Factors” included in our 2015 Annual Report on Form 10-K and First Quarter 2016 Quarterly Report on Form 10-Q. There have been no material changes during Second Quarter 2016.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Repurchase of Equity Securities:
(Dollar amounts in thousands, expect number of shares and per share amounts)
Period in 2016
Total
Number of
Shares Repurchased
 
Average Price
Paid Per  Share
 
Total Number of  Shares
Repurchased as Part of
Publicly Announced
Programs (1)
 
Approximate
Dollar Value of
Shares that
May Yet  be
Repurchased
Under the
Programs (1)
January 1-31
1,147,337

 
$
78.44

 
1,147,337

 
$
862,125

February 1-29
869,898

 
70.69

 
869,898

 
800,645

March 1-31
1,405,025

 
76.12

 
1,405,025

 
693,717

April 1-30
1,033,098

 
79.90

 
1,033,098

 
611,195

May 1-31
845,869

 
87.01

 
845,869

 
537,609

June 1-30
439,031

 
84.75

 
439,031

 
500,406

Total
5,740,258

 
$
78.71

 
5,740,258

 
$
500,406

 
(1)
Shares purchased pursuant to the November 15, 2013 publicly announced share repurchase authorization of up to $600,000 of outstanding common stock, which was increased by an authorization announced on September 9, 2015 for the repurchase of up to an additional $750,000 of outstanding common stock. See Note 12 of the Notes to the consolidated financial statements for a description of certain matters, which is incorporated herein by reference.

66


Item 6. Exhibits
Pursuant to the rules and regulations of the SEC, the Company has filed or incorporated by reference certain agreements as exhibits to this quarterly Report on Form 10-Q. These agreements may contain representations and warranties by the parties. These representations and warranties have been made solely for the benefit of the other party or parties to such agreements and (i) may have been qualified by disclosures made to such other party or parties, (ii) were made only as of the date of such agreements or such other date(s) as may be specified in such agreements and are subject to more recent developments, which may not be fully reflected in the Company’s public disclosure, (iii) may reflect the allocation of risk among the parties to such agreements and (iv) may apply materiality standards different from what may be viewed as material to investors. Accordingly, these representations and warranties may not describe the Company’s actual state of affairs at the date hereof and should not be relied upon.
The following exhibits either (a) are filed with this Report or (b) have previously been filed with the SEC and are incorporated herein by reference to those prior filings. Exhibits are available upon request at the investor relations section of our website at www.assurant.com. Our website is not a part of this Report and is not incorporated by reference in this Report.

10.1
 
Employment Letter Agreement, dated March 8, 2016, by and between Assurant, Inc. and Ajay Waghray. *
 
 
 
10.2
 
Form of Restricted Stock Unit Award Agreement for Time-based Awards under the Assurant, Inc. Long Term Equity Incentive Plan, dated May 10, 2016. *
 
 
 
10.3
 
Employment Letter Agreement, dated April 26, 2016, by and between Assurant, Inc. and Richard Dziadzio. *
 
 
 
10.4
 
Restricted Stock Unit Award Agreement for Time-based Awards under the Assurant, Inc. Long Term Equity Incentive Plan, dated July 18, 2016, by and between Assurant, Inc. and Richard Dziadzio. *
 
 
 
10.5
 
Form of Assurant, Inc. Change in Control Agreement, dated May 13, 2016. *
 
 
 
10.6
 
Assurant, Inc. Amended and Restated Directors Compensation Plan, effective as of May 13, 2016. *
 
 
 
10.7
 
Retirement Agreement, dated June 29, 2016, by and between Assurant, Inc. and S. Craig Lemasters. *
 
 
 
12.1
  
Computation of Ratio of Consolidated Earnings to Fixed Charges.
 
 
31.1
  
Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
 
 
31.2
  
Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.
 
 
32.1
  
Certification of Chief Executive Officer of Assurant, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
32.2
  
Certification of Chief Financial Officer of Assurant, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
101
  
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statement of Changes in Stockholders’ Equity, (v) the Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements.
*
Management contract or compensatory plan

67


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized. 
 
 
 
 
 
 
 
ASSURANT, INC.
 
 
 
 
Date: August 2, 2016
 
By:
 
/s/     ALAN B. COLBERG      
 
 
Name:
 
Alan B. Colberg
 
 
Title:
 
President, Chief Executive Officer and Director
 
 
 
 
Date: August 2, 2016
 
By:
 
/s/    RICHARD S. DZIADZIO
 
 
Name:
 
Richard S. Dziadzio
 
 
Title:
 
Executive Vice President, Chief Financial Officer and Treasurer


68


EXHIBIT 10.1


PRIVILEGED AND CONFIDENTIAL    

March 8, 2016
 
Mr. Ajay Waghray
24 Chelsea Court
Basking Ridge, NJ 07920

Dear Ajay:
 
We are pleased to offer you employment with Assurant, Inc. (the “Company”) to commence May 9, 2016 on the terms and conditions set forth below.

1. Duties. You will serve as Executive Vice President & Chief Technology Officer of the Company, based in our Atlanta office. In this position, you will report to me and you will become a member of the Company’s Management Committee.
 
2. Compensation. The Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) has approved your 2016 target total direct compensation of $2,231,250 for 2016, including an annualized base salary of $525,000 a target annual incentive award opportunity of 100% of your annual base salary and a target long-term incentive award opportunity of 225% of your annual base salary. Actual incentive payments are determined on the basis of Company results and are not guaranteed. For 2016, your short-term incentive award will be calculated on the basis of your 2016 annualized base salary; it will not be pro-rated. Long-term equity incentive awards are granted by the Compensation Committee pursuant to the Amended and Restated Assurant, Inc. Long-Term Equity Incentive Plan (“ALTEIP”). You are eligible to receive the 2016 long-term equity incentive award, which is scheduled for Compensation Committee consideration on May 12, 2016.

3. Other Benefits. Together with this letter, you will be provided with a Change of Control Employment Agreement containing a two times multiple. As a senior executive, your benefits will also include executive 401(k) and executive long-term disability.

The Company will reimburse you for reasonable relocation expenses in accordance with the Company’s executive relocation policy.
 
Based upon your level, you are eligible for 29 PTO (paid time off) days, which are a combination of sick and vacation days, per year.
 
4. Sign-On Equity Award. Within 30 days after commencement of your employment with the Company, you will receive an equity award of 10,000 shares of Company stock. The equity award will be subject to the terms and conditions of the Company’s standard ALTEIP award agreement with a five-year vesting schedule of 10% vesting on each anniversary during the first four years and 60% vesting in year five.

As with all our employees, your employment will be on an at-will basis and the terms thereof will be subject to applicable Company policies, which may be changed by management. Employment is contingent upon proof of employment eligibility under the Immigration Reform and Control Act of 1986. Please bring identification with you on your first day to substantiate your eligibility to work in the United States (and complete the employment eligibility verification form).

You hereby acknowledge and agree that this offer of employment supersedes and replaces any prior offer of employment provided to you by the Company, either orally or in writing or by any other means, and that this letter, if





executed by you, shall constitute the sole understanding between you and the Company regarding your employment with the Company.

    If the foregoing accurately sets forth the terms of your employment with the Company, please so indicate by signing below and returning one signed copy of this letter agreement to me by 5:00 p.m., Eastern Daylight Time on March [11], 2016 (the “Execution Time”). This offer of employment shall remain outstanding until the Execution Time, provided that the Company retains the right to rescind this offer of employment in the event that it becomes aware (i) that you have disclosed the existence, or the terms, of this offer to anyone other than your current employer, immediate family members or your legal or financial advisors or (ii) of circumstances which, if you were employed by the Company, would constitute the basis for a termination of your employment by the Company for Cause. If we have not received a signed copy of this offer letter by the Execution Time, this offer of employment, and this offer letter, and all other terms and conditions outlined shall automatically lapse, terminate and be of no further effect.



Sincerely,
 
 
 
 
 
/s/ Alan Colberg
 
 
Alan Colberg
President and Chief Executive Officer
Assurant, Inc.
 
 
 
 
 
Agreed to and Accepted by:
 
 
 
 
 
/s/ Ajay Waghray
 
3/11/2016
Ajay Waghray
 
Date









EXHIBIT 10.2

A S S U R A N T, I N C.
R E S T R I C T E D S T O C K U N I T AWARD A G R E E M E N T
2016 Time-Based Award

THIS AGREEMENT, dated as of_________________, between Assurant, Inc., a Delaware corporation (the “Company”), and ___________________(the “Participant”).

In consideration of the mutual promises and covenants made herein and the mutual benefits to be derived herefrom, the parties hereto agree as follows:

1.Grant, Vesting and Forfeiture of Restricted Stock Units.

(a)Grant. Subject to the provisions of this Award Agreement (this “Agreement”) and the provisions of the Amended and Restated Assurant, Inc. Long Term Equity Incentive Plan (the “Plan”), the Company hereby grants to the Participant, as of ___________(the “Grant Date”), _________ Restricted Stock Units (the “Restricted Stock Units”), each with respect to one share of common stock of the Company, par value $0.01 per Share (“Common Stock”). All capitalized terms used herein, to the extent not defined, shall have the meaning set forth in the Plan.

(b)Vesting during the Restriction Period. Subject to the terms and conditions of this Agreement, the Restricted Stock Units shall vest and shall no longer be subject to any restriction on the anniversaries of the Grant Date set forth below (the period during which restrictions apply, the “Restriction Period”):  
Vesting Dates
(Anniversaries of Grant Date)
Portion of
Restricted Stock Units Vesting
First Anniversary
10%
Second Anniversary
10%
Third Anniversary
10%
Fourth Anniversary
10%
Fifth Anniversary
60%
   
(c)Forfeiture; Termination of Employment. Upon the Participant’s Termination of Employment for any reason during the Restriction Period, all Restricted Stock Units still subject to restriction shall be forfeited. Notwithstanding the foregoing, (i) upon the Participant’s Termination of Employment during the Restriction Period due to the Participant’s Retirement at any time following the end of the calendar year in which the Grant Date occurred, the restrictions applicable to any Restricted Stock Units shall immediately lapse, and such Restricted Stock Units shall become free of all restrictions and become fully vested; and (ii) upon the Participant’s Termination of Employment during the Restriction Period by the Company without Cause, or Termination of Employment due to death or Disability, the Participant shall vest in a number of Restricted Stock Units equal to the excess, if any, of (A) the product of (x) the total number of Restricted Stock Units and (y) a fraction, the numerator of which is the number of full months in the Restriction Period from the Grant Date until the date of Termination of Employment (provided that, for this purpose, the month in which the Grant Date occurs shall be considered a full month) and the denominator of which is the total number of months in the Restriction Period over (B) the number of Restricted Stock Units that previously vested as of the Termination of Employment without respect to this provision. For purposes of this Agreement, employment with the Company shall include employment with the Company’s Affiliates and its successors. Nothing in this Agreement or the Plan shall confer upon the Participant any right to continue





in the employ of the Company or any of its Affiliates or interfere in any way with the right of the Company or any such Affiliates to terminate the Participant’s employment at any time.

2.Settlement of Units. As soon as practicable after the date on which the Restriction Period expires, and in no event later than 30 calendar days after such date, the Company shall deliver to the Participant or his or her personal representative, in book-position or certificate form, one Share that does not bear any restrictive legend for each vested Restricted Stock Unit.

3.Dividend Equivalents. The Participant shall have the right to receive Dividend Equivalents with respect to Shares underlying Restricted Stock Units that are outstanding under this Agreement. The Dividend Equivalents represent the right to receive an amount equal to the aggregate regular cash dividends that would have been paid to the Participant if the Participant had been the record owner, on each record date for a cash dividend during the period from the Grant Date through the date on which the applicable Restricted Stock Units are settled, cancelled or forfeited of a number of Shares equal to the applicable number of Restricted Stock Units that vest pursuant to this Agreement. The Dividend Equivalents shall be paid, in cash, as soon as practicable, but in no event more than 45 calendar days following, the applicable record date for each such cash dividend.

4.Nontransferability of the Restricted Stock Units. During the Restriction Period and until such time as the Restricted Stock Units are ultimately settled as provided in Section 2 above, the Restricted Stock Units and the Shares covered by the Restricted Stock Units shall not be transferable by the Participant by means of sale, assignment, exchange, encumbrance, pledge, hedge or otherwise. Any purported or attempted transfer of such Shares or such rights shall be null and void.

5.Rights as a Stockholder. During the Restriction Period, the Participant shall not be entitled to any rights of a stockholder with respect to the Restricted Stock Units (including, without limitation, any voting rights).

6.Adjustment; Change of Control. In the event of certain transactions during the Restricted Period, the Restricted Stock Units shall be subject to adjustment as provided in Section 3.4 of the Plan or any applicable successor provision under the Plan. In the event of a Change of Control before the Restricted Stock Units vest, the restrictions applicable to the Restricted Stock Units shall lapse, such Restricted Stock Units shall become free of all restrictions and become fully vested, consistent with Section 9.1 of the Plan, and shall be settled within 5 calendar days following the Change of Control; provided, however, that any Restricted Stock Units that constitute “nonqualified deferred compensation” as defined under Section 409A of the Code shall not be settled upon such Change of Control unless the Change of Control constitutes a “change in control event” within the meaning of Section 409A of the Code and will instead be settled at such time as specified in Section 2.

7.Payment of Transfer Taxes, Fees and Other Expenses. The Company agrees to pay any and all original issue taxes and stock transfer taxes that may be imposed on the issuance of Shares received by a Participant in connection with the Restricted Stock Units, together with any and all other fees and expenses necessarily incurred by the Company in connection therewith.

8.Taxes and Withholding. No later than the date as of which an amount first becomes includible in the gross income of the Participant for federal, state, local, foreign income, employment or other tax purposes with respect to any Restricted Stock Units, the Participant shall pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, all federal, state, local and foreign taxes that are required by applicable laws and regulations to be withheld with respect to such





amount. The obligations of the Company under this Agreement shall be conditioned on compliance by the Participant with this Section 8, and the Company shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to the Participant, including deducting such amount from the delivery of Shares upon settlement of the Restricted Stock Units that gives rise to the withholding requirement.

9.Protective Covenants. In consideration of the grant of the Restricted Stock Units, Participant agrees to the protective covenants contained in this Section 9.

(a)Acknowledgments.

(i)    Condition of Grant. Participant acknowledges and agrees that he/she has received good and valuable consideration for entering into this Agreement, including, without limitation, the grant of the Restricted Stock Units contained herein, access to and use of Company’s Confidential Information (as that term is defined below) and access to the Company’s customer and employee relationships and goodwill, and further acknowledges that the Company would not make the grant of the Restricted Stock Units contained herein in the absence of his/her execution of and compliance with this Agreement.

(ii)    Access to Confidential Information, Relationships, and Goodwill. Participant acknowledges and agrees that he/she is being provided and entrusted with Confidential Information, including highly confidential customer information that is subject to extensive measures to maintain its secrecy within the Company, is not known in the trade or disclosed to the public, and would materially harm the Company’s legitimate business interests if it was disclosed or used in violation of this Agreement. Participant also acknowledges and agrees that he/she is being provided and entrusted with access to the Company’s customer and employee relationships and goodwill. Participant further acknowledges and agrees that the Company would not provide access to the Confidential Information, customer and employee relationships, and goodwill in the absence of Participant’s execution of and compliance with this Agreement. Participant further acknowledges and agrees that the Company’s Confidential Information, customer and employee relationships, and goodwill are valuable assets of the Company and are legitimate business interests that are properly subject to protection through the covenants contained in this Agreement.

(iii)    Potential Unfair Competition. Participant acknowledges and agrees that as a result of his/her employment with the Company, his/her knowledge of and access to Confidential Information, and his/her relationships with the Company’s customers and employees, Participant would have an unfair competitive advantage if Participant were to engage in activities in violation of this Agreement.

(iv)    No Undue Hardship. Participant acknowledges and agrees that, in the event that his/her employment with the Company terminates, Participant possesses marketable skills and abilities that will enable Participant to find suitable employment without violating the covenants set forth in this Agreement.

(v)    Voluntary Execution. Participant acknowledges and affirms that he/she is executing this Agreement voluntarily, that he/she has read this Agreement carefully and had a full and reasonable opportunity to consider this Agreement (including an opportunity to consult with legal counsel), and that he/she has not been pressured or in any way coerced, threatened or intimidated into signing this Agreement.






(b)Definitions. The following capitalized terms used in this Agreement shall have the meanings assigned to them below, which definitions shall apply to both the singular and the plural forms of such terms:
(i)    “Competitive Services” means any specialty protection product or related service or any other business engaged, directly or indirectly, in sales or the provisions of products or services or other activities in competition with the sales, provision of products or services or other activities of the Company or any of its subsidiaries or affiliates.
(ii)    “Confidential Information” means any and all data and information relating to the Company, its activities, business, or clients that (i) is disclosed to Participant or of which Participant becomes aware as a consequence of his/her employment with the Company; (ii) has value to the Company; and (iii) is not generally known outside of the Company. “Confidential Information” shall include, but is not limited to the following types of information regarding, related to, or concerning the Company: trade secrets (as defined by the Delaware Trade Secrets Act); financial plans and data; management planning information; business plans; operational methods; market studies; marketing plans or strategies; pricing information; product development techniques or plans; customer lists; customer files, data and financial information; details of customer contracts; current and anticipated customer requirements; identifying and other information pertaining to business referral sources; past, current and planned research and development; computer aided systems, software, strategies and programs; business acquisition plans; management organization and related information (including, without limitation, data and other information concerning the compensation and benefits paid to officers, directors, employees and management); personnel and compensation policies; new personnel acquisition plans; and other similar information. “Confidential Information” also includes combinations of information or materials which individually may be generally known outside of the Company, but for which the nature, method, or procedure for combining such information or materials is not generally known outside of the Company. In addition to data and information relating to the Company, “Confidential Information” also includes any and all data and information relating to or concerning a third party that otherwise meets the definition set forth above, that was provided or made available to the Company by such third party, and that the Company has a duty or obligation to keep confidential. This definition shall not limit any definition of “confidential information” or any equivalent term under state or federal law. “Confidential Information” shall not include information that has become generally available to the public by the act of one who has the right to disclose such information without violating any right or privilege of the Company.
(iii)    “Material Contact” means contact between Participant and a customer or potential customer of the Company (i) with whom or which Participant has or had dealings on behalf of the Company; (ii) whose dealings with the Company are or were coordinated or supervised by Participant; (iii) about whom Participant obtains Confidential Information in the ordinary course of business as a result of his/her employment with the Company; or (iv) who receives products or services of the Company, the sale or provision of which results or resulted in compensation, commissions, or earnings for Participant within the two (2) years prior to Participant’s Termination Date.
(iv)    “Person” means any individual or any corporation, partnership, joint venture, limited liability company, association or other entity or enterprise.
(v)        “Principal or Representative” means a principal, owner, partner, shareholder, joint venturer, investor, member, trustee, director, officer, manager, employee, agent, representative or consultant.
(vi)    “Protected Customer” means any Person to whom the Company has sold its products or services or actively solicited to sell its products or services, and with whom Participant has had





Material Contact on behalf of the Company during his/her employment with the Company.
(vii)    “Protective Covenants” means the protective covenants contained in Section 9 hereof.
(viii)    “Restricted Period” means any time during Participant’s employment with the Company, as well as one (1) year from Participant’s Termination Date.
(ix)    “Restricted Territory” means the territory within 25 miles of the Participant’s primary place of employment; and any other territory where Participant is working on behalf of the Company during the one (1) year preceding the conduct in question (if the conduct occurs while Participant is still employed by the Company) or the Termination Date (if the conduct occurs after Participant’s Termination), as applicable.
(x)        “Termination” means the termination of Participant’s employment with the Company, either voluntarily by the Participant or by the Company for cause.
(xi)    “Termination Date” means the date of Participant’s Termination.
(c)Restriction on Disclosure and Use of Confidential Information. Participant agrees that Participant shall not, directly or indirectly, use any Confidential Information on Participant’s own behalf or on behalf of any Person other than Company, or reveal, divulge, or disclose any Confidential Information to any Person not expressly authorized by the Company to receive such Confidential Information. This obligation shall remain in effect for as long as the information or materials in question retain their status as Confidential Information. Participant further agrees that he/she shall fully cooperate with the Company in maintaining the Confidential Information to the extent permitted by law. The parties acknowledge and agree that this Agreement is not intended to, and does not, alter either the Company’s rights or Participant’s obligations under any state or federal statutory or common law regarding trade secrets and unfair trade practices. Anything herein to the contrary notwithstanding, Participant shall not be restricted from: (i) disclosing information that is required to be disclosed by law, court order or other valid and appropriate legal process; provided, however, that in the event such disclosure is required by law, Participant shall provide the Company with prompt notice of such requirement so that the Company may seek an appropriate protective order prior to any such required disclosure by Participant; and (ii) reporting possible violations of federal, state, or local law or regulation to any governmental agency or entity, or from making other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation, and Participant shall not need the prior authorization of the Company to make any such reports or disclosures and shall not be required to notify the Company that Participant has made such reports or disclosures.

(d)Non-Competition. Participant agrees that, during the Restricted Period, he/she will not, without prior written consent of the Company, directly or indirectly (i) carry on or engage in Competitive Services within the Restricted Territory on his/her own or on behalf of any Person or any Principal or Representative of any Person, or (ii) own, manage, operate, join, control or participate in the ownership, management, operation or control, of any business, whether in corporate, proprietorship or partnership form or otherwise where such business is engaged in the provision of Competitive Services within the Restricted Territory.

(e)    Non-Solicitation of Protected Customers. Participant agrees that, during the Restricted Period, he/she shall not, without the prior written consent of the Company, directly or indirectly, on his/her own behalf or as a Principal or Representative of any Person, solicit, divert, take





away, or attempt to solicit, divert, or take away a Protected Customer for the purpose of engaging in, providing, or selling Competitive Services.
(f)    Non-Recruitment of Employees and Independent Contractors. Participant agrees that during the Restricted Period, he/she shall not, directly or indirectly, whether on his/her own behalf or as a Principal or Representative of any Person, recruit, solicit, or induce or attempt to recruit, solicit or induce any employee or independent contractor of the Company to terminate his/her employment or other relationship with the Company or to enter into employment or any other kind of business relationship with the Participant or any other Person.
(g)    Return of Materials. Participant agrees that he/she will not retain or destroy (except as set forth below), and will immediately return to the Company on or prior to the Termination Date, or at any other time the Company requests such return, any and all property of the Company that is in his/her possession or subject to his/her control, including, but not limited to, customer files and information, papers, drawings, notes, manuals, specifications, designs, devices, code, email, documents, diskettes, CDs, tapes, keys, access cards, credit cards, identification cards, equipment, computers, mobile devices, other electronic media, all other files and documents relating to the Company and its business (regardless of form, but specifically including all electronic files and data of the Company), together with all Protected Works and Confidential Information belonging to the Company or that Participant received from or through his/her employment with the Company. Participant will not make, distribute, or retain copies of any such information or property. To the extent that Participant has electronic files or information in his/her possession or control that belong to the Company or contain Confidential Information (specifically including but not limited to electronic files or information stored on personal computers, mobile devices, electronic media, or in cloud storage), on or prior to the Termination Date, or at any other time the Company requests, Participant shall (a) provide the Company with an electronic copy of all of such files or information (in an electronic format that readily accessible by the Company); (b) after doing so, delete all such files and information, including all copies and derivatives thereof, from all non-Company-owned computers, mobile devices, electronic media, cloud storage, and other media, devices, and equipment, such that such files and information are permanently deleted and irretrievable; and (c) provide a written certification to the Company that the required deletions have been completed and specifying the files and information deleted and the media source from which they were deleted. Participant agrees that he/she will reimburse the Company for all of its costs, including reasonable attorneys’ fees, of recovering the above materials and otherwise enforcing compliance with this provision if he/she does not return the materials to the Company or take the required steps with respect to electronic information or files on or prior to the Termination Date or at any other time the materials and/or electronic file actions are requested by the Company or if Participant otherwise fails to comply with this provision.
(h)    Enforcement of Protective Covenants.
(i)    Rights and Remedies Upon Breach. The parties specifically acknowledge and agree that the remedy at law for any breach of the Protective Covenants will be inadequate, and that in the event Participant breaches, or threatens to breach, any of the Protective Covenants, the Company shall have the right and remedy, without the necessity of proving actual damage or posting any bond, to enjoin, preliminarily and permanently, Participant from violating or threatening to violate the Protective Covenants and to have the Protective Covenants specifically enforced by any court of competent jurisdiction, it being agreed that any breach or threatened breach of the Protective Covenants would cause irreparable injury to the Company and that money damages would not provide an adequate remedy to the Company. Participant understands and agrees that if he/she violates any of the obligations set forth in the Protective Covenants, the period of restriction applicable to each obligation violated shall cease to run during the pendency of any litigation over such violation, provided that such litigation was initiated during





the period of restriction. Such rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Company at law or in equity. Participant understands and agrees that, if the Parties become involved in legal action regarding the enforcement of the Protective Covenants and if the Company prevails in such legal action, the Company will be entitled, in addition to any other remedy, to recover from Participant its reasonable costs and attorneys’ fees incurred in enforcing such covenants. The Company’s ability to enforce its rights under the Protective Covenants or applicable law against Participant shall not be impaired in any way by the existence of a claim or cause of action on the part of Participant based on, or arising out of, this Agreement or any other event or transaction.
(ii)    Severability and Modification of Covenants. Participant acknowledges and agrees that each of the Protective Covenants is reasonable and valid in time and scope and in all other respects. The parties agree that it is their intention that the Protective Covenants be enforced in accordance with their terms to the maximum extent permitted by law. Each of the Protective Covenants shall be considered and construed as a separate and independent covenant. Should any part or provision of any of the Protective Covenants be held invalid, void, or unenforceable, such invalidity, voidness, or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Agreement or such Protective Covenant. If any of the provisions of the Protective Covenants should ever be held by a court of competent jurisdiction to exceed the scope permitted by the applicable law, such provision or provisions shall be automatically modified to such lesser scope as such court may deem just and proper for the reasonable protection of the Company’s legitimate business interests and may be enforced by the Company to that extent in the manner described above and all other provisions of this Agreement shall be valid and enforceable.
(i)    Disclosure of Agreement. Participant acknowledges and agrees that, during the Restricted Period, he/she will disclose the existence and terms of this Agreement to any prospective employer, business partner, investor or lender prior to entering into an employment, partnership or other business relationship with such prospective employer, business partner, investor or lender. Participant further agrees that the Company shall have the right to make any such prospective employer, business partner, investor or lender of Participant aware of the existence and terms of this Agreement.
10.Notices. Notices and other communications under this Agreement must be in writing and shall be given by hand delivery to the other party or by facsimile, overnight courier, or registered or certified mail, return receipt requested, postage prepaid, addressed as follows:
If to the Participant:
 
 
At the most recent address
 
on file at the Company
If to the Company:
 
 
Assurant, Inc.
 
28 Liberty Street, 41st Floor
 
New York, New York 10005
 
Attention: Secretary

 
or to such other address or facsimile number as any party shall have furnished to the other in writing in accordance with this Section 9. Notices and communications shall be effective when actually received by the addressee. Notwithstanding the foregoing, the Participant consents to electronic delivery of documents required to be delivered by the Company under the securities laws.





11.Effect of Agreement. This Agreement is personal to the Participant and, without the prior written consent of the Company, shall not be assignable by the Participant otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Participant’s legal representatives. This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.

12.Applicable Law; Forum Selection; Consent to Jurisdiction: The Company and Participant agree that this Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of Delaware without giving effect to its conflicts of law principles, as applied to contracts executed in and performed wholly within the State of Delaware. Participant agrees that the exclusive forum for any action to enforce this Agreement, as well as any action relating to or arising out of this Agreement, shall be the state or federal courts of the State of Delaware. With respect to any such court action, Participant hereby (a) irrevocably submits to the personal jurisdiction of such courts; (b) consents to service of process; (c) consents to venue; and (d) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction, service of process, or venue. Both parties hereto further agree that the state and federal courts of the State of Delaware are convenient forums for any dispute that may arise herefrom and that neither party shall raise as a defense that such courts are not convenient forums.

13.Terms of Plan. In addition to the terms and conditions set forth in this Agreement, the Restricted Stock Units are subject to the terms and conditions of the Plan, which is hereby incorporated by reference.

14.Waiver. Failure of either party to insist, in one or more instances, on performance by the other in strict accordance with the terms and conditions of this Agreement shall not be deemed a waiver or relinquishment of any right granted in this Agreement or of the future performance of any such term or condition or of any other term or condition of this Agreement, unless such waiver is contained in a writing signed by the party making the waiver.

15.Severability. If any one or more of the provisions contained in this Agreement are held to be invalid, illegal or unenforceable, the other provisions of this Agreement shall be construed and enforced as if the invalid, illegal or unenforceable provision had never been included.

16.Conflicts and Interpretation. In the event of any conflict between this Agreement and the Plan, the Plan shall control. In the event of any ambiguity in this Agreement, or any matters as to which this Agreement is silent, the Plan shall govern including, without limitation, the provisions thereof pursuant to which the Committee has the power, among others, to (a) interpret the Plan, (b) prescribe, amend and rescind rules and regulations relating to the Plan, and (c) make all other determinations deemed necessary or advisable for the administration of the Plan. The Participant and the Company each acknowledges that this Agreement (together with the Plan) constitutes the entire agreement and supersedes all other agreements and understandings, both written and oral, among the parties or either of them, with respect to the subject matter hereof.

17.Amendment. The Company may modify, amend or waive the terms of the Restricted Stock Unit award, prospectively or retroactively, but no such modification, amendment or waiver shall materially impair the rights of the Participant without his or her consent, except as required by applicable law, stock exchange rules, tax rules or accounting rules. The waiver by either party of compliance with any provision of this Agreement shall not operate or be construed as a waiver of any





other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.

18.Section 409A of the Code. It is the intention of the Company that the Restricted Stock Units shall either (a) not constitute “nonqualified deferred compensation” as defined under Section 409A of the Code or (b) comply in all respects with the requirements of Section 409A of the Code and the regulations promulgated thereunder, such that no delivery of Shares pursuant to this Agreement will result in the imposition of taxation or penalties as a consequence of the application of Section 409A of the Code. Shares in respect of any Restricted Stock Units that (i) constitute “nonqualified deferred compensation” as defined under Section 409A of the Code and (ii) vest as a consequence of the Participant’s termination of employment shall not be delivered until the date that the Participant incurs a “separation from service” within the meaning of Section 409A of the Code (or, if the Participant is a “specified employee” within the meaning of Section 409A of the Code and the regulations promulgated thereunder, the date that is six months following the date of such “separation from service”). If the Company determines after the Grant Date that an amendment to this Agreement is necessary to ensure the foregoing, it may, notwithstanding Section 14, make such an amendment, effective as of the Grant Date or any later date, without the consent of the Participant. Notwithstanding any provision of this Agreement or the Plan, in the event that any taxes or penalties are imposed on the Participant by reason of Section 409A of the Code, the Participant acknowledges and agrees that such taxes or penalties shall be the exclusive obligation of the Participant, and the Company shall have no liability therefor.

19.Headings. The headings of Sections herein are included solely for convenience of reference and shall not affect the meaning or interpretation of any of the provisions of this Agreement.

20.Counterparts. This Agreement may be executed in counterparts, which together shall constitute one and the same original.






EXHIBIT 10.3

PRIVILEGED AND CONFIDENTIAL

April 26, 2016
 
Richard Dziadzio
401 East 60th Street, Apt #12C
New York, NY 10022


Dear Richard:
 
We are pleased to offer you employment with Assurant, Inc. (the “Company”) to commence June 1, 2016 on the terms and conditions set forth below.

1. Duties. You will serve as Executive Vice President, Chief Financial Officer & Treasurer of the Company, based in our New York City office. In this position you will report to me and you will become a member of the Company’s Management Committee.
 
2. Compensation. The Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) has approved your 2016 target total direct compensation of $2,656,250 for 2016, including an annualized base salary of $625,000, a target annual incentive award opportunity of 100% of your annual base salary and a target long-term incentive award opportunity of 225% of your annual base salary. Actual incentive payments are determined on the basis of Company results and are not guaranteed. Your 2016 long-term incentive award will be granted no later than 30 days after the commencement of your employment. Long-term incentive awards are granted by the Compensation Committee pursuant to the Amended and Restated Assurant, Inc. Long-Term Equity Incentive Plan (“ALTEIP”).

3. Other Benefits. Together with this letter, you will be provided with a Change of Control Employment Agreement containing a two times multiple. As a senior executive, your benefits will also include executive 401(k) and executive long-term disability.

Based upon your level, you are eligible for 24 PTO (paid time off) days, which are a combination of sick and vacation days, per year.
     
4. Sign-On Equity Award. Within 30 days after commencement of your employment with the Company, you will receive an additional equity award of 10,000 restricted stock units (“RSUs”). The equity award will be subject to the terms and conditions of the Company’s standard ALTEIP award agreement with a five-year vesting schedule of 10% vesting on each anniversary of grant during the first four years and 60% vesting in year five. All RSUs provided to you through this Sign-On Equity Award shall immediately vest in the event of an involuntary termination of your employment by the Company without cause during the five-year vesting period.

As with all our employees, your employment will be on an at-will basis and the terms thereof will be subject to applicable Company policies, which may be changed by management. Employment is contingent upon proof of employment eligibility under the Immigration Reform and Control Act of 1986. Please bring identification with you on your first day to substantiate your eligibility to work in the United States (and complete the employment eligibility verification form).






You hereby acknowledge and agree that this offer of employment supersedes and replaces any prior offer of employment provided to you by the Company, either orally or in writing or by any other means, and that this letter, if executed by you, shall constitute the sole understanding between you and the Company regarding your employment with the Company.

     If the foregoing accurately sets forth the terms of your employment with the Company, please so indicate by signing below and returning one signed copy of this letter agreement to me by 5:00 p.m., Eastern Daylight Time on May 2, 2016 (the “Execution Time”). This offer of employment shall remain outstanding until the Execution Time, provided that the Company retains the right to rescind this offer of employment in the event that it becomes aware (i) that you have disclosed the existence, or the terms, of this offer to anyone other than your current employer, immediate family members or your legal or financial advisors or (ii) of circumstances which, if you were employed by the Company, would constitute the basis for a termination of your employment by the Company for Cause. If we have not received a signed copy of this offer letter by the Execution Time, this offer of employment, and this offer letter, and all other terms and conditions outlined shall automatically lapse, terminate and be of no further effect.



Sincerely,
 
 
 
 
 
/s/ Alan Colberg
 
 
Alan Colberg
President and Chief Executive Officer
Assurant, Inc.
 
 
 
 
 
Agreed to and Accepted by:
 
 
 
 
 
/s/ Richard Dziadzio
 
4/27/16
Richard Dziadzio
 
Date





EXHIBIT 10.4

A S S U R A N T, I N C.
R E S T R I C T E D S T O C K U N I T AWARD A G R E E M E N T
2016 Time-Based Award

THIS AGREEMENT, dated as of July 18, 2016, between Assurant, Inc., a Delaware corporation (the “Company”), and Richard Dziadzio (the “Participant”).

In consideration of the mutual promises and covenants made herein and the mutual benefits to be derived herefrom, the parties hereto agree as follows:

1.Grant, Vesting and Forfeiture of Restricted Stock Units.
(a)Grant. Subject to the provisions of this Award Agreement (this “Agreement”) and the provisions of the Amended and Restated Assurant, Inc. Long Term Equity Incentive Plan (the “Plan”), the Company hereby grants to the Participant, as of July 18, 2016 (the “Grant Date”), 10,000 Restricted Stock Units (the “Restricted Stock Units”), each with respect to one share of common stock of the Company, par value $0.01 per Share (“Common Stock”). All capitalized terms used herein, to the extent not defined, shall have the meaning set forth in the Plan.

(b)Vesting during the Restriction Period. Subject to the terms and conditions of this Agreement, the Restricted Stock Units shall vest and shall no longer be subject to any restriction on the anniversaries of the Grant Date set forth below (the period during which restrictions apply, the “Restriction Period”):  
Vesting Dates
(Anniversaries of Grant Date)
Portion of
Restricted Stock Units Vesting
First Anniversary
10%
Second Anniversary
10%
Third Anniversary
10%
Fourth Anniversary
10%
Fifth Anniversary
60%
   
(c)Forfeiture; Termination of Employment. Upon the Participant’s Termination of Employment for any reason during the Restriction Period, all Restricted Stock Units still subject to restriction shall be forfeited. Notwithstanding the foregoing, (i) upon the Participant’s Termination of Employment during the Restriction Period by the Company without Cause, or upon a Termination of Employment due to the Participant’s Retirement at any time following the end of the calendar year in which the Grant Date occurred, the restrictions applicable to any Restricted Stock Units shall immediately lapse, and such Restricted Stock Units shall become free of all restrictions and become fully vested; and (ii) upon the Participant’s Termination of Employment during the Restriction Period due to death or Disability, the Participant shall vest in a number of Restricted Stock Units equal to the excess, if any, of (A) the product of (x) the total number of Restricted Stock Units and (y) a fraction, the numerator of which is the number of full months in the Restriction Period from the Grant Date until the date of Termination of Employment (provided that, for this purpose, the month in which the Grant Date occurs shall be considered a full month) and the denominator of which is the total number of months in the Restriction Period over (B) the number of Restricted Stock Units that previously vested as of the Termination of Employment without respect to this provision. For purposes of this Agreement, employment with the Company shall include employment with the Company’s Affiliates and its successors. Nothing in this Agreement or the Plan shall confer upon the Participant any right to continue





in the employ of the Company or any of its Affiliates or interfere in any way with the right of the Company or any such Affiliates to terminate the Participant’s employment at any time.

2.Settlement of Units. As soon as practicable after the date on which the Restriction Period expires, and in no event later than 30 calendar days after such date, the Company shall deliver to the Participant or his or her personal representative, in book-position or certificate form, one Share that does not bear any restrictive legend for each vested Restricted Stock Unit.

3.Dividend Equivalents. The Participant shall have the right to receive Dividend Equivalents with respect to Shares underlying Restricted Stock Units that are outstanding under this Agreement. The Dividend Equivalents represent the right to receive an amount equal to the aggregate regular cash dividends that would have been paid to the Participant if the Participant had been the record owner, on each record date for a cash dividend during the period from the Grant Date through the date on which the applicable Restricted Stock Units are settled, cancelled or forfeited of a number of Shares equal to the applicable number of Restricted Stock Units that vest pursuant to this Agreement. The Dividend Equivalents shall be paid, in cash, as soon as practicable, but in no event more than 45 calendar days following, the applicable record date for each such cash dividend.

4.Nontransferability of the Restricted Stock Units. During the Restriction Period and until such time as the Restricted Stock Units are ultimately settled as provided in Section 2 above, the Restricted Stock Units and the Shares covered by the Restricted Stock Units shall not be transferable by the Participant by means of sale, assignment, exchange, encumbrance, pledge, hedge or otherwise. Any purported or attempted transfer of such Shares or such rights shall be null and void.

5.Rights as a Stockholder. During the Restriction Period, the Participant shall not be entitled to any rights of a stockholder with respect to the Restricted Stock Units (including, without limitation, any voting rights).

6.Adjustment; Change of Control. In the event of certain transactions during the Restricted Period, the Restricted Stock Units shall be subject to adjustment as provided in Section 3.4 of the Plan or any applicable successor provision under the Plan. In the event of a Change of Control before the Restricted Stock Units vest, the restrictions applicable to the Restricted Stock Units shall lapse, such Restricted Stock Units shall become free of all restrictions and become fully vested, consistent with Section 9.1 of the Plan, and shall be settled within 5 calendar days following the Change of Control; provided, however, that any Restricted Stock Units that constitute “nonqualified deferred compensation” as defined under Section 409A of the Code shall not be settled upon such Change of Control unless the Change of Control constitutes a “change in control event” within the meaning of Section 409A of the Code and will instead be settled at such time as specified in Section 2.

7.Payment of Transfer Taxes, Fees and Other Expenses. The Company agrees to pay any and all original issue taxes and stock transfer taxes that may be imposed on the issuance of Shares received by a Participant in connection with the Restricted Stock Units, together with any and all other fees and expenses necessarily incurred by the Company in connection therewith.

8.Taxes and Withholding. No later than the date as of which an amount first becomes includible in the gross income of the Participant for federal, state, local, foreign income, employment or other tax purposes with respect to any Restricted Stock Units, the Participant shall pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, all federal, state, local and foreign taxes that are required by applicable laws and regulations to be withheld with respect to such





amount. The obligations of the Company under this Agreement shall be conditioned on compliance by the Participant with this Section 8, and the Company shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to the Participant, including deducting such amount from the delivery of Shares upon settlement of the Restricted Stock Units that gives rise to the withholding requirement.

9.Protective Covenants. In consideration of the grant of the Restricted Stock Units, Participant agrees to the protective covenants contained in this Section 9.

(a)Acknowledgments.

(i)    Condition of Grant. Participant acknowledges and agrees that he/she has received good and valuable consideration for entering into this Agreement, including, without limitation, the grant of the Restricted Stock Units contained herein, access to and use of Company’s Confidential Information (as that term is defined below) and access to the Company’s customer and employee relationships and goodwill, and further acknowledges that the Company would not make the grant of the Restricted Stock Units contained herein in the absence of his/her execution of and compliance with this Agreement.

(ii)    Access to Confidential Information, Relationships, and Goodwill. Participant acknowledges and agrees that he/she is being provided and entrusted with Confidential Information, including highly confidential customer information that is subject to extensive measures to maintain its secrecy within the Company, is not known in the trade or disclosed to the public, and would materially harm the Company’s legitimate business interests if it was disclosed or used in violation of this Agreement. Participant also acknowledges and agrees that he/she is being provided and entrusted with access to the Company’s customer and employee relationships and goodwill. Participant further acknowledges and agrees that the Company would not provide access to the Confidential Information, customer and employee relationships, and goodwill in the absence of Participant’s execution of and compliance with this Agreement. Participant further acknowledges and agrees that the Company’s Confidential Information, customer and employee relationships, and goodwill are valuable assets of the Company and are legitimate business interests that are properly subject to protection through the covenants contained in this Agreement.

(iii)    Potential Unfair Competition. Participant acknowledges and agrees that as a result of his/her employment with the Company, his/her knowledge of and access to Confidential Information, and his/her relationships with the Company’s customers and employees, Participant would have an unfair competitive advantage if Participant were to engage in activities in violation of this Agreement.

(iv)    No Undue Hardship. Participant acknowledges and agrees that, in the event that his/her employment with the Company terminates, Participant possesses marketable skills and abilities that will enable Participant to find suitable employment without violating the covenants set forth in this Agreement.

(v)    Voluntary Execution. Participant acknowledges and affirms that he/she is executing this Agreement voluntarily, that he/she has read this Agreement carefully and had a full and reasonable opportunity to consider this Agreement (including an opportunity to consult with legal counsel), and that he/she has not been pressured or in any way coerced, threatened or intimidated into signing this Agreement.






(b)Definitions. The following capitalized terms used in this Agreement shall have the meanings assigned to them below, which definitions shall apply to both the singular and the plural forms of such terms:
(i)    “Competitive Services” means any specialty protection product or related service or any other business engaged, directly or indirectly, in sales or the provisions of products or services or other activities in competition with the sales, provision of products or services or other activities of the Company or any of its subsidiaries or affiliates.
(ii)    “Confidential Information” means any and all data and information relating to the Company, its activities, business, or clients that (i) is disclosed to Participant or of which Participant becomes aware as a consequence of his/her employment with the Company; (ii) has value to the Company; and (iii) is not generally known outside of the Company. “Confidential Information” shall include, but is not limited to the following types of information regarding, related to, or concerning the Company: trade secrets (as defined by the Delaware Trade Secrets Act); financial plans and data; management planning information; business plans; operational methods; market studies; marketing plans or strategies; pricing information; product development techniques or plans; customer lists; customer files, data and financial information; details of customer contracts; current and anticipated customer requirements; identifying and other information pertaining to business referral sources; past, current and planned research and development; computer aided systems, software, strategies and programs; business acquisition plans; management organization and related information (including, without limitation, data and other information concerning the compensation and benefits paid to officers, directors, employees and management); personnel and compensation policies; new personnel acquisition plans; and other similar information. “Confidential Information” also includes combinations of information or materials which individually may be generally known outside of the Company, but for which the nature, method, or procedure for combining such information or materials is not generally known outside of the Company. In addition to data and information relating to the Company, “Confidential Information” also includes any and all data and information relating to or concerning a third party that otherwise meets the definition set forth above, that was provided or made available to the Company by such third party, and that the Company has a duty or obligation to keep confidential. This definition shall not limit any definition of “confidential information” or any equivalent term under state or federal law. “Confidential Information” shall not include information that has become generally available to the public by the act of one who has the right to disclose such information without violating any right or privilege of the Company.
(iii)    “Material Contact” means contact between Participant and a customer or potential customer of the Company (i) with whom or which Participant has or had dealings on behalf of the Company; (ii) whose dealings with the Company are or were coordinated or supervised by Participant; (iii) about whom Participant obtains Confidential Information in the ordinary course of business as a result of his/her employment with the Company; or (iv) who receives products or services of the Company, the sale or provision of which results or resulted in compensation, commissions, or earnings for Participant within the two (2) years prior to Participant’s Termination Date.
(iv)    “Person” means any individual or any corporation, partnership, joint venture, limited liability company, association or other entity or enterprise.
(v)        “Principal or Representative” means a principal, owner, partner, shareholder, joint venturer, investor, member, trustee, director, officer, manager, employee, agent, representative or consultant.
(vi)    “Protected Customer” means any Person to whom the Company has sold its products or services or actively solicited to sell its products or services, and with whom Participant has had





Material Contact on behalf of the Company during his/her employment with the Company.
(vii)    “Protective Covenants” means the protective covenants contained in Section 9 hereof.
(viii)    “Restricted Period” means any time during Participant’s employment with the Company, as well as one (1) year from Participant’s Termination Date.
(ix)    “Restricted Territory” means the territory within 25 miles of the Participant’s primary place of employment; and any other territory where Participant is working on behalf of the Company during the one (1) year preceding the conduct in question (if the conduct occurs while Participant is still employed by the Company) or the Termination Date (if the conduct occurs after Participant’s Termination), as applicable.
(x)        “Termination” means the termination of Participant’s employment with the Company, either voluntarily by the Participant or by the Company for cause.
(xi)    “Termination Date” means the date of Participant’s Termination.
(c)Restriction on Disclosure and Use of Confidential Information. Participant agrees that Participant shall not, directly or indirectly, use any Confidential Information on Participant’s own behalf or on behalf of any Person other than Company, or reveal, divulge, or disclose any Confidential Information to any Person not expressly authorized by the Company to receive such Confidential Information. This obligation shall remain in effect for as long as the information or materials in question retain their status as Confidential Information. Participant further agrees that he/she shall fully cooperate with the Company in maintaining the Confidential Information to the extent permitted by law. The parties acknowledge and agree that this Agreement is not intended to, and does not, alter either the Company’s rights or Participant’s obligations under any state or federal statutory or common law regarding trade secrets and unfair trade practices. Anything herein to the contrary notwithstanding, Participant shall not be restricted from: (i) disclosing information that is required to be disclosed by law, court order or other valid and appropriate legal process; provided, however, that in the event such disclosure is required by law, Participant shall provide the Company with prompt notice of such requirement so that the Company may seek an appropriate protective order prior to any such required disclosure by Participant; and (ii) reporting possible violations of federal, state, or local law or regulation to any governmental agency or entity, or from making other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation, and Participant shall not need the prior authorization of the Company to make any such reports or disclosures and shall not be required to notify the Company that Participant has made such reports or disclosures.

(d)Non-Competition. Participant agrees that, during the Restricted Period, he/she will not, without prior written consent of the Company, directly or indirectly (i) carry on or engage in Competitive Services within the Restricted Territory on his/her own or on behalf of any Person or any Principal or Representative of any Person, or (ii) own, manage, operate, join, control or participate in the ownership, management, operation or control, of any business, whether in corporate, proprietorship or partnership form or otherwise where such business is engaged in the provision of Competitive Services within the Restricted Territory.

(e)    Non-Solicitation of Protected Customers. Participant agrees that, during the Restricted Period, he/she shall not, without the prior written consent of the Company, directly or indirectly, on his/her own behalf or as a Principal or Representative of any Person, solicit, divert, take





away, or attempt to solicit, divert, or take away a Protected Customer for the purpose of engaging in, providing, or selling Competitive Services.
(f)    Non-Recruitment of Employees and Independent Contractors. Participant agrees that during the Restricted Period, he/she shall not, directly or indirectly, whether on his/her own behalf or as a Principal or Representative of any Person, recruit, solicit, or induce or attempt to recruit, solicit or induce any employee or independent contractor of the Company to terminate his/her employment or other relationship with the Company or to enter into employment or any other kind of business relationship with the Participant or any other Person.
(g)    Return of Materials. Participant agrees that he/she will not retain or destroy (except as set forth below), and will immediately return to the Company on or prior to the Termination Date, or at any other time the Company requests such return, any and all property of the Company that is in his/her possession or subject to his/her control, including, but not limited to, customer files and information, papers, drawings, notes, manuals, specifications, designs, devices, code, email, documents, diskettes, CDs, tapes, keys, access cards, credit cards, identification cards, equipment, computers, mobile devices, other electronic media, all other files and documents relating to the Company and its business (regardless of form, but specifically including all electronic files and data of the Company), together with all Protected Works and Confidential Information belonging to the Company or that Participant received from or through his/her employment with the Company. Participant will not make, distribute, or retain copies of any such information or property. To the extent that Participant has electronic files or information in his/her possession or control that belong to the Company or contain Confidential Information (specifically including but not limited to electronic files or information stored on personal computers, mobile devices, electronic media, or in cloud storage), on or prior to the Termination Date, or at any other time the Company requests, Participant shall (a) provide the Company with an electronic copy of all of such files or information (in an electronic format that readily accessible by the Company); (b) after doing so, delete all such files and information, including all copies and derivatives thereof, from all non-Company-owned computers, mobile devices, electronic media, cloud storage, and other media, devices, and equipment, such that such files and information are permanently deleted and irretrievable; and (c) provide a written certification to the Company that the required deletions have been completed and specifying the files and information deleted and the media source from which they were deleted. Participant agrees that he/she will reimburse the Company for all of its costs, including reasonable attorneys’ fees, of recovering the above materials and otherwise enforcing compliance with this provision if he/she does not return the materials to the Company or take the required steps with respect to electronic information or files on or prior to the Termination Date or at any other time the materials and/or electronic file actions are requested by the Company or if Participant otherwise fails to comply with this provision.
(h)    Enforcement of Protective Covenants.
(i)    Rights and Remedies Upon Breach. The parties specifically acknowledge and agree that the remedy at law for any breach of the Protective Covenants will be inadequate, and that in the event Participant breaches, or threatens to breach, any of the Protective Covenants, the Company shall have the right and remedy, without the necessity of proving actual damage or posting any bond, to enjoin, preliminarily and permanently, Participant from violating or threatening to violate the Protective Covenants and to have the Protective Covenants specifically enforced by any court of competent jurisdiction, it being agreed that any breach or threatened breach of the Protective Covenants would cause irreparable injury to the Company and that money damages would not provide an adequate remedy to the Company. Participant understands and agrees that if he/she violates any of the obligations set forth in the Protective Covenants, the period of restriction applicable to each obligation violated shall cease to run during the pendency of any litigation over such violation, provided that such litigation was initiated during





the period of restriction. Such rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Company at law or in equity. Participant understands and agrees that, if the Parties become involved in legal action regarding the enforcement of the Protective Covenants and if the Company prevails in such legal action, the Company will be entitled, in addition to any other remedy, to recover from Participant its reasonable costs and attorneys’ fees incurred in enforcing such covenants. The Company’s ability to enforce its rights under the Protective Covenants or applicable law against Participant shall not be impaired in any way by the existence of a claim or cause of action on the part of Participant based on, or arising out of, this Agreement or any other event or transaction.
(ii)    Severability and Modification of Covenants. Participant acknowledges and agrees that each of the Protective Covenants is reasonable and valid in time and scope and in all other respects. The parties agree that it is their intention that the Protective Covenants be enforced in accordance with their terms to the maximum extent permitted by law. Each of the Protective Covenants shall be considered and construed as a separate and independent covenant. Should any part or provision of any of the Protective Covenants be held invalid, void, or unenforceable, such invalidity, voidness, or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Agreement or such Protective Covenant. If any of the provisions of the Protective Covenants should ever be held by a court of competent jurisdiction to exceed the scope permitted by the applicable law, such provision or provisions shall be automatically modified to such lesser scope as such court may deem just and proper for the reasonable protection of the Company’s legitimate business interests and may be enforced by the Company to that extent in the manner described above and all other provisions of this Agreement shall be valid and enforceable.
(i)    Disclosure of Agreement. Participant acknowledges and agrees that, during the Restricted Period, he/she will disclose the existence and terms of this Agreement to any prospective employer, business partner, investor or lender prior to entering into an employment, partnership or other business relationship with such prospective employer, business partner, investor or lender. Participant further agrees that the Company shall have the right to make any such prospective employer, business partner, investor or lender of Participant aware of the existence and terms of this Agreement.
10.Notices. Notices and other communications under this Agreement must be in writing and shall be given by hand delivery to the other party or by facsimile, overnight courier, or registered or certified mail, return receipt requested, postage prepaid, addressed as follows:
If to the Participant:
 
 
At the most recent address
 
on file at the Company
If to the Company:
 
 
Assurant, Inc.
 
28 Liberty Street, 41st Floor
 
New York, New York 10005
 
Attention: Secretary

 
or to such other address or facsimile number as any party shall have furnished to the other in writing in accordance with this Section 9. Notices and communications shall be effective when actually received by the addressee. Notwithstanding the foregoing, the Participant consents to electronic delivery of documents required to be delivered by the Company under the securities laws.





11.Effect of Agreement. This Agreement is personal to the Participant and, without the prior written consent of the Company, shall not be assignable by the Participant otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Participant’s legal representatives. This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.

12.Applicable Law; Forum Selection; Consent to Jurisdiction: The Company and Participant agree that this Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of Delaware without giving effect to its conflicts of law principles, as applied to contracts executed in and performed wholly within the State of Delaware. Participant agrees that the exclusive forum for any action to enforce this Agreement, as well as any action relating to or arising out of this Agreement, shall be the state or federal courts of the State of Delaware. With respect to any such court action, Participant hereby (a) irrevocably submits to the personal jurisdiction of such courts; (b) consents to service of process; (c) consents to venue; and (d) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction, service of process, or venue. Both parties hereto further agree that the state and federal courts of the State of Delaware are convenient forums for any dispute that may arise herefrom and that neither party shall raise as a defense that such courts are not convenient forums.

13.Terms of Plan. In addition to the terms and conditions set forth in this Agreement, the Restricted Stock Units are subject to the terms and conditions of the Plan, which is hereby incorporated by reference.

14.Waiver. Failure of either party to insist, in one or more instances, on performance by the other in strict accordance with the terms and conditions of this Agreement shall not be deemed a waiver or relinquishment of any right granted in this Agreement or of the future performance of any such term or condition or of any other term or condition of this Agreement, unless such waiver is contained in a writing signed by the party making the waiver.

15.Severability. If any one or more of the provisions contained in this Agreement are held to be invalid, illegal or unenforceable, the other provisions of this Agreement shall be construed and enforced as if the invalid, illegal or unenforceable provision had never been included.

16.Conflicts and Interpretation. In the event of any conflict between this Agreement and the Plan, the Plan shall control. In the event of any ambiguity in this Agreement, or any matters as to which this Agreement is silent, the Plan shall govern including, without limitation, the provisions thereof pursuant to which the Committee has the power, among others, to (a) interpret the Plan, (b) prescribe, amend and rescind rules and regulations relating to the Plan, and (c) make all other determinations deemed necessary or advisable for the administration of the Plan. The Participant and the Company each acknowledges that this Agreement (together with the Plan) constitutes the entire agreement and supersedes all other agreements and understandings, both written and oral, among the parties or either of them, with respect to the subject matter hereof.

17.Amendment. The Company may modify, amend or waive the terms of the Restricted Stock Unit award, prospectively or retroactively, but no such modification, amendment or waiver shall materially impair the rights of the Participant without his or her consent, except as required by applicable law, stock exchange rules, tax rules or accounting rules. The waiver by either party of compliance with any provision of this Agreement shall not operate or be construed as a waiver of any





other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.

18.Section 409A of the Code. It is the intention of the Company that the Restricted Stock Units shall either (a) not constitute “nonqualified deferred compensation” as defined under Section 409A of the Code or (b) comply in all respects with the requirements of Section 409A of the Code and the regulations promulgated thereunder, such that no delivery of Shares pursuant to this Agreement will result in the imposition of taxation or penalties as a consequence of the application of Section 409A of the Code. Shares in respect of any Restricted Stock Units that (i) constitute “nonqualified deferred compensation” as defined under Section 409A of the Code and (ii) vest as a consequence of the Participant’s termination of employment shall not be delivered until the date that the Participant incurs a “separation from service” within the meaning of Section 409A of the Code (or, if the Participant is a “specified employee” within the meaning of Section 409A of the Code and the regulations promulgated thereunder, the date that is six months following the date of such “separation from service”). If the Company determines after the Grant Date that an amendment to this Agreement is necessary to ensure the foregoing, it may, notwithstanding Section 14, make such an amendment, effective as of the Grant Date or any later date, without the consent of the Participant. Notwithstanding any provision of this Agreement or the Plan, in the event that any taxes or penalties are imposed on the Participant by reason of Section 409A of the Code, the Participant acknowledges and agrees that such taxes or penalties shall be the exclusive obligation of the Participant, and the Company shall have no liability therefor.

19.Headings. The headings of Sections herein are included solely for convenience of reference and shall not affect the meaning or interpretation of any of the provisions of this Agreement.

20.Counterparts. This Agreement may be executed in counterparts, which together shall constitute one and the same original.





EXHIBIT 10.5


CHANGE IN CONTROL AGREEMENT

This Agreement, dated as of _________, 2016 (the "Effective Date"), is between Assurant, Inc., a Delaware corporation (the "Company"), and _____________ (the "Executive") (the “Agreement”).

Recital and Meaning of Capitalized Terms
A.
The Company wishes to promote continuity of management in the event of a Change in Control and to provide the Executive with certain benefits in the event that Executive’s employment with the Company is terminated by the Company without Cause or by the Executive with Good Reason following or in anticipation of such a Change in Control under the circumstances specified below.
B.
Wherever they may appear in this document, all capitalized terms have the meanings given in the definitions above or below (as the case may be).
NOW, THEREFORE, the Company and the Executive hereby agree as follows:
1.
TERM AND EFFECT OF AGREEMENT
A.
Term. This Agreement shall be effective as of the Effective Date and shall continue in effect until the Expiration Date. The initial Expiration Date shall be December 31, 2016 but, on that date and each December 31 thereafter, the Expiration Date shall automatically be extended by one additional year unless, not later than the immediately preceding June 30, the Company has given written notice to the Executive that the Expiration Date shall not be so extended; provided, however, that if a Change in Control shall have occurred prior to the original or extended Expiration Date, the Expiration Date shall automatically be extended to the second anniversary of the Change in Control.
B.
Effect of This Agreement. Prior to the Period of Employment hereunder, the employment of the Executive by the Company shall be at will and may be terminated at any time for any reason in the





sole and unlimited discretion of the Company or the Executive.
2.
CERTAIN DEFINITIONS
A.
Change in Control.
For purposes of this Agreement, a Change in Control shall mean a change in control of the Company, which shall be deemed to have occurred upon:
i.
the consummation of an acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of shares of outstanding voting securities of the Company entitled to vote generally in the election of directors (the "Outstanding Voting Securities") that, when combined with any other securities owned beneficially by the acquirer, would result in such acquirer beneficially owning thirty percent or more of either (a) the then outstanding shares of common stock of the Company or (b) the combined voting power of the then Outstanding Voting Securities, excluding any Person that is the surviving or resulting entity in a transaction described in Section 2.A.(iii) below that does not also result in a Change in Control thereunder.
ii. the failure, at any time following the date hereof, of those individuals who as of the date hereof constitute the Board of Directors of the Company (the “Incumbent Board”) and any new directors (“Successor Directors”) appointed to fill interim vacancies or nominated for election by the Company's stockholders in either case pursuant to a vote of at least a majority of the directors then in office who are either Incumbent Directors or Successor Directors, to constitute a majority of the Board of Directors of the Company, provided, however, that, for purposes of this subparagraph, any individual appointed or approved for nomination as a result of an actual or threatened contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents shall not be treated or counted





as a Successor Director;
iii.
the consummation of a transaction approved by the stockholders of the Company that is a merger, consolidation, reorganization or similar corporate transaction, regardless of whether the Company is the surviving corporation in such transaction, other than a merger, consolidation, or reorganization that results in the Outstanding Voting Securities immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity constituting) more than fifty percent of the combined voting power of the voting securities of the Company (or such surviving entity) outstanding immediately after such merger, consolidation, reorganization or transaction; or
iv. the consummation of a transaction or series of transactions approved by the stockholders of the Company that is ( a) the sale or other disposition of all or substantially all of the assets (by way of reinsurance or otherwise) of the Company or (b) a complete liquidation or dissolution of the Company or the Company.
B. Period of Employment. The Period of Employment shall mean the period of time commencing on the date of a Change in Control and ending on the earlier of the Expiration Date or the Termination Date (as defined below) or, if there has been a public announcement of a proposed transaction that results in a Change in Control, commencing on the date of the first such announcement in the event that the Executive’s employment is thereafter terminated by the Company (an “Anticipatory Termination”). For avoidance of doubt, the previous sentence does not confer upon the Executive the prerogative of terminating his or her employment voluntarily for Good Reason before a Change of Control has occurred and thereby being entitled to any benefits under this Agreement.
C. Contract Term. The Contract Term shall mean the period of time commencing on the date of a Change in Control and ending on the Expiration Date or, in the case of an Anticipatory Termination, commencing on the date of the first public announcement referred to in the immediately preceding Section 2.B.





D. Termination Date. The Termination Date shall mean the date as of which the Executive's employment with the Company shall cease as specified in Section 5 or 6, below.
E. Target. When used in relation to any incentive award or bonus payment “Target” means the target (whether stated as a percentage of base salary or as an amount in U.S. dollars) for the Executive approved by the Compensation Committee of the Board of Directors (or the Board of Directors as a whole) in (a) the year immediately preceding a Change in Control or (b) the year during the Period of Employment when such target is established, whichever is greater.
3.
EXECUTIVE'S RESPONSIBILITIES; LOCATION
A.
Position, Duties, Responsibilities. Commencing on the date of the Change in Control, the Executive shall serve in the position and have the duties and responsibilities as in effect immediately prior to the date of the Change in Control.
B.
Best Efforts. During the Period of Employment, the Executive shall devote his full time, best efforts and undivided attention during normal business hours to the business and affairs of the Company, except reasonable time for vacations, illness or incapacity.
C.
Principal Business Office. During the Period of Employment, the Executive's principal business office shall be located in the [___________] metropolitan area.
4.
COMPENSATION, PERQUISITES AND EMPLOYEE BENEFITS
A.
Base Salary. During the Period of Employment, the Executive shall receive an annual base salary at a rate not less than the rate in effect immediately prior to the date of commencement of the Contract Term.
B.
Incentive Compensation. During the Period of Employment, the Executive shall continue to be a full participant in the Company's short-term annual incentive compensation plan (“Annual Bonus”) and the Company’s long term incentive plan (“LTIP”), as well as any comparable successor plans (the “Incentive Plans”), as the Incentive Plans are in effect immediately prior to the Contract Term and with such changes and improvements in the Incentive Plans or other





incentive compensation plans as may from time to time be approved by the Compensation Committee of the Company’s Board of Directors with incentive opportunities no less favorable, in the aggregate, than the aggregate incentive opportunities provided to the Executive before the Contract Term. The Executive shall also be entitled to participate in any other incentive compensation plans generally available to senior executives of the Company. If any of the Incentive Plans is terminated or discontinued, the Executive shall be entitled to participate in other incentive compensation plans with terms at least as favorable to the Executive, in the aggregate, as were the Incentive Plans in effect before the termination or discontinuance of the Incentive Plans. Each such Annual Bonus shall be paid no later than two-and-a-half months after the end of the fiscal year for which the Annual Bonus is awarded, unless the Executive shall elect to defer the receipt of such Annual Bonus pursuant to an arrangement that meets the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), excluding arrangements authorized pursuant to Treasury Regulation § 1.409A-1(e).
C.
Employee Benefits. During the Period of Employment, the Executive shall be entitled to participate in all employee benefit plans and programs as in effect for senior executives of the Company immediately prior to the date of the Change in Control (the “Benefit Plans”) under the terms of the Benefit Plans, with such changes and improvements in the Benefit Plans as may from time to time be made in accordance with the practices of the Company, provided, however, that, for purposes of this paragraph, no plan, arrangement or expectation with respect to severance or other benefit or payment that may be made upon termination of employment (other than as provided in this document) shall be considered a Benefit Plan.
5.
DEATH OR DISABILITY
A.
Death. If the Executive should die during the Period of Employment, his or her employment shall be deemed to have terminated on the last day of the month in which death shall have occurred.





B.
Disability. “Disability” shall mean an illness or accident that has prevented the Executive from performing his duties under this Agreement for a period of six consecutive months. In the event that the Executive suffers a Disability during the Period of Employment, his employment shall terminate on the last day of such six-month period.
6.
TERMINATION OF EMPLOYMENT BY THE COMPANY OR THE EXECUTIVE
Either the Company or the Executive may, at any time, terminate the Executive’s employment with the Company.
A.
Cause. The termination of the Executive's employment by the Company during the Contract Term shall be deemed to be for “Cause” only if it is due to:
(1)
conviction of the Executive for a felony;
(2)
an act or acts of dishonesty by the Executive;
(3)
a willful, deliberate and intentional failure by the Executive during the Period of Employment (not including any failure by reason of incapacity due to illness or accident) to comply with the provisions of this Agreement relating to the time and best efforts to be devoted by the Executive to the affairs of the Company, if such failure demonstrably results in material injury to the Company, the determination of the existence or non-existence of willful, deliberate and intentional failure and material injury, if contested and not resolved between the parties, to be submitted to binding arbitration as specified below in section 6.C.(3), with the decision of the arbitrator on this issue (as on all other issues properly submitted to arbitration) being final and non-appealable; or
(4)
the Executive’s gross misconduct resulting in material risk (which may be legal or reputational risk) or injury (whether material or immaterial) to the Company, the determination of the existence or non-existence of gross misconduct and material risk or injury, if contested and not resolved between the parties, to be submitted to binding arbitration as specified below in section 6.C.(3), with the decision of the arbitrator on this





issue (as on all other issues properly submitted to arbitration) being final and non-appealable;
provided that notice of such termination is given in accordance with Section 6.C., below.
B.
Good Reason. The termination of the Executive's employment by the Executive during the Contract Term shall be deemed to be for “Good Reason” only if such termination shall be the result of:
(1)
a reduction during the Period of Employment in the level, as of the date of the Change in Control, of either (a) the Executive's base salary or (b) the Executive's Target Incentive Plan opportunities or (c) if material, the Benefit Plan coverages (other than a reduction in awards or benefits that is generally applicable to participants in a plan in accordance with the terms of the plan in effect immediately prior to the date of the Change in Control);
(2)
a material diminution during the Period of Employment in the Executive's position, powers, authority, duties or responsibilities, or the business to which those powers, authority, duties or responsibilities apply;
(3)
removal during the Period of Employment of the Executive from the office he held immediately prior to the Change in Control or material change during the Period of Employment in the Executive's chain of supervision as it existed immediately prior to the Change in Control;
(4)
any requirement that the Executive work at a principal place of business other than [_______________] [insert address of office], if it is more than 30 miles from the Executive's residence at the time of the Change in Control;
(5)
a material breach of this Agreement by the Company, provided that notice of the Executive's election to terminate his employment for Good Reason under this Agreement is given in accordance with Section 6.C., below.
The Executive’s failure to elect to terminate his or her employment with respect to one event giving rise to Good Reason does not preclude the Executive from making the election with respect to a





subsequent event.
C. Termination Procedure    
(1)
Notice
(a)
Notice of termination of employment under this Agreement shall be provided in writing by the Company or the Executive, as applicable, and shall specify the date of termination of employment, which date shall in no event be earlier than 60 days from the date of such notice.
(b)
In the event that the Company elects to terminate the Executive's employment, in the notice required by the immediately preceding subparagraph, the Company shall state whether the termination is for Cause. If so, such notice shall state that the Executive has engaged in conduct set forth in Section 6.A., above, with the particulars thereof specified in detail.
(c)
In the event that the Executive elects to terminate employment, in the notice required by this Section 6.C., the Executive shall state whether the voluntary termination of employment is for Good Reason. If so, such notice shall state the reason or reasons for such termination, as set forth in Section 6.B., with the particulars thereof specified in detail, and shall be given within three calendar months after the most recent event giving rise to Good Reason.
(2)
Cure
(a)
In the case of the Executive's alleged breach as set forth in Section 6.A.(2), the Executive shall be given the opportunity to remedy such alleged breach within 30 days from his receipt of the notice referred to above.
(b)
In the case of the Executive's allegation of Good Reason as set forth in Section 6.B., the Company shall be given the opportunity to remedy the alleged Good Reason within 30 days from its receipt of the notice referred to above.
(3)
Arbitration.
Any dispute arising out of or relating to this Agreement - including but not limited to any





dispute concerning its alleged breach, termination, validity, enforceability or interpretation thereof - shall be finally resolved by arbitration in accordance with the International Institute for Conflict Prevention and Resolution (“CPR”) Rules for Administered Arbitration (the “Administered Rules” or “Rules”) by a sole arbitrator. The arbitration shall be governed by the Federal Arbitration Act, 9 U.S.C. §§ 1 et seq., and judgment upon the award rendered by the arbitrator may be entered by any court having jurisdiction thereof. The place of the arbitration shall be New York, New York. Notwithstanding the foregoing, the Company may bring an action in the courts mentioned in paragraph 12.B., below, for the purpose of seeking injunctive or other equitable relief; any such action shall not be subject to a motion to compel arbitration.
7.
CONSEQUENCES OF TERMINATION, DEATH OR DISABILITY
A.
Termination by the Company Other Than for Cause or by the Executive for
Good Reason. In the event that, within two years from the date of a Change in Control followed by termination of the Executive’s employment by the Company other than for Cause or by the Executive for Good Reason (or, in the case of an Anticipatory Termination by the Company, preceding the Change of Control), if the Executive has executed and has not revoked, within fifty-two days after the Date of Termination, a general release in the form attached hereto as Appendix A, the Company shall pay to the Executive the following amounts and provide the following benefits:
(1)
a lump sum in cash within sixty days after the Date of Termination equal to
the sum of
(a) (i) the Executive’s Annual Base Salary through the Date of Termination to the extent not theretofore paid, (ii) the Executive’s business expenses that are reimbursable but have not been reimbursed by the Company as of the Date of Termination; (iii) the Executive’s annual bonus for the fiscal year immediately preceding the fiscal year in which the Date of





Termination occurs, if such bonus has been determined by the Compensation Committee of the Company’s Board of Directors but not paid as of the Date of Termination or, if no such determination has been made as of the Date of Termination, the Target Annual Bonus for such immediately preceding fiscal year; (iv) any accrued paid time off to the extent not theretofore paid (the sum of the amounts described in clauses (i), (ii), (iii) and (iv) being referred to herein as the “Accrued Obligations”) and (v) an amount equal to the product of (x) the Target Annual Bonus and (y) 0.5 (the “Pro Rata Bonus”); provided that, notwithstanding the foregoing, if the Executive has made an irrevocable election under any deferred compensation arrangement subject to Section 409A of the Code to defer any portion of the Annual Bonus described in clause (iii) above, then for all purposes of this Section 7 (including, without limitation, Sections 7.B. through 7.D.), such deferral election, and the terms of the applicable arrangement shall apply to the same portion of the amount described in such clause (iii), and such portion shall not be considered as part of the “Accrued Obligations” but shall instead be an “Other Benefit” and
(b) two times the sum of (x) the Executive’s Annual Base Salary and (y) the Target Annual Bonus.
(2) a lump sum amount equal to, and at the same after tax cost to the Executive, as eighteen (18) months of Company contributions towards the Executive’s health care and life insurance benefits as in effect immediately prior to the Executive’s Termination Date.. The health care benefits provided during the Benefit Continuation Period hereunder shall be provided concurrently with any health care benefits that may be provided during such period pursuant to Section 4980B of the United States Internal Revenue Code (the “Code”), as amended. For purposes of determining eligibility and the Company’s contribution (but not the time of commencement of benefits) of the Executive for retiree welfare benefits pursuant to the retiree welfare benefit plans, the Executive shall be considered to have remained employed





until the second anniversary of the Date of Termination, and the Company shall take such actions as are necessary to cause the Executive to be eligible to commence in the applicable retiree welfare benefit plans as of the applicable benefit commencement date;
(3) outplacement services, for a limited period not longer than twelve months following the Executive’s Date of Termination, the scope and provider of which shall be selected by the Company in the Company’s reasonable discretion but which, in any event, shall be of a scope suitable for a senior executive officer of a public company; and
(4) except as otherwise set forth in the last sentence of Section 8, to the extent not theretofore paid or provided, any Other Benefits (as defined in Section 8) in accordance with the terms of the underlying plans or agreements.
B.
Death. If the Executive’s employment is terminated by reason of the Executive’s death during the Period of Employment, the Company shall pay the Executive’s estate or beneficiaries the Accrued Obligations, the Pro Rata Bonus and the Other Benefits (subject to the proviso in Section 7.A.(1)(a) to the extent applicable), and shall have no other severance obligations under this Agreement. The Accrued Obligations and the Pro Rata Bonus shall be paid to the Executive’s estate or beneficiary, as applicable, in a lump sum in cash within 30 days of the Termination Date.
C.
Disability. If the Executive’s employment is terminated by reason of the Executive’s Disability during the Period of Employment, the Company shall pay the Executive the Accrued Obligations and Pro Rata Bonus and the Other Benefits (subject to the proviso in Section 7.A.(1)(a), to the extent applicable) and shall have no other severance obligations under this Agreement. The Accrued Obligations and the Pro Rata Bonus shall be paid to the Executive in a lump sum in cash within 30 days of the Termination Date.
D.
Cause; Other Than for Good Reason. If the Executive’s employment is terminated for Cause during the Period of Employment, the Company shall pay the Executive’s annual base salary through the Termination Date and the Other Benefits (disregarding the proviso set forth in subject





to the proviso in Section 7.A.(1)(a), to the extent applicable), and shall have no other severance obligations under this Agreement. If the Executive voluntarily terminates employment during the Period of Employment other than for Good Reason, the Company shall pay to the Executive the Accrued Obligations, the Pro Rata Bonus and the Other Benefits, subject to the proviso in Section 7.A.(1)(a), to the extent applicable) 7(1)(A), and shall have no other severance obligations under this Agreement. In such case, all the Accrued Obligations and the Pro Rata Bonus shall be paid to the Executive in a lump sum in cash within 30 days of the Termination Date.
E.
Consideration for Restrictive Covenants. The Company and the Executive hereby stipulate that such portion of the amounts payable pursuant to section 7.A. of this Agreement as may be determined to be reasonable by Ernst & Young LLP (the “Accounting Firm”) is in consideration, in part, for Executive’s agreeing and adhering to the Restrictive Covenants set forth in Section 11.A. The Executive agrees to report such payments on all applicable tax returns in a manner consistent with the preceding sentence.
8.
NON-EXCLUSIVITY OF RIGHTS
Nothing in this Agreement shall prevent or limit the Executive’s continuing or future participation in any plan, program, policy or practice provided by the Company and for which the Executive may qualify. Amounts that are vested benefits or that the Executive is otherwise entitled to receive under any plan, policy, practice or program of or any other contract or agreement with the Company at or subsequent to the Termination Date (“Other Benefits”) shall be payable in accordance with such plan, policy, practice or program or contract or agreement, except as explicitly modified by this Agreement. Without limiting the generality of the foregoing, the Executive’s resignation under this Agreement with or without Good Reason shall in no way affect the Executive’s ability to terminate employment by reason of the Executive’s “retirement” under, or to be eligible to receive benefits under, any compensation and benefits plans, programs or arrangements of the Company, including without limitation any retirement or pension plans or arrangements or substitute plans adopted by





the Company or any of its respective successors, and any termination which otherwise qualifies as Good Reason shall be treated as such even if it is also a “retirement” for purposes of any such plan. Notwithstanding the foregoing, if the Executive receives payments and benefits pursuant to Section 7 of this Agreement, the Executive shall not be entitled to any severance pay or benefits under any severance plan, program or policy of the Company.
9.
FULL SETTLEMENT; NO MITIGATION REQUIREMENT; LEGAL FEES
The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense, or other claim, right or action that the Company may have against the Executive or others. In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement. Except as specifically provided in Section 7.A.(2), such amounts shall not be reduced whether or not the Executive obtains other employment. The Company agrees to pay as incurred (within 10 days following the Company’s receipt of an invoice from the Executive), at any time from the Effective Date of this Agreement through the Executive’s remaining lifetime (or, if longer, through the 20th anniversary of the Effective Date) to the full extent permitted by law, all legal fees and expenses that the Executive may reasonably incur as a result of any contest (regardless of the outcome thereof) by the Company, the Executive or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance thereof (including as a result of any contest by the Executive about the amount of any payment pursuant to this Agreement), plus, in each case, interest on any delayed payment at the applicable federal rate provided for in Section 7872(f)(2)(A) of the Code (“Interest”) determined as of the date such legal fees and expenses were incurred. In order to comply with Section 409A of the Code, in no event shall the payments by the Company under this Section 9 be made later than the end of the calendar year next following the calendar year in which such fees and expenses were incurred, provided, that





the Executive shall have submitted an invoice for such fees and expenses at least 10 days before the end of the calendar year next following the calendar year in which such fees and expenses were incurred. The amount of such legal fees and expenses that the Company is obligated to pay in any given calendar year shall not affect the legal fees and expenses that the Company is obligated to pay in any other calendar year, and the Executive’s right to have the Company pay such legal fees and expenses may not be liquidated or exchanged for any other benefit.
10.
TREATMENT OF CERTAIN PARACHUTE PAYMENTS
A.
Anything in this Agreement to the contrary notwithstanding, in the event it shall be determined that (i) any Payment (or any acceleration of any Payment) to or for the benefit of Executive would be subject to the Excise Tax, and (ii) the reduction of the amounts payable to Executive under this Agreement to the Safe Harbor Amount would provide the Executive with a greater after-tax amount than if such amounts were not reduced, then the amounts payable to Executive under this Agreement shall be reduced (but not below zero) by an amount sufficient to reduce the Parachute Value of the Payments to the Safe Harbor Amount. The reduction of the Parachute Value of the Payments, if applicable, shall be made by reducing the payments and benefits under the following sections of this Agreement in the following order: (i) Section 7.A.(1)(b), hereof, (ii) Section 7.A.(1)(A)(v) hereof and (iii) Section 7.A.(2) hereof unless an alternative method of reduction was elected by Executive prior to the date set forth in the first paragraph of this Agreement. If the reductions described in the preceding sentence are not sufficient to reduce the Parachute Value of the Payments to the Safe Harbor Amount, further reduction of the Parachute Value of the Payments shall be made in the manner which has the least economic cost to the Executive.
B.
All determinations required to be made under this Section 10, including the Safe Harbor Amount, whether and when an Excise Tax is due, the amount of Excise Tax and the assumptions to be used in arriving at such determinations, shall be made by the Accounting Firm on the basis of such reasonable assumptions as may be determined by the Accounting Firm or as may be agreed to by





the Company and the Executive and as are reasonably acceptable to the Accounting Firm. The Accounting Firm shall be requested to provide detailed supporting calculations both to the Company and the Executive within 15 business days of the receipt of notice from the Executive that there has been a Payment or such earlier time as is requested by the Company. In the event that the Accounting Firm is serving as accountant or auditor for the individual, entity or group effecting the Change of Control or is otherwise unable to perform the assignment contemplated by this subparagraph, the Executive may appoint another nationally recognized accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm shall be borne solely by the Company. Any determination by the Accounting Firm shall be binding upon the Company and the Executive. If the Accounting Firm determines that no Excise Tax is payable by Executive, it shall furnish Executive with a written opinion to such effect, and to the effect that failure to report the Excise Tax, if any, on Executive’s applicable federal income tax return will not result in the imposition of a negligence or similar penalty. In the event the Accounting Firm determines that the Parachute Value of the Payments shall be reduced to the Safe Harbor Amount, it shall furnish Executive with a written opinion to such effect. The determination by the Accounting Firm shall be binding upon the Company and Executive (except as provided in paragraph (c) below).
C.
If it is established pursuant to a final determination of a court or the Internal Revenue Service (the “IRS”) proceeding, which has been finally and conclusively resolved, that Payments have been made to, or provided for the benefit of, Executive by the Company, which are in excess of the limitations provided in this Section 10 (hereinafter referred to as an “Excess Payment”), such Excess Payment shall be deemed for all purposes to be a loan to Executive made on the date Executive received the Excess Payment and Executive shall repay the Excess Payment to the Company on demand, together with interest on the Excess Payment at the applicable federal rate





(as defined in Section 1274(d) of the Code) from the date of Executive’s receipt of such Excess Payment until the date of such repayment. As a result of the uncertainty in the application of Section 4999 of the Code at the time of the determination, it is possible that Payments which will not have been made by the Company should have been made (an “Underpayment”), consistent with the calculations required to be made under this Section 10. In the event that it is determined (i) by the Accounting Firm, the Company (which shall include the position taken by the Company, or together with its consolidated group, on its federal income tax return) or the IRS or (ii) pursuant to a determination by a court, that an Underpayment has occurred, the Company shall pay an amount equal to such Underpayment to Executive within 10 days of such determination together with interest on such amount at the applicable federal rate from the date such amount would have been paid to Executive until the date of payment. Executive shall cooperate, to the extent his or her expenses are reimbursed by the Company, with any reasonable requests by the Company in connection with any contests or disputes with the IRS in connection with the Excise Tax or the determination of the Excess Payment.
D.
Definitions. The following terms shall have the following meanings for purposes of this Section 10.
(i)    “Excise Tax” shall mean the excise tax imposed by Section 4999 of the Code, together with any interest or penalties imposed with respect to such excise tax.    
(ii)    “Parachute Value” of a Payment shall mean the present value as of the date of the change of control for purposes of Section 280G of the Code of the portion of such Payment that constitutes a “parachute payment” under Section 280G(b)(2), as determined by the Accounting Firm for purposes of determining whether and to what extent the Excise Tax will apply to such Payment.
(iii)    A “Payment” shall mean any payment or distribution in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of the Executive,





whether paid or payable pursuant to this Agreement or otherwise.
(iv)    The “Safe Harbor Amount” means 2.99 times the Executive’s “base amount,” within the meaning of Section 280G(b)(3) of the Code.
11.
NONSOLICITATION, NONDISPARAGEMENT , NONCOMPETITION
A.
Restrictions on Solicitation and Competitive Activities. During the Period of Employment and the 12-month period immediately following the Termination Date, the Executive shall not, directly or indirectly, (1) solicit, induce or attempt to induce or otherwise counsel, advise, ask or encourage any employee of the Company or any affiliated company to leave the employ of the Company or to accept employment or assignment with any other employer as an employee or independent contractor (without regard to who initiated the first communication), (2) solicit, induce or attempt to induce any customer, client, account, vendor or other person having a business relationship with the Company to cease doing some or all business with the Company (without regard to who initiated the first communication), (3) interfere with the relationship or (if communications between such person and the Company concerning a possible business relationship have commenced) the prospective relationship between any such person or entity and the Company, (4) participate -whether as an owner, employee, consultant, agent, independent contractor or in any other capacity, except as a holder of five percent or less of the common equity of a publicly held corporation - in any business that is engaged, directly or indirectly, in sales or the provision of products or services or other activities in competition with the sales, provision of products or services or other activities of the Company or any of its subsidiaries or affiliates, provided, however, that the scope of this subparagraph (d) shall be limited to the geographic area or areas where the Company is actually engaged in such business or, to the actual or constructive knowledge of the Executive, is actively planning to engage or considering engaging in such business .
B.
Nondisparagement. During the Period of Employment and during the 24-month period





immediately following the Termination Date, the Executive shall not, and shall cause his representatives and agents not to disparage the Company, its affiliated companies or any of their employees or directors. As used herein, to "disparage" shall mean to engage in any oral or written communication of false, misleading or derogatory information or any oral or written communication of information with negligent disregard of its truth or falsity.
C.
Confidentiality. The Executive shall hold in a fiduciary capacity for the benefit of the Company all Confidential Information, Knowledge or Data relating to the Company and any of its affiliates. For purposes of this section, “Confidential Information, Knowledge or Data” means non-public information, knowledge or data that the Executive obtains during the Executive’s employment by the Company or under a confidentiality agreement with or for the benefit of the Company. After termination of the Executive’s employment with the Company, the Executive shall not, without the prior written consent of the Company or as may be required by law or legal process, communicate or divulge any such Confidential Information, Knowledge or Data to anyone other than the Company.
D.
Specific Performance and Injunctive Relief. The Executive agrees that, if he or she violates this Section 11, the Company will suffer irreparable injury for which damages at law will be difficult to establish with precision and would be an inadequate remedy. Accordingly, the Executive agrees that the Company shall have the rights and remedies of specific performance and injunctive relief, in addition to any other rights or remedies that may be available to it at law or in equity, in respect of any failure, or threatened failure, on the part of the Executive to comply with the provisions of this Section 11 and that such rights and remedies may include, but shall not be limited to, a temporary restraining order and a preliminary and permanent injunction to restrain any violation or threatened violation of this Agreement by the Executive, as well as a permanent injunction, a writ of specific performance and a right of offset for any amount otherwise owed to the Executive by the Company. For avoidance of





doubt, this paragraph 11.C. shall not preclude or limit any right of the Company’s that it may otherwise have to damages at law, in addition to equitable relief, insofar as such damages may be a component or subject of any arbitral award issued pursuant to arbitration pursuant to Section 6.C.(3), above.
12.
MISCELLANEOUS PROVISIONS
A.
Successors and Assigns.
(1)
This Agreement is personal to the Executive. Without the prior written consent of the Company, the Executive may not assign this Agreement of any rights or benefits hereunder other than by will or the laws of descent and distribution. Notwithstanding the foregoing, in the event of the Executive’s death or disability, this Agreement shall inure to the benefit of and be enforceable by the Executive’s executor or other legal representative.
(2)
This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. Except as expressly provided herein (including in the immediately following subparagraph (3)), without the prior written consent of the Executive the Company may not assign this Agreement or its duties and obligations thereunder.
(3)
The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) (a “Successor”) to all or substantially all of the business and/or assets of the Company expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. To any Successor who so expressly assumes and agrees to perform this Agreement, the Company may assign or otherwise convey this Agreement in its entirety, including all rights against the Executive and all obligation and duties of the Executive hereunder.
B.
Choice of Law; Jurisdiction and Venue for An Action Seeking Equitable Relief. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware,





without reference to principles of conflict of laws. Notwithstanding the arbitration provision set forth in paragraph 6.C.(3), above, an action for injunctive or other equitable relief hereunder may be brought in the federal or state courts located in the Borough of Manhattan, City of New York, State of New York, or in any other court or courts having subpoena power over, and whose order area enforceable in, the geographic area where any activities in violation of Section 11 are or may be threatened or are or may be taking place . The parties hereby agree that any such court, to the extent it has subject matter jurisdiction, is an appropriate venue for any such action hereunder. The parties agree to submit to the venue and personal jurisdiction of any such court and not to argue forum non conveniens or otherwise to contest the appropriateness of laying venue to any such action in any such court.
C.
Modifications, Waiver. This Agreement may not be amended or modified other than by a written agreement executed by the parties hereto or their respective successors and legal representatives, provided, however, that, as used in this paragraph, an amendment or modification may be “executed” by any otherwise lawful means, including, where lawful and appropriate, properly authorized electronic signature, facsimile or offer and acceptance by email or other electronic means. No forbearance or failure to enforce any obligation under this Agreement shall be construed as, or argued to be, a waiver or estoppel of any right a party to this Agreement may otherwise have to enforce the same or a similar obligation at any other time, notwithstanding the passage or time, or any other obligation under this Agreement.
D.
Notices. All notices and other communications hereunder shall be in writing and shall be given by hand delivery to the other party, by registered or certified mail, return receipt requested, postage prepaid, addressed as follows:






If to the Executive:

At the most recent address on file at the Company.

If to the Company:

Assurant, Inc.
28 Liberty Street,
41st Floor
New York, New York 10005
Attention: Chief Legal Officer
or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee.
E.
Enforceability and Severability. The invalidity or enforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement. The parties intend that this Agreement shall be enforced in accordance with its terms to the full extent permitted by law. In this event that any court or arbitrator of competent jurisdiction should find that any provision of this agreement - including but not limited to the provisions of Section 11 hereof - is unenforceable to its full extent, the parties intend that such provisions shall be enforced to the full extent permissible under the law (including but not limited to with respect to its geographic and temporal scope).
F.
Withholding. The Company may withhold from any amounts payable under this Agreement such United States federal, state or local or foreign taxes as shall be required.
G.
Employment at Will. The Executive and the Company acknowledge that, except as otherwise provided herein or under any other written agreement between the Executive and the Company, the employment of the Executive by the Company is at will. Prior to the Effective Date, the Executive’s employment may be terminated by either the Executive or the Company, in which case the Executive shall have no further rights under this Agreement.
H.
Complete Agreement. This Agreement embodies the complete understanding of the parties with respect to the subject matter hereof. There are no prior or contemporaneous agreements (oral or





written, express or implied) between the parties with respect to such subject matter. From and after the Effective Date, except as specifically provided herein, this Agreement shall supersede any other agreement or alleged agreement between the parties with respect to the subject matter hereof.
I.
Payments in the Event of Anticipatory Termination. Notwithstanding any provision in this Agreement to the contrary, in the event of an Anticipatory Termination, no payment that the Company shall be required to make under this Agreement shall be due except in the event of, and following, the date of such Change of Control, at the time specified under Section 7 for payments due to termination by the Company without Cause.
J.
Code Section 409A. The Agreement is intended to comply with the requirements of Section 409A of the Code or an exception or exclusion therefrom and shall in all respects be administered in accordance with Section 409A of the Code. Severance payments shall be made under the “separation pay” exception under Section 409A of the Code, to the maximum extent possible, and then under the “short-term deferral” exclusion Section 409A of the Code or another applicable exception. Within the time period permitted by the applicable Treasury Regulations, the Company may, in consultation with the Executive, modify the Agreement, in the least restrictive manner necessary and without any diminution in the value of the payments to the Executive, in order to cause the provisions of the Agreement to comply with the requirements of Section 409A of the Code, so as to avoid the imposition of taxes and penalties on the Executive pursuant to Section 409A of the Code. With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Code Section 409A, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, and (iii) such payments shall be made on or before the last day of Executive’s taxable year following the taxable year in which the expense occurred.





K.
Reduction of Payments for Annual Bonus Payments Already Made. Notwithstanding any provision of this Agreement to the contrary, in the event that the Effective Date and the Termination Date occur in the same fiscal year, any payment to the Executive pursuant to Section 7.A. hereof shall be reduced (but not below zero) by any amounts paid or payable to the Executive pursuant to the Annual Bonus in the same year.
L.
Survivorship. Upon the expiration or other termination of this Agreement or the Executive’s employment, the respective rights and obligations of the parties hereto shall survive to the extent necessary to carry out the intentions of the parties under this Agreement.
IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and, pursuant to the authorization from the Company’s Board of Directors or its Compensation Committee, the Company has executed this Agreement, all as of the day and year first above written.

 
 
 
[Name]
 
 
 
 
Assurant, Inc.
 
 
 
 
By:
 
 
Print Name:
 
 
Title:
 








APPENDIX A
FORM OF GENERAL RELEASE

This Release (this “Release”) is granted effective as of the [__] day of [________], 20[__], by [_____] (the “Executive”) in favor of Assurant, Inc. (the “Company”). This is the release referred to in that certain Change In Control Agreement dated as of _____________by and between the Company and the Executive (the “CIC Agreement”). The Executive gives this Release in consideration of the Company’s promises and covenants as recited in the CIC Agreement, with respect to which this Release is an integral part.

Section 1.    Release of the Company. The Executive, for himself/herself, his/her successors, assigns, attorneys and all those entitled to assert his/her rights, now and forever hereby releases and discharges the Company and its respective officers, directors, stockholders, trustees, employees, agents, parent corporations, subsidiaries, affiliates, estates, successors, assigns and attorneys (the “Released Parties”), from any and all claims, actions, causes of action, sums of money due, suits, debts, liens, covenants, contracts, obligations, costs, expenses, damages, judgments, agreements, promises, demands, claims for attorney’s fees and costs or liabilities whatsoever, in law or in equity, which the Executive ever had or now has against the Released Parties, including any claims arising by reason of or in any way connected with any employment relationship which existed between the Company or any of its parents, subsidiaries, affiliates, or predecessors and the Executive. It is understood and agreed that this Release is intended to cover all actions, causes of action, claims or demands for any damage, loss or injury, which may be traced either directly or indirectly to the aforesaid employment relationship, or the termination of that relationship, that the Executive has, had or purports to have, from the beginning of time to the date of this Release, whether known or unknown, that now exists, no matter how remotely they may be related to the aforesaid employment relationship including but not limited to claims for employment discrimination under federal or state law, except as provided in Paragraph 2; claims arising under Title VII of the Civil Rights Act, 42 U.S.C. § 2000(e), et seq. or the Americans With Disabilities Act, 42 U.S.C. § 12101 et seq.; claims for statutory or common law wrongful discharge, including any claims arising under the Fair Labor Standards Act, 29 U.S.C. § 201 et seq.; claims for attorney’s fees, expenses and costs; claims for defamation; claims for wages or paid time off; claims for benefits, including any claims arising under the Employee Retirement Income Security Act, 29 U.S.C. § 1001, et seq.; and provided, however, that nothing herein shall release the Company of its obligations to the Executive under the CIC Agreement or any other contractual obligations between the Company or its affiliates and the Executive, or any indemnification obligations to Executive under the Company’s bylaws, certificate of incorporation, New York law or otherwise.

Section 2.    Release of Claims Under Age Discrimination in Employment Act. Without limiting the generality of the foregoing, the Executive agrees that by executing this Release, he/she has released and waived any and all claims he/she has or may have as of the date of this Release for age discrimination under the Age Discrimination in Employment Act, 29 U.S.C. § 621, et seq. It is understood that the Executive is advised to consult with an attorney prior to executing this Release; that the Executive in fact has consulted a knowledgeable, competent attorney regarding this Release; that the Executive may, before executing this Release, consider this Release for a period of forty-five (45) calendar days calendar days; and that the consideration the Executive receives for this Release is in addition to amounts to which the Executive was already entitled. It is further understood that this Release is not effective until seven (7) calendar days after the execution of this Release and that the Executive may revoke this Release within seven (7) calendar days from the date of execution hereof.






The Executive agrees that he/she has carefully read this Release and is signing it voluntarily. The Executive acknowledges that he/she has had forty-five (45) days from receipt of this Release to review it prior to signing or that, if the Executive is signing this Release prior to the expiration of such 45-day period, the Executive is waiving his/her right to review the Release for such full 45-day period prior to signing it. The Executive has the right to revoke this release within seven (7) days following the date of its execution by him/her.

Section 3.    Certain Exceptions. Notwithstanding any provision of the CIC Agreement to the contrary, this Release shall not affect and expressly excludes any claim relating to: (1) obligations under this Agreement; (2) obligations that, in each case, by their terms are to be performed after the date hereof (including, without limitation, obligations to the Executive under any equity compensation awards or agreements or obligations under any pension plan or other benefit or deferred compensation plan, all of which shall remain in effect in accordance with their terms); (3) obligations to indemnify the Executive respecting acts or omissions in connection with the Executive’s service as a director, officer or employee of the Company or any Affiliated Company (as defined in the CIC Agreement); (4) obligations with respect to insurance coverage under any directors’ and officers’ liability insurance policies; (5) Executive’s rights to obtain contribution in the event of the entry of judgment against Executive as a result of any act or failure to act for which both the Executive and the Company or any Affiliated Company (as defined in the CIC Agreement) are jointly responsible; (6) any rights that the Executive may have as a stockholder of the Company; and (7) on facts or circumstances arising after the date hereof.

THE EXECUTIVE HAS CAREFULLY READ THIS RELEASE AND ACKNOWLEDGES THAT IT CONSTITUTES A GENERAL RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS AGAINST THE COMPANY UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT. THE EXECUTIVE ACKNOWLEDGES THAT HE/SHE HAS HAD A FULL OPPORTUNITY TO CONSULT WITH AN ATTORNEY OR OTHER ADVISOR OF THE EXECUTIVE’S CHOOSING CONCERNING HIS/HER EXECUTION OF THIS RELEASE AND THAT HE/SHE IS SIGNING THIS RELEASE VOLUNTARILY AND WITH THE FULL INTENT OF RELEASING THE COMPANY FROM ALL SUCH CLAIMS.




 
[Name]






EXHIBIT 10.6
    

ASSURANT, INC.
AMENDED AND RESTATED DIRECTORS COMPENSATION PLAN


ARTICLE 1
PURPOSE

1.1    PURPOSE. The purpose of the Assurant, Inc. Amended and Restated Directors Compensation Plan is to attract, retain and compensate highly-qualified individuals who are not employees of Assurant, Inc. or any of its subsidiaries or affiliates for service as members of the Board by providing them with competitive compensation and an ownership interest in the Common Stock of the Company. The Company intends that the Plan will benefit the Company and its stockholders by allowing Non-Employee Directors to have a personal financial stake in the Company through an ownership interest in the Common Stock and will closely associate the interests of Non-Employee Directors with that of the Company’s stockholders.

1.2    ELIGIBILITY. All active Non-Employee Directors shall automatically be participants in the Plan.

ARTICLE 2
DEFINITIONS

2.1    DEFINITIONS. Unless the context clearly indicates otherwise, the following terms shall have the following meanings:

(a)    “Base Annual Retainer” means the annual cash retainer (excluding expenses) payable by the Company to a Non-Employee Director pursuant to Section 4.1 hereof for service as a director of the Company (i.e., excluding any Supplemental Annual Retainer), as such amount may be changed from time to time.

(b)    “Board” means the Board of Directors of the Company.

(c)    “Company” means Assurant, Inc., a Delaware corporation.

(d)    “Common Stock” means the common stock, par value $0.01 per share, of the Company.

(e)    “Disability” means any illness or other physical or mental condition of a Non-Employee Director that renders him or her incapable of performing as a director of the Company, or any medically determinable illness or other physical or mental condition resulting from a bodily injury, disease or mental disorder which, in the judgment of the Board, is permanent and continuous in nature. The Board may require such medical or other evidence as it deems necessary to judge the nature and permanency of a Non-Employee Director’s condition.

(f)    “Effective Date” has the meaning set forth in Section 7.6 of the Plan.


(g)    “Non-Employee Director” means a director of the Company who is not an employee of the Company.

(h)    “Plan” means the Assurant, Inc. Amended and Restated Directors Compensation Plan, as amended from time to time.






(i)    “Plan Year(s)” means the calendar year.

(j)    “Restricted Stock Unit” means a unit denominated in shares of Common Stock contingently awarded in accordance with Article 5.

(k)    “Supplemental Annual Retainer” means the annual retainer (excluding expenses) payable by the Company to a Non-Employee Director pursuant to Section 4.2 hereof for service as a chair of a committee of the Board, as such amount may be changed from time to time.

ARTICLE 3
ADMINISTRATION

3.1    ADMINISTRATION. The Plan shall be administered by the Board. Subject to the provisions of the Plan, the Board shall be authorized to interpret the Plan, to establish, amend and rescind any rules and regulations relating to the Plan, and to make all other determinations necessary or advisable for the administration of the Plan. The Board’s interpretation of the Plan, and all actions taken and determinations made by the Board pursuant to the powers vested in it hereunder, shall be conclusive and binding upon all parties concerned including the Company, its stockholders and persons granted awards under the Plan. The Board may appoint a plan administrator to carry out the ministerial functions of the Plan, but the administrator shall have no other authority or powers of the Board.

3.2    RELIANCE. In administering the Plan, the Board may rely upon any information furnished by the Company, its public accountants and other experts. No individual will have personal liability by reason of anything done or omitted to be done by the Company or the Board in connection with the Plan.

3.3    INDEMNIFICATION. Each person who is or has been a member of the Board or who otherwise participates in the administration or operation of the Plan shall be indemnified by the Company against, and held harmless from, any loss, cost, liability or expense that may be imposed upon or incurred by him or her in connection with or resulting from any claim, action, suit or proceeding in which such person may be involved by reason of any action taken or failure to act under the Plan and shall be fully reimbursed by the Company for any and all amounts paid by such person in satisfaction of judgment against him or her in any such action, suit or proceeding, provided he or she will give the Company an opportunity, by written notice to the Board, to defend the same at the Company’s own expense before he or she undertakes to defend it on his or her own behalf. This right of indemnification shall not be exclusive of any other rights of indemnification.


ARTICLE 4
CASH COMPENSATION

4.1    BASE ANNUAL RETAINER. Each Non-Employee Director shall be paid a Base Annual Retainer for service as a director during each Plan Year, payable in such installments as the Board may determine at its discretion. The amount of the Base Annual Retainer shall be established from time to time by the Board. Until changed by the Board, the Base Annual Retainer shall be $100,000 for a full Plan Year. Each person who first becomes a Non-Employee Director on a date other than January 1 of any year shall be paid a pro-rata retainer equal to the Base Annual Retainer for such Plan Year, multiplied by a fraction, the numerator of which is the number of full months and portions thereof before the end of the Plan Year, and the denominator of which is 12. Payment of such prorated Base Annual Retainer shall begin on the date that the person first becomes a Non-Employee Director.






4.2    SUPPLEMENTAL ANNUAL RETAINER. Non-Employee Directors who serve as Chair of the Board or as a chair of a committee of the Board during a Plan Year shall be paid a Supplemental Annual Retainer with respect to such service, payable quarterly at the same times as installments of the Base Annual Retainer are paid. The amount of the Supplemental Annual Retainer shall be established from time to time by the Board. Until changed by the Board, the Supplemental Annual Retainer for a full Plan Year shall be as follows:

 
Chair
Chair of the Board
$125,000
Audit Committee
$ 25,000
Compensation Committee
$ 20,000
Nominating and Corporate Governance Committee
$ 20,000
Finance and Risk Committee
$ 20,000
Executive Committee
$ 0
Any additional committee formed in the future
$ 15,000

A pro-rata Supplemental Annual Retainer will be paid to any Non-Employee Director who becomes Chair of the Board or chairs a committee of the Board on a date other than the beginning of a Plan Year, based on the number of full months and portions thereof between the date such Non-Employee Director commenced service and the beginning of the next Plan Year.


4.3    TRAVEL EXPENSE REIMBURSEMENT. All Non-Employee Directors shall be reimbursed for reasonable travel expenses (including spouse’s expenses to attend events to which spouses are invited) in connection with attendance at meetings of the Board and its committees, or other Company functions at which the Chief Executive Officer requests the Non-Employee Director to participate. If the travel expense is related to the reimbursement of commercial airfare, such reimbursement will not exceed first class rates. If the travel expense is related to reimbursement of non-commercial air travel, such reimbursement shall not exceed the rate for comparable travel by means of commercial airlines.

ARTICLE 5
EQUITY COMPENSATION

5.1    EQUITY GRANTS.

(a)    Initial Stock Grant. Each Non-Employee Director shall receive, on the later of the Effective Date of the Plan or the first date he or she becomes a Non-Employee Director, an award of a number of Restricted Stock Units equal to the quotient of (x) $125,000 and (y) the closing price of the Common Stock on the New York Stock Exchange on such date, rounded up to the nearest whole unit. In no event will a director receive an initial award of shares if the next annual meeting of stockholders is within four months of the date he or she becomes a Non-Employee Director.
 
(b)    Annual Equity Grants. On the day following each annual meeting of the Company’s stockholders, each Non-Employee Director in service on that date will receive an award of a number of Restricted Stock Units equal to the quotient of (x) $125,000 and (y) the closing price of the Common Stock on the New York Stock Exchange on such day, rounded up to the nearest whole unit.






(c)    Source of Awards. The Restricted Stock Units described in this Article 5 shall be granted, and the shares of Common Stock underlying such Restricted Stock Units shall be issued, pursuant and subject to the terms and conditions of the Assurant, Inc. Long-Term Incentive Plan (the “ALTEIP”).

(d)    Award Agreements. All awards of Restricted Stock Units to a Non-Employee Director under the ALTEIP shall be evidenced by a written Award Agreement between the Company and the Non-Employee Director, which shall include such provisions, not inconsistent with the ALTEIP, as may be specified by the Board.

ARTICLE 6
AMENDMENT, MODIFICATION AND TERMINATION

6.1    AMENDMENT, MODIFICATION AND TERMINATION. The Board may, at any time and from time to time, amend, modify or terminate the Plan; provided, that no such amendment, modification or termination shall adversely affect awards outstanding as of the effective date of such amendment; provided, further, however, that if an amendment to the Plan would constitute a change requiring shareholder approval under applicable laws, policies or regulations or the applicable listing or other requirements of a securities exchange on which the Common Stock is listed or traded, then such amendment shall be subject to stockholder approval.



ARTICLE 7
GENERAL PROVISIONS

7.1    ELECTION TO DEFER PAYMENT. A Participant may elect to defer receipt of any cash payment under the Plan. Such election shall be made in writing and delivered to the plan administrator in compliance with, and such deferral shall be governed solely by the terms of, the Assurant, Inc. Deferred Compensation Plan.

7.2    RESTRICTIONS OF LENDERS. The Company’s obligations under the Plan shall be subject to, and may from time to time be prohibited by, agreements that may be in effect from time to time among or between the Company or its affiliates and their respective lenders. In the event that the Company would not be able to perform any of its agreements or fulfill any of its obligations hereunder without violating such a loan agreement, the Company shall be excused from such performance or fulfillment with no liability therefor to the Non-Employee Directors; provided that if and when such performance or fulfillment would no longer be such a violation, the Company shall have the obligation to complete such performance or fulfillment at that time.

7.3    DURATION OF THE PLAN. The Plan shall remain in effect until the day immediately following the 2018 annual meeting of Company’s stockholders, unless terminated earlier by the Board.

7.4    EXPENSES OF THE PLAN. The expenses of administering the Plan shall be borne by the Company.

7.5    GOVERNING LAW. To the extent not governed by federal law, the Plan and all Award Certificates shall be construed in accordance with and governed by the laws of the State of Delaware.






7.6    EFFECTIVE DATE. The Plan was originally adopted by the Board on October 15, 2003 and was approved by the sole stockholder on October 15, 2003. The Plan was amended by the Board on December 12, 2003, became effective on February 4, 2004 (the “Effective Date”), was amended and restated on June 3, 2005, amended on March 9, 2007, amended on November 9, 2007, amended and restated effective May 15, 2009, amended and restated effective January 1, 2010, amended and restated effective January 1, 2011, amended and restated effective January 1, 2013 and amended and restated effective May 13, 2016..


 
ASSURANT, INC.
 
 
 
/s/ Robyn Price Stonehill
By:
Robyn Price Stonehill
Title:
Executive Vice President, Chief Human Resources Officer






EXHIBIT 10.7



RETIREMENT AGREEMENT

THIS RETIREMENT AGREEMENT (this “Agreement”) is entered into as of June 29, 2016, by and between Assurant, Inc. (the “Company”) and Steven C. Lemasters (the “Employee”).

WHEREAS, the Employee holds the position of Executive Vice President of the Company and President and Chief Executive Officer of the Company’s Assurant Solutions;

WHEREAS, as of February 16, 2016, the Employee ceased to hold the position of President and Chief Executive Officer of Assurant Solutions but remained employed as Executive Vice President of the Company (the latter position and all offices and directorships that the Employee holds with any affiliate or subsidiary of the Company being hereafter referred to as the Employee’s “Executive Positions”);

WHEREAS, on July 1, 2016 (the “Retirement Date”), the Employee will retire and, without abrogating, diminishing or otherwise relinquishing any vested retirement or other benefits or payments to which the Employee is entitled under the terms of applicable plans and award agreements (except as provided in Section 2.A), the Employee and the Company wish to terminate the employment relationship between them on the terms set forth in this Agreement and to agree to certain post- employment covenants;

NOW, THEREFORE, in consideration of the mutual covenants, promises and representations in this Agreement and the execution of a release in the form attached as in Exhibit A hereto, the parties hereto agree as follows:

1.
Termination of Employment

The Employee’s employment with the Company shall cease effective as of the Retirement Date. As of the Retirement Date, the Employee resigns from his Executive Positions. From and after the Retirement Date, the Employee shall not hold any office or position with, nor maintain any other status as an employee or agent of, the Company or any subsidiary or affiliate of the Company. Effective on the Retirement Date, all agreements between the Employee and the Company or any subsidiary thereof are hereby terminated and shall be of no further force and effect, provided, however, that this sentence does not in any way limit and shall have no effect on any rights that the Employee may have, or on any obligations that the Company may have to the Employee, under the Company’s benefit plans (including qualified and nonqualified pension plans) as provided in Section 3, below or the Employee’s rights and entitlement to his awards previously granted under the Assurant Long-Term Equity Incentive Plan (“ALTEIP”) as provided in Section 4, below, in accordance with the terms of the ALTEIP and the applicable award agreements.
2.
Severance

A.Severance Amount. The Company shall pay to the Employee, as severance pay in connection with termination of employment, an aggregate amount of $1,170,000 (the “Severance Amount”).    The Severance Amount shall be payable in eighteen (18) consecutive monthly installments of $65,000





each, the first payment to be made on or around August 15, 2016 and the other payments to be made on the fifteenth (or the last business day immediately preceding the fifteenth) of each succeeding month thereafter. Each such payment shall be subject to applicable tax withholding requirements. The Severance Amount shall be in lieu of any other Severance Amounts to which the Employee may be entitled under the Assurant, Inc. Change of Control Employment Agreement for Divisional Officers by and between the Company and the Employee dated January 1, 2009 and under any other severance plan, program or policy of the Company or any subsidiary.

B.Pro-Rated Bonus.    As additional severance pay in connection with termination of employment, on the date of the first monthly payment made under Section 2.A, above, the Company shall pay to the Employee a lump sum of $292,500 (the “Pro-Rated Bonus”). The Pro- Rated Bonus is equal to a 2016 pro-rated bonus as of the Retirement Date at the Employee’s target incentive opportunity under the Company’s Executive Short-Term Incentive Plan (the “ESTIP”). For avoidance of doubt, the Employee shall not be entitled to any payment under the ESTIP on or after the Retirement Date. The Pro-Rated Bonus and the Severance Amount in Section 2.A are referred to herein as the “Severance Payments.

    C. Other Entitlements. The Employee shall retain his office and use of his administrative assistant through the Retirement Date and, in addition to the entitlements set forth in Sections 3 and 4, below, the Employee shall receive (i) his base salary which remains unpaid through the Retirement Date, and (ii) reimbursement for any unreimbursed business expenses accrued through the Retirement Date.

3.
Employee Benefits

A.Nonqualified Plans. The Employee shall be entitled to payment of his accrued benefits as of the Retirement Date pursuant to the terms of the Assurant Executive 401(k) Plan, the Assurant Executive Pension Plan, the Assurant Deferred Compensation Plan and the Assurant Supplemental Executive Retirement Plan (the “Plans”).

B.Payment in Lieu of COBRA Continuation. On the date of the first monthly payment made under Section 2, above, the Company shall pay to the Employee a lump sum of $38,631, to
provide the Employee with an amount that, after tax, will approximate eighteen (18) months of Company contributions toward any group medical, dental, vision and/or prescription drug plan benefits to which the Employee and/or the Employee’s eligible dependents would be entitled to under Section 4980B of the Internal Revenue Code (“COBRA”).

C.Other Benefits. Except as specifically provided herein, this Agreement shall have no effect on the rights of the Employee to payments or other benefits due to the Employee pursuant to the terms of any employee benefit plans of the Company, including, without limitation the tax- qualified pension plans and retiree medical plans in which the Employee participates, but not including the Company’s severance plan. The Employee shall be entitled to receive such benefits and payments to which the Employee is entitled pursuant to the terms of such employee benefit plans. No portion of the Severance Payments shall be taken into account in determining the amount of any such employee benefit. Within fifteen (15) days after the Retirement Date, the Company shall pay the Employee for his accrued but unused paid time off pursuant to the Company’s policy.

4.
Equity Rights

A.Trading Restrictions. Effective immediately following the Retirement Date, the Employee shall no longer be subject to the Company’s securities trading policies. The Employee is reminded, however, that trading on the basis of material non-public information, or providing such information to others so





that they may trade, may be a violation of the federal securities laws.

B.Stock Ownership Requirements. Effective immediately, the Employee shall no longer be subject to the Company’s stock ownership policy for the Company’s executive employees (but he shall be subject to the Company’s insider trading policies through and including the Retirement Date).

C. Treatment of Outstanding Long Term Incentive Awards. The Employee is entitled to “retirement” treatment under the ALTEIP, and, as such, all restricted stock units granted before 2016 (and any dividend equivalents accrued to date) shall fully vest on the Retirement Date and his performance share units shall fully vest on the Retirement Date subject to attainment of the applicable performance goals, with the delivery date for such awards as provided in the ALTEIP and the applicable award agreement.

5.
Employee Covenants

A.Confidential Information. The Employee shall not, (a) except as required by law or by order of a government agency or court of competent jurisdiction or in connection with any dispute between us, disclose to any person, firm, corporation or other business entity any Confidential Information (as defined herein) proprietary to the Company concerning the business, finances, products, services, operations, clients, employees, affairs or prospects of the Company or any subsidiary or affiliate thereof, for any reason or purpose whatsoever, or (b) make use of any Confidential Information for personal purposes or for the benefit of any person, firm, corporation or other entity except the Company or any subsidiary or affiliate thereof.    Confidential Information” means information not generally known or available outside the Company and information entrusted to the Company in confidence by third parties. Confidential Information includes but is not limited to Company inventions, technical data, trade secrets, know-how, research, product or service ideas or plans, software codes and designs, processes, network agreements, provider or network discounts, contract terms, formulas, techniques, lists of or information relating to suppliers, intermediaries (including brokers and agents) and customers, prices, costs, coverages, employee compensation arrangements, pricing methodologies, cost data, market share data, marketing plans, licenses, strategic plans, internal annual or long-term plans, program information, business plans, financial forecasts, non-public financial data, budgets and all other non-public business information disclosed to the Employee by the Company or of which the Employee learned while in the employ of the Company.

The Company and the Employee agree that all public or internal statements or announcements regarding the Employee’s departure from the Company, whether made by the Company, its officers and/or directors or the Employee will be consistent with the Employee’s decision to retire from the Company. Further, except as is necessary to obtain new employment or as required by law or by order of a government agency or court of competent jurisdiction, and/or in connection with any dispute between us. Unless and until this Agreement has been made public by filing with the Securities and Exchange Commission, the Employee will not disclose the contents or substance of this Agreement or the Release (as defined in Section 8 hereof) to anyone except his immediate family or any tax, legal or other counsel he has consulted regarding the meaning or effect hereof or thereof, and he will instruct each of the foregoing not to disclose the same. Within ten (10) calendar days following the Retirement Date, the Employee shall return to the Company any documents, records, files and other information (whether recorded or stored in paper or electronic form) and any property belonging or relating to the Company, its affiliates, customers, clients or employees. The Employee acknowledges that all such materials are, and will remain, the exclusive property of the Company, and the Employee may not retain originals or copies of such materials. Notwithstanding the foregoing, the Employee shall be entitled to retain his personal papers, photos, and work videos, his contact lists, and any information or documents relating to his compensation or which he reasonably believes is necessary for his personal tax return preparation.






B.Non-Solicitation. For a period of eighteen (18) months following the Retirement Date, the Employee shall not, whether on his own behalf or on behalf of or in conjunction with any other person or entity, acting in any capacity whatsoever, directly or indirectly, (1) solicit for employment or hire any employee who is employed by the Company or any subsidiary or affiliate thereof as of the Retirement Date or attempt to persuade or influence any such employee to leave the employ of the Company or any subsidiary or affiliate thereof or to be employed by (or to serve as an agent, consultant or independent contractor for) any other person or entity, or (2) solicit or attempt to persuade any actual (or, to the Employee’s actual or constructive knowledge, prospective) customer, client, agent, contractor or other party to a contractual or other business relationship with Assurant Solutions to discontinue or curtail such relationship in whole or in part or to replace such relationship in whole or in part with a business relationship with any other person or entity. For avoidance of doubt, the promises and prohibitions reflected in this Section 5.B shall apply without regard to whether the Employee or another party initiated the first communication regarding, or leading to, any solicitation or attempt to persuade that is prohibited by this Section 5.B. The parties agree and stipulate that, in connection with any dispute, litigation or other proceeding concerning any alleged or threatened violation of this Section 5.B, the issue of who initiated the first communication shall be irrelevant and immaterial and no evidence thereof shall be admitted or considered by the court or other tribunal charged with resolving or adjudicating such dispute, litigation or proceeding. For the avoidance of doubt, nothing herein shall prevent any person or entity from engaging in activities in which the Employee is prohibited from engaging hereunder as long as the Employee does not directly or indirectly provide any information or other assistance to such other person or entity in connection with such activities.

C.Non-Competition. For a period of eighteen (18) months following the Retirement Date, the Employee shall not, whether on his own behalf or on behalf of or in conjunction with any other person or entity, acting in any capacity whatsoever (including, but not limited to, as an owner of any business, except as a stockholder of a publicly held corporation of which the Employee beneficially owns no more than five percent of any class of equity security), in any geographic area where Assurant Solutions is operating as of the Retirement Date (or within 6 months prior thereof) directly or indirectly compete with Assurant Solutions (or with the businesses that comprised Assurant Solutions as of the Retirement Date, even if the Company no longer uses the term “Assurant Solutions” to identify the segment, such businesses being collectively referred to hereinafter as “Assurant Solutions”) for the business of, or for any direct commercial relationship with, any client, customer, contract holder, policyholder, broker, agent or other intermediary in any line of business in which Assurant Solutions is engaged as of the Retirement Date. For avoidance of doubt, the prohibitions of this Section 5.C include, but are not be limited to, a prohibition against the Employee’s engagement as a consultant to any competitor of Assurant Solutions within the scope of this Section 5.C. Notwithstanding the foregoing, following the Retirement Date, the Employee may be engaged as a consultant to or employee of a company that does not compete with Assurant Solutions but which may be an affiliate (but not a direct or indirect parent company) of a company that competes with Assurant Solutions (a “Competing Affiliate”), provided that (i) the Employee does not directly or indirectly provide services or information to, or supervise or advise any employee of, or serve on the Board of Directors of, or act as a consultant to, the Competing Affiliate, (ii) to the reasonable satisfaction of the Company, it has been demonstrated that commercially reasonable steps have been taken to prevent any direct or indirect communications between Employee and the Competing Affiliate, its employees, officers, executives, directors, consultants, independent contractors and agents concerning any potentially competitively sensitive information, and (iii) before the Employee undertakes any such activity, the Company, by its Chief Executive Officer or Chief Legal Officer, consents in writing to such activity, which consent shall not be unreasonably withheld.

D.Non-Disparagement. The Employee shall not publicly or privately disparage or denigrate





the Company, its subsidiaries, affiliates, employees, officers or directors in respect of their integrity, character, business practices, performance, skills, acumen, experience or success. The Company shall not, and shall direct its officers and directors not to, publicly or privately disparage or denigrate the Employee in respect of the Employee’s integrity, character, business practices, performance, skills, acumen, experience or success. The respective parties shall be responsible for, and bear any and all liability with respect to, any breach of this Section 5.D only if such breach is knowingly and willfully committed and involves a material public disparagement of the other party. Notwithstanding the foregoing, neither the Company nor the Employee shall be entitled to terminate, rescind, repudiate or seek judicial invalidation of this Agreement or any of its provisions as a remedy for any breach or alleged breach of this Section 5.D. and any person shall be permitted to make truthful statements to the extent (i) required by law or any court, or governmental, regulatory or self-regulatory agency or (ii) necessary in connection with any dispute between the Company or any subsidiary or affiliate of the Company and the Employee, which is governed by Section 6.C. or Section 10 of this Agreement.

E.Litigation Against the Company. The Employee shall not act as an expert witness, or consultant in any litigation against the Company or any of its subsidiaries or affiliates, except as a fact witness if legally compelled to do so by subpoena or other writ or order of a court or government agency of competent jurisdiction.

F.
No Other Restrictions. Except as expressly provided in this Section 5, there are
no other restrictions on the Employee’s activities following the Retirement Date and this Section 5 supersedes any similar restrictions in any other agreement, plan or policy applicable to the Employee or to which he is a party.

6.
Enforcement of Restrictions; Rights and Remedies

A.Reasonableness.    The Employee hereby acknowledges and agrees that: the restrictions provided in this Agreement are reasonable in time and scope in light of (i) the Company’s interest in protecting its business; and (ii) his ability to work and earn a living will not be unreasonably restrained by the application of these restrictions.

B.Injunctive Relief. The Employee recognizes and agrees that should he fail to materially comply with the restrictions set forth herein, which restrictions are vital to the protection of the Company’s business, the Company will suffer irreparable injury and harm for which there is no adequate remedy at law. Therefore, the Employee agrees that in the event of the breach or threatened breach by him of any of the terms and conditions of Sections 5.A, 5.B, 5.C or 5.D hereof, the Company shall be entitled to preliminary and permanent injunctive relief against him as may be awarded by a court having jurisdiction over the dispute in addition to, and not in lieu of, any other rights or remedies available to the Company at law or in equity.

C.All Other Disputes and All Other Relief. Except for disputes in which the Company seeks injunctive relief, and in connection with such disputes except insofar as required for injunctive relief, any disputes arising out of or relating to this Agreement - including but not limited to any dispute concerning its alleged breach, termination, validity, enforceability or interpretation thereof - shall be finally resolved by arbitration in accordance with the International Institute for Conflict Prevention and Resolution (“CPR”) Rules for Administered Arbitration (the “Administered Rules” or “Rules”) by a sole arbitrator. The arbitration shall be governed by the Federal Arbitration Act, 9 U.S.C. §§ 1 et seq., and judgment upon the award rendered by the arbitrator may be entered by any court having jurisdiction thereof. The place of the arbitration shall be New York, New York.






D.Conditions to Company’s Obligation to Make
Payments; Liquidated Damages and Setoff

i.
Conditions to Company’s Obligation to Make Payments. The consideration for the Company’s promises under Section 2 hereof are the Employee’s Release under Section 7 and Exhibit A hereof and each and every other promise that Employee makes herein. At every point in time, the Company’s obligation to make all not-yet-due payments under Section 2 hereof is expressly conditioned on the Employee’s not having materially breached Sections 5.A, 5.B, 5.C and 5.D hereof. In the event of a material breach by the Employee of any of the provisions of Sections 5.A, 5.B, 5.C or 5.D hereof, the Company shall have the right to cease making any future payments under Section 2 of this Agreement and no such payment shall be due or payable at any time thereafter; provided that the payments under Section 2 shall not be subject to such forfeiture unless the Company provides the Employee with written notice of acts or omissions giving rise to such forfeiture and, if curable, the Employee fails to cure such acts or omissions within ten (10) business days of receipt of such notice.

ii.
Liquidated Damages and Set-Off. The parties hereto acknowledge that the actual financial and monetary injury to the Company and its reputation that would result from Employee’s material breach of the provisions of Section 5.D hereof would be real and substantial but impossible to ascertain with precision or certainty. Therefore, they agree that if a court of law has entered a temporary restraining order or preliminary injunction in favor of the Company with respect to the Employee’s breach of Section 5.A., 5.B., 5.C., or 5.D, the Company may withhold any further payments otherwise due hereunder, up to a cumulative amount of one million dollars ($1,000,000) and that no further payment under Section 2 hereof shall be made unless and until the cumulative total of the payments withheld under this Subsection 6.D.ii is equal one million dollars ($1,000,000), provided, however, that if any such restraining order injunction is subsequently vacated or dissolved (and if the order vacating or dissolved such restraining order or injunction is not stayed, pending appeal or otherwise), without the entry of another permanent or continuing preliminary injunction, then the Company shall, within 10 business days of its receipt of the order dissolving or vacating such restraining order or injunction, pay to the Employee the total of all sums so withheld, plus five percent per annum simple interest (prorated as necessary for the applicable time period) on amounts withheld.

iii.
No Mitigation/No Other Offset. The Company acknowledges that the Employee shall not be required to mitigate damages by seeking other employment, and that except as expressly provided in this Section 6, there shall be no offset against any payments or entitlements due to the Employee whether under this Agreement or otherwise on account of any remuneration the Employee receives future employment (including self-employment) or on account of any claims the Company or any affiliate may have against him.

E.
Independence of Rights and Remedies. The rights and remedies enumerated in this Section 6 are and shall be independent of each other, and shall be severally enforced. Such rights and remedies shall be in addition to, and not in lieu of, any other rights or remedies available to the Company or the Employee at law or in equity, provided, however, that no damages at law shall be sought except in arbitration under Section 6.C hereof.






7.
Release of Claims

The parties shall execute a General Release and Covenant not to Sue in the form attached hereto as Exhibit A (the “Release”) no later than July 1, 2016. Notwithstanding anything contained herein to the contrary, the Company’s obligation to make the Severance Payments is conditioned on the Employee’s execution, delivery and non-revocation of the Release in the time period required herein and his compliance with the terms of the Release.
8.
Notices

All notices, requests and other communications pursuant to this Agreement shall be in writing and shall be deemed to have been duly given if delivered in person, by courier or sent by express, registered or certified mail, postage prepaid, addressed as follows:

If to the Employee:

Steven C. Lemasters

at his last known home address on file at Assurant or, following Assurant’s receipt of any change of address notice given by Employee, at the new address specified therein;

If to the Company:

Executive Vice President, Chief Legal Officer and Secretary Assurant, Inc.
28 Liberty Street 41st Floor
New York, NY 10005



Either party may, by written notice to the other, change the address to which notices to such party are to be delivered or mailed.

9.
Tax Matters

A.
Withholding of Taxes.

All Severance Payments and other benefits required to be provided by the Company to the Employee under this Agreement shall be subject to the withholding of such amounts relating to taxes and other payroll deductions as the Company may reasonably determine it should withhold pursuant to any applicable law, regulation or Company policy.

B.
Section 409A of the Internal Revenue Code.

The intent of the parties is that payments and benefits under this Agreement comply with Internal Revenue Code section 409A and applicable guidance promulgated thereunder (collectively, “Section 409A”). Accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance with Section 409A. In no event shall the Company be liable for any additional tax, interest or penalties that may be imposed on the Employee by the Internal Revenue Service under Section 409A or any damages for failing to comply with Section 409A, unless such tax, interest or penalties are imposed





on the Employee because of the
Company’s or any affiliate’s breach of this Agreement. Each monthly installment of the Severance Amount as provided in Section 2.A of this Agreement shall be considered a separate payment, as described in Treasury Regulations Section 1.409A-2(b)(2), for purposes of Section 409A. With respect to any payment constituting nonqualified deferred compensation subject to Section 409A: (A) all expenses or other reimbursements provided herein shall be payable in accordance with the Company’s policies in effect from time to time, but in any event shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by Employee; (B) no such reimbursement or expenses eligible for reimbursement in any taxable year shall in any way affect the expenses eligible for reimbursement in any other taxable year; and (C) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchanged for another benefit.

10.
Governing Law; Personal Jurisdiction and Venue

This Agreement shall be construed, interpreted and enforced in accordance with the laws the State of Georgia without giving effect to the choice of law principles thereof. The parties hereto agree that any action for injunctive relief to enforce any provision of this Agreement may be brought in any state or federal court in the Borough of Manhattan, New York, New York. Such parties hereby submit to the personal jurisdiction and venue of any such court in which any such action is brought. In addition, any such action for injunctive relief may be brought in any other court that otherwise has subjective matter jurisdiction, personal jurisdiction and venue in connection with such action.

11.
Waiver of Breach

No waiver of any provision of this Agreement shall have any force and effect unless it is in writing signed by the party giving the waiver. Any waiver or forbearance, express or implied, of any breach of this Agreement shall not be construed to be a continuing waiver or a consent to any other or subsequent breach on the part either of the Employee or of the Company.


12.
Non-Assignment; Successors

Neither party hereto may assign his or its rights or delegate his or its duties under this Agreement without the prior written consent of the other party; provided, however, that (i) this Agreement shall inure to the benefit of and be binding upon the successors and assigns of the Company upon any sale of all or substantially all of the Company’s assets, or upon any merger, consolidation or reorganization of the Company with or into any other corporation, all as though such successors and assigns of the Company and their respective successors and assigns were the Company, and (ii) this Agreement shall inure to the benefit of the heirs, assigns or designees of the Employee to the extent of any payments due to them hereunder. In the event the Employee dies while any payment or entitlement is due to him hereunder, such payment or entitlement shall be paid or provided to his spouse (or if she is not alive, his estate). In the event of any sale of all or substantially all of the Company’s assets or merger of the Company in which the Company is not the surviving entity, as used in this Agreement the term “Company” shall be deemed to refer to the surviving corporation, successor or assign of the Company; provided that, the references in Section 5 shall be construed to continue to apply only to the business of the Company (and its employees, clients and contractual relationships) immediately prior to such sale or merger.
13.
Severability and Intent for a Court to Enforce Covenants to Maximum Extent

If any provision of this Agreement is determined by a court of competent jurisdiction not to be fully





enforceable by injunctive relief, the Employee and the Company agree that it is the intention of the parties that such provision should be enforceable to the maximum extent allowable under applicable law. If any provision of this Agreement is held to be invalid or unenforceable, such invalidation or unenforceability shall not affect the validity or enforceability of any other provision of this Agreement (or any portion thereof). If, and only if, a court finds that Section 5.B or 5.C hereof is not enforceable to the full extent provided by its terms, the parties agree that such court may, and hereby memorialize their intention that such court shall, enforce such provisions by injunctive relief to the full geographic and temporal extent that such court may find permissible under applicable law.
14.
Indemnification

The Company represents and warrants that, in connection with any activities or circumstances concerning the Company (and its constituent parts), the Employee (and his legal representatives and heirs) will continue to be eligible to be indemnified on the same basis as senior executives of the Company or any affiliate are so indemnified with respect to third party claims and shall continue to be covered under directors’ and officers’ liability insurance policies on the same basis as senior executives of the Company are so covered until such time as suits can no longer be brought against the Employee as a matter of law.

15. Entire Agreement

This Agreement, together with the Mutual General Release and Covenant Not to Sue the form of which is set forth as Exhibit A hereto, constitutes the entire agreement by and between the Company and the Employee with respect to the subject matter hereof and supersedes any and all prior or contemporaneous agreements or understandings between the Employee and the Company with respect to such subject matter, whether written or oral. This Agreement may be amended or modified only in a written document executed by the Employee and the Company.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.


 
EMPLOYEE:
 
 
 
/s/ S. Craig Lemasters
 
Steven C. Lemasters
 
 
 
 
 
ASSURANT, INC.
 
 
By:
/s/ Alan Colberg
 
Alan Colberg
 
Chief Executive Officer and President






EXHIBIT A

MUTUAL GENERAL RELEASE AND COVENANT NOT TO SUE

THIS GENERAL RELEASE AND COVENANT NOT TO SUE (this
Release”) is entered into as of    •, 2016, by and between Steven C. Lemasters (the “Employee”) and Assurant, Inc. (the “Company”), pursuant to the terms of the Separation Agreement, dated as of     •, 2016, by and between the Employee and the Company, to which this Release is attached (the “Separation Agreement”).

1.Release by the Employee

The Employee hereby releases and forever discharges, and covenants not to sue, the Company or its subsidiaries, affiliates, their directors, members, officers, employees, agents, stockholders, successors and assigns, both individually and in their official capacities, (together, the “Company Released Parties”) from, and with respect to, any and all actions, causes of action, covenants, contracts, claims, demands, suits, and liabilities whatsoever, which the Employee ever had, now has or which his heirs, executors, administrators and assigns, or any of them hereafter can, shall or may have by reason of or related to the Employee’s employment with, or termination of employment from, the Company and/or its subsidiaries and affiliates.

By signing this Release, the Employee is providing a complete waiver of all claims against the Company Released Parties that may have arisen, whether known or unknown, up and until the effective date of this Release. This includes, but is not limited to, claims based on Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1866, the Age Discrimination in Employment Act of 1967 (including the Older Workers Benefit Protection Act) (the “ADEA”), the Americans With Disabilities Act, the Fair Labor Standards Act, the Equal Pay Act, the Family and Medical Leave Act, the Employee Retirement Income Security Act of 1974 (except as to claims pertaining to vested benefits under employee benefit plans maintained by the Company Released Parties), and all applicable amendments to the foregoing acts and laws, or any common law, public policy, contract (whether oral or written, express or implied) or tort law, and any other local, state or Federal law, regulation or ordinance having any bearing whatsoever on the terms and conditions of the Employee’s employment and the cessation thereof.

The Employee further agrees, promises and covenants that, to the maximum extent permitted by law neither, he, nor any person, organization, or other entity acting on his behalf has or will file, charge, claim, sue, or cause or permit to be filed, charged or claimed, any action for damages or other relief (including injunctive, declaratory, monetary or other relief) against the Company Released Parties involving any matter occurring in the past up to the date of this Release, or involving or based upon any claims, demands, causes of action, obligations, damages or liabilities which are the subject of this Release. This Release shall not affect the Employee’s rights under the Separation Agreement or under the Older Workers Benefit Protection Act to have a judicial determination of the validity of this Release and does not purport to limit any right the Employee may have to file a charge under the ADEA or other civil rights statute or to participate in an investigation or proceeding conducted by the Equal Employment Opportunity Commission or other investigative agency. This Release does, however, waive and release any right to recover damages under the ADEA or any other civil rights statute.

Notwithstanding anything to the contrary contained in this Release, nothing in this Section 1 shall apply to, or release the Company or any Company Released Party from, or prevent the Employee from suing with respect to, any rights and claims of the Employee directly or indirectly arising from or under





or related to any obligation or commitment of the Company under the Separation Agreement, any rights the Employee has as a Company shareholder or his rights to be indemnified and/or advanced expenses under the corporate documents of the Company and any affiliate or, if greater, under applicable law and to be covered under any applicable directors’ and officers’ insurance policies.

2.
Release by the Company

The Company on behalf of itself and its subsidiaries and affiliates hereby releases and forever discharges, and covenants not to sue, the Employee from, and with respect to, any and all actions, causes of action, covenants, contracts, claims, demands, suits, and liabilities whatsoever, which the Company ever had, now has or shall or may have by reason of or related to the Employee’s employment with, or termination of employment from, the Company and/or its subsidiaries and affiliates.

The Company on behalf of itself and its subsidiaries and affiliates further agrees, promises and covenants that, to the maximum extent permitted by law neither, they, nor any person, organization, or other entity acting on their behalf has or will file, charge, claim, sue, or cause or permit to be filed, charged or claimed, any action for damages or other relief (including injunctive, declaratory, monetary or other relief) against the Employee involving any matter occurring in the past up to the date of this Release, or involving or based upon any claims, demands, causes of action, obligations, damages or liabilities which are the subject of this Release.

Notwithstanding anything to the contrary contained in this Release, nothing in this Section 2 shall apply to, or release the Employee from, any rights and claims of the Company or its subsidiaries and affiliates, or any liability he may have to the Company, directly or indirectly arising from or related to the Separation Agreement, including, without limitation (i) any obligation or commitment of the Employee under the Separation Agreement, (ii) any breach of representation or covenant of the Employee under the Separation Agreement or (iii) any right of the Company to enforce the terms of the Separation Agreement.

3.
Construction

This Release shall be governed by and construed in accordance with the laws of the State of New York. If any provision in this Release is held invalid or unenforceable for any reason, the remaining provisions shall be construed as if the invalid or unenforceable provision(s) had not been included.

4.Consideration and Revocation Periods. The Employee has had at least 21 days to review and consider the terms of this Release. The terms of this release shall be effective if the Employee does not revoke it in writing within seven days of the date first written above.






IN WITNESS WHEREOF, the parties have executed this Release on the date first written above.


 
EMPLOYEE:
 
 
 
 
 
Steven C. Lemasters
 
 
 
 
 
ASSURANT, INC.
 
 
By:
 
 
Alan Colberg
 
Chief Executive Officer and President





EXHIBIT 12.1
ASSURANT, INC.
COMPUTATION OF RATIO OF CONSOLIDATED EARNINGS TO FIXED CHARGES
(in millions of U.S. dollars except for ratio amounts)

 
June 30,
2016
 
2015
 
2014
 
2013
 
2012
 
2011
Income before income taxes
$
573.0

 
$
201.2

 
$
744.1

 
$
789.7

 
$
757.8

 
$
706.2

Fixed charges
34.2

 
65.7

 
68.5

 
86.8

 
70.2

 
70.2

Income as adjusted
$
607.2

 
$
266.9

 
$
812.6

 
$
876.5

 
$
828.0

 
$
776.4

Fixed charges:
 
 
 
 
 
 
 
 
 
 
 
   Interest expense, including discount
      amortization and preferred stock dividends (1)
$
29.7

 
$
55.1

 
$
58.4

 
$
77.7

 
$
60.3

 
$
60.4

   Portion of rents representative of an appropriate
      interest factor
4.5

 
10.6

 
10.1

 
9.1

 
9.9

 
9.8

Total fixed charges
$
34.2

 
$
65.7

 
$
68.5

 
$
86.8

 
$
70.2

 
$
70.2

Ratio of consolidated earnings to fixed
  charges
17.75

 
4.06

 
11.86

 
10.10

 
11.79

 
11.06

_____________________________ 
(1)
Preferred stock issued is recorded as a liability, thus the corresponding dividend is recorded as interest expense.




EXHIBIT 31.1
CERTIFICATIONS
I, Alan B. Colberg, certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Assurant, Inc. for the period ended June 30, 2016;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.  The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: August 2, 2016

 
 
/s/ Alan B. Colberg
 
Alan B. Colberg
President, Chief Executive Officer and Director





EXHIBIT 31.2
CERTIFICATIONS
I, Richard S. Dziadzio, certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Assurant, Inc. for the period ended June 30, 2016;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.  The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: August 2, 2016


 
/s/ Richard S. Dziadzio
 
Richard S. Dziadzio
Executive Vice President, Chief Financial Officer and Treasurer





Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF
ASSURANT, INC.
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
§ 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Assurant, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Alan B. Colberg, President, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 2, 2016

 
 
/s/ Alan B. Colberg
 
Alan B. Colberg
President, Chief Executive Officer and Director





Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER OF
ASSURANT, INC.
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
§ 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Assurant, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard S. Dziadzio, Executive Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 2, 2016


 
/s/ Richard S. Dziadzio
 
Richard S. Dziadzio
Executive Vice President, Chief Financial Officer and Treasurer





Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings